data_2lur_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lur _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 89.9 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.828 0.347 . . . . 61.33 110.867 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.76 46.04 2.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 72.33 112.5 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.9 mp0 -139.82 -177.42 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 72.43 110.914 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.9 124.43 13.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 70.54 111.128 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.7 p -104.97 63.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 73.32 110.865 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.2 t -55.5 -25.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 75.11 111.155 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.07 -17.86 66.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.724 -0.75 . . . . 72.31 112.501 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.02 32.3 7.99 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 64.15 112.529 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -140.46 104.3 4.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 75.32 111.138 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.2 31.24 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 72.42 110.912 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -74.62 84.36 2.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.89 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.44 158.48 36.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.557 0.694 . . . . 72.14 111.146 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 87.63 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.66 2.24 . . . . 64.22 112.374 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.91 3.42 19.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.762 . . . . 50.45 112.497 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.71 151.23 42.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 64.01 110.909 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 p -124.01 160.55 27.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 65.13 111.151 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.1 t -85.39 142.55 29.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 61.4 110.907 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 19' ' ' TRP . 10.9 t -141.36 52.39 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 63.3 110.851 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 46.6 t90 -35.83 138.74 0.42 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.545 0.688 . . . . 64.15 110.941 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.4 Cg_endo -69.85 -36.85 2.19 Favored 'Cis proline' 0 C--O 1.232 0.187 0 C-N-CA 122.659 -1.809 . . . . 74.51 112.321 0.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 m -68.15 -170.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 75.15 111.129 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.3 t -150.96 140.96 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.915 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.83 -103.43 0.24 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.737 . . . . 54.12 112.519 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -139.75 -169.83 2.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.85 0.357 . . . . 74.34 110.812 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -108.06 -26.95 10.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.905 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -48.78 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 74.14 110.857 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -95.87 -68.47 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.929 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.0 32.48 3.52 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 65.23 112.487 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 63.1 111.127 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.896 0.379 . . . . 72.5 110.916 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.17 40.37 97.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 74.12 112.526 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -108.85 -178.85 3.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 74.12 110.934 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.89 143.35 32.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 73.02 111.148 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.72 20.36 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 73.11 110.884 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 p -50.98 -40.39 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 75.33 111.094 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.33 -1.61 69.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 61.23 112.487 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.79 56.49 18.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 73.55 112.483 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -150.37 43.81 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 75.53 111.125 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.1 p -125.91 56.38 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 64.14 110.886 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.3 121.42 32.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.32 110.859 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.67 158.72 64.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.62 0.724 . . . . 75.45 111.138 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 90.6 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.707 2.271 . . . . 74.43 112.332 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.94 1.64 23.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 64.03 112.481 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.57 157.84 32.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.881 0.372 . . . . 64.53 110.877 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.63 -175.16 2.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 74.51 111.143 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.3 t -118.83 142.27 47.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.432 . . . . 75.33 110.877 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 m -139.84 59.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.24 110.88 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.53 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 36.4 t90 -37.79 138.99 0.61 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.581 0.705 . . . . 71.24 110.929 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.74 -40.82 1.02 Allowed 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.71 -1.788 . . . . 74.13 112.334 0.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.74 -177.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 73.41 111.141 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.7 t -134.2 160.94 36.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 61.54 110.918 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.86 -95.93 0.5 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 74.45 112.481 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -149.38 -179.18 6.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 64.02 110.829 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -102.91 -28.37 12.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.33 110.846 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -83.2 -64.57 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 74.15 110.831 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -82.95 -69.03 0.66 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 73.12 110.865 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.15 44.83 2.71 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 50.4 112.511 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 71.24 111.116 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.906 0.384 . . . . 53.23 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.08 68.42 1.67 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 64.42 112.497 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -146.57 -177.29 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 74.33 110.892 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.46 151.15 30.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 72.44 111.162 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.6 t -150.09 28.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 70.12 110.825 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.55 -36.42 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.32 111.136 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.32 -10.59 81.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 73.11 112.478 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.08 7.93 76.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 53.33 112.492 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -111.49 88.66 2.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 74.44 111.204 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.2 t -150.25 47.77 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.908 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -90.16 113.56 25.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.899 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.17 158.62 75.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 72.51 111.125 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 87.63 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.734 2.289 . . . . 72.53 112.351 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.8 3.47 20.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 71.03 112.491 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 m -135.29 149.49 49.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.94 0.4 . . . . 74.34 110.839 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.21 179.36 4.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.178 -0.465 . . . . 70.14 111.11 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -102.7 144.49 31.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 62.32 110.91 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 19' ' ' TRP . 8.6 t -141.6 52.46 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 71.35 110.836 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.524 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 40.8 t90 -34.88 138.75 0.34 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.577 0.703 . . . . 74.42 110.899 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.8 Cg_endo -69.74 -38.51 1.6 Allowed 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.73 -1.779 . . . . 73.41 112.344 -0.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.09 -171.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 75.33 111.126 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.9 t -131.31 151.79 51.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 73.5 110.911 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.69 -97.98 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 72.32 112.533 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -148.03 -169.29 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 74.41 110.846 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -103.76 -17.46 15.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.857 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -100.51 -67.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.21 110.879 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -92.38 -69.65 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 74.15 110.902 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.18 76.49 0.86 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 74.34 112.479 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 73.42 111.133 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.927 0.394 . . . . 55.25 110.905 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.15 46.01 4.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 41.23 112.472 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -144.66 -179.67 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 73.03 110.942 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -145.83 139.15 26.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.171 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 1.431 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -128.05 79.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 64.54 110.913 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.28 -17.02 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 73.24 111.141 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.87 6.76 25.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.69 -0.766 . . . . 73.14 112.494 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.35 56.4 15.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 75.23 112.522 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -148.07 73.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 72.52 111.16 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.804 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 17.5 p -149.06 25.83 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 70.11 110.845 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -66.31 135.0 53.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.888 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.94 159.53 40.08 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.503 0.668 . . . . 75.43 111.196 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 79.9 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.638 2.225 . . . . 64.54 112.355 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.56 -0.22 5.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.757 . . . . 73.21 112.483 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.0 163.48 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.957 0.408 . . . . 72.44 110.849 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -133.04 175.17 9.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 74.12 111.178 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 28.0 t -101.5 155.32 18.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 71.05 110.884 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 19' ' ' TRP . 3.2 t -150.08 57.54 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 75.31 110.852 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.535 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 41.8 t90 -36.67 138.85 0.48 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.536 0.684 . . . . 75.12 110.863 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 54.2 Cg_endo -69.73 -38.83 1.49 Allowed 'Cis proline' 0 C--O 1.231 0.131 0 C-N-CA 122.712 -1.787 . . . . 74.13 112.346 -0.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.4 -169.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.175 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 1.431 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -150.11 155.31 39.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 75.21 110.891 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.06 -90.75 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 72.11 112.457 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -148.82 -174.53 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 73.3 110.905 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -109.89 -25.48 10.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 71.34 110.878 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -88.27 -67.67 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.23 110.888 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -76.07 -69.14 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 75.12 110.927 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.56 38.93 2.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 72.43 112.494 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 73.44 111.129 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.825 0.345 . . . . 72.23 110.869 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.21 43.55 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 74.54 112.449 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -148.77 -173.59 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 73.42 110.912 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.46 130.11 20.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 73.23 111.144 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.2 p -110.83 66.55 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 74.3 110.872 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.58 -27.17 20.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 75.53 111.119 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.35 -14.88 70.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 73.43 112.484 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.74 28.15 19.7 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 75.44 112.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -129.26 98.74 4.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.364 . . . . 64.12 111.186 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.1 20.78 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 73.33 110.862 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -71.38 84.73 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 73.3 110.879 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.22 158.85 34.06 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.557 0.694 . . . . 72.2 111.186 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 80.91 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.674 2.25 . . . . 73.55 112.346 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.03 1.31 6.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 61.05 112.489 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.93 156.54 43.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 72.21 110.871 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.97 168.66 13.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 71.1 111.11 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -92.88 147.27 22.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 71.22 110.837 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 19' ' ' TRP . 33.4 t -144.91 54.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.867 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.542 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 53.0 t90 -36.89 138.6 0.51 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 73.22 110.946 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.81 -37.79 1.86 Allowed 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 -1.811 . . . . 73.42 112.343 -0.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 m -66.09 -170.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 64.42 111.138 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.1 t -144.88 141.55 29.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 75.5 110.9 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.81 -91.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.758 . . . . 70.04 112.47 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -148.15 177.93 8.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 73.52 110.908 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -96.29 -26.28 15.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 74.53 110.89 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.69 -62.55 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 75.53 110.829 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -83.24 -68.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 70.44 110.927 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.2 49.14 0.89 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 60.35 112.469 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 72.33 111.121 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.902 0.382 . . . . 74.21 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.14 31.18 61.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 64.22 112.517 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.91 -169.41 1.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.944 0.402 . . . . 71.32 110.817 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.69 140.76 43.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 75.12 111.112 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.659 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.8 t -143.52 30.69 1.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 75.44 110.852 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.8 t -54.88 -29.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 73.33 111.172 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.73 -3.91 64.0 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.752 -0.737 . . . . 63.4 112.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.29 53.83 19.69 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.733 -0.746 . . . . 70.41 112.453 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -139.75 66.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 74.14 111.167 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.659 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 19.5 m -118.21 58.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 70.01 110.879 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -90.07 64.55 6.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 53.3 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.6 149.96 38.02 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.618 0.723 . . . . 74.25 111.151 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 92.79 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.677 2.251 . . . . 74.02 112.348 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.73 3.44 28.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 70.33 112.456 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 t -132.99 141.09 48.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 72.11 110.898 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.54 -179.69 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 65.3 111.114 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 t -103.09 142.16 34.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 73.45 110.86 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' TRP . 39.2 m -139.79 49.58 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 52.44 110.869 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.535 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 40.9 t90 -35.98 138.8 0.43 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.521 0.676 . . . . 74.12 110.961 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.5 Cg_endo -69.76 -35.28 2.75 Favored 'Cis proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.671 -1.804 . . . . 72.32 112.383 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 m -68.71 -170.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 52.04 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.3 t -132.43 156.93 45.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 62.24 110.89 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.79 -102.27 0.35 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 62.54 112.533 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -148.29 163.07 38.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 65.31 110.845 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -85.27 -25.47 27.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.55 110.904 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -86.27 -62.86 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 72.52 110.911 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -82.34 -69.0 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.952 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.95 49.22 1.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.696 -0.764 . . . . 74.33 112.492 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 73.22 111.118 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.891 0.377 . . . . 64.3 110.91 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.07 38.56 1.66 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 63.31 112.49 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -138.61 -175.04 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 75.23 110.889 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.09 128.47 17.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.42 111.15 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.4 p -108.27 61.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 75.45 110.866 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.0 t -52.56 -28.56 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.14 111.138 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.08 -28.22 70.7 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.723 -0.751 . . . . 71.31 112.477 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.21 27.88 6.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.773 -0.727 . . . . 60.51 112.492 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 t -149.87 119.34 6.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 72.33 111.094 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.41 67.1 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.42 110.904 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -90.18 85.62 6.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.33 110.906 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.89 154.93 41.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.711 . . . . 74.03 111.167 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 87.66 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.699 2.266 . . . . 73.43 112.329 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.86 7.19 29.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 73.43 112.41 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 m -140.15 159.26 42.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 75.33 110.927 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.16 177.42 6.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 75.1 111.095 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -93.78 144.11 25.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 64.23 110.895 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 19' ' ' TRP . 74.7 m -144.26 53.78 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.4 110.904 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.543 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 54.2 t90 -36.46 138.67 0.47 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.53 0.681 . . . . 74.34 110.924 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.5 Cg_endo -69.8 -37.62 1.92 Allowed 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.696 -1.793 . . . . 75.2 112.351 0.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.9 m -67.11 -169.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 74.34 111.127 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.6 t -149.33 141.03 23.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 62.35 110.869 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.92 -101.43 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 75.21 112.485 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -135.38 -170.61 2.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 71.53 110.858 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -106.41 -31.91 8.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.1 110.87 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -82.79 -64.41 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 75.1 110.858 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -81.23 -69.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.4 110.957 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.35 26.54 6.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 74.45 112.51 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 73.21 111.079 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.857 0.361 . . . . 74.51 110.888 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.82 66.58 0.67 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 52.42 112.481 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -141.43 174.34 10.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.419 . . . . 74.22 110.83 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.0 140.43 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 71.44 111.16 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.73 17.54 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 73.45 110.893 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.8 t -49.12 -49.4 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 74.41 111.091 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.85 -25.79 66.26 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.739 -0.743 . . . . 64.33 112.485 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.63 22.06 19.8 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.759 -0.734 . . . . 71.11 112.505 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -149.26 91.41 1.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 72.31 111.106 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p -149.35 30.35 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 73.02 110.905 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -58.97 128.69 38.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 72.32 110.893 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.14 155.42 70.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.556 0.693 . . . . 74.44 111.149 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 96.49 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 74.1 112.331 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.18 -1.19 29.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 75.24 112.512 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.6 m -127.06 143.84 51.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 75.42 110.891 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 p -114.83 134.51 55.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 62.31 111.16 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 t -60.0 136.42 58.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.911 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' TRP . 19.3 m -139.7 54.44 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 72.21 110.841 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.537 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 38.5 t90 -35.93 138.71 0.43 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.485 0.66 . . . . 73.43 110.945 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.537 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.79 -39.91 1.23 Allowed 'Cis proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.672 -1.803 . . . . 74.51 112.363 -0.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -63.7 -175.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.52 111.105 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.5 t -140.73 148.01 40.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.903 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.05 -75.81 0.37 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 51.5 112.482 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -151.87 -171.83 4.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 72.22 110.89 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -117.24 -33.67 4.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 72.11 110.858 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -80.31 -54.84 5.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.476 . . . . 75.4 110.85 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -88.47 -68.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.51 110.93 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.71 18.1 28.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.754 . . . . 73.15 112.484 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.901 0.381 . . . . 75.12 111.081 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 95.8 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.9 0.381 . . . . 73.11 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.04 44.26 5.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 73.42 112.489 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -148.41 175.82 10.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 74.4 110.876 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -143.85 125.12 14.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 75.34 111.17 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p -104.17 61.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 70.35 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -54.24 -26.4 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 72.12 111.158 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.76 -23.33 67.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 72.32 112.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.39 32.43 5.76 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 75.22 112.492 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -147.54 112.02 5.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 71.41 111.173 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 27.04 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 72.53 110.842 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -64.37 95.66 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.907 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.59 158.22 76.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.588 0.709 . . . . 75.11 111.1 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 94.26 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.71 2.273 . . . . 71.42 112.349 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.18 3.9 38.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 62.12 112.546 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.9 m -134.3 133.23 40.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 71.32 110.881 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -117.0 128.83 55.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.14 111.142 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -56.53 141.76 41.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 70.42 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' TRP . 2.8 t -144.35 53.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 73.12 110.832 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.543 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 52.9 t90 -35.79 138.67 0.42 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.558 0.694 . . . . 64.42 110.912 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.1 Cg_endo -69.77 -37.96 1.8 Allowed 'Cis proline' 0 C--N 1.341 0.137 0 C-N-CA 122.713 -1.786 . . . . 73.31 112.315 -0.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 m -67.89 -169.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 73.35 111.149 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 t -151.58 140.9 21.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.844 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.08 -92.25 0.15 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 44.23 112.469 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -148.78 -170.34 3.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 70.51 110.859 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.04 -38.43 3.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 71.25 110.887 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.66 -57.08 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 71.34 110.875 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -84.68 -69.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 74.13 110.89 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.74 44.44 2.47 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.739 -0.743 . . . . 73.44 112.487 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 75.24 111.131 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.864 0.364 . . . . 73.21 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.97 30.17 23.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 64.31 112.501 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -126.4 -175.76 3.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 74.14 110.875 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.16 127.79 16.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 74.22 111.142 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.5 p -108.38 61.8 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 71.53 110.866 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -53.09 -27.54 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.1 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.96 -26.33 69.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.739 . . . . 72.34 112.509 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.33 31.38 5.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 73.21 112.488 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 t -149.84 114.97 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 74.52 111.137 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.68 50.03 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 71.31 110.924 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -81.43 88.35 6.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 71.53 110.862 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.49 157.93 39.98 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.558 0.694 . . . . 73.01 111.183 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 90.11 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.273 . . . . 70.42 112.303 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.38 6.33 33.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 64.41 112.495 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.86 153.4 45.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 73.32 110.919 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -125.37 172.9 9.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 64.3 111.133 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.66 145.32 24.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.902 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 19' ' ' TRP . 46.0 m -144.9 54.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 72.05 110.871 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.553 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 52.5 t90 -36.54 138.85 0.47 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.543 0.687 . . . . 74.32 110.935 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.69 -37.83 1.84 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.722 -1.783 . . . . 60.22 112.35 -0.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 m -67.05 -170.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 74.54 111.123 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.5 t -148.58 141.17 24.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 74.43 110.935 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.4 -97.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 65.42 112.487 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -148.73 -170.22 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 64.52 110.873 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.09 -40.38 3.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.88 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -50.89 22.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 75.25 110.856 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -92.63 -69.22 0.76 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 73.4 110.888 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.89 49.67 1.24 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 63.12 112.512 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 75.45 111.08 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 CA--C 1.526 0.038 0 CA-C-O 120.882 0.372 . . . . 75.11 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.9 43.8 95.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.742 . . . . 72.1 112.473 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -112.43 -168.96 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 74.2 110.923 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.85 132.56 22.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 75.04 111.088 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 p -130.98 62.57 1.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 63.13 110.9 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.3 t -54.28 -30.23 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 73.25 111.153 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.71 -17.78 72.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 61.24 112.492 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.0 16.62 40.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 64.23 112.52 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.59 99.08 7.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 75.32 111.157 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.79 29.89 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 71.35 110.895 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -76.38 88.06 3.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 74.43 110.897 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.37 154.63 46.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.537 0.684 . . . . 71.21 111.182 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 84.53 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.701 2.267 . . . . 75.32 112.315 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.99 0.96 8.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 65.43 112.504 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.87 151.91 36.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 73.44 110.937 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -122.98 173.94 7.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.32 111.145 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.6 t -94.84 148.97 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 72.43 110.877 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 19' ' ' TRP . 4.7 t -144.93 53.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 70.03 110.867 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 44.3 t90 -33.77 138.35 0.29 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.54 0.686 . . . . 75.03 110.949 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.82 -40.44 1.11 Allowed 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 -1.809 . . . . 74.41 112.32 0.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 m -66.99 -170.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 73.11 111.152 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.1 t -138.85 148.35 43.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.45 110.903 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.73 -95.66 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.752 . . . . 62.5 112.505 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -151.31 -171.04 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 73.45 110.878 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -102.91 -22.29 13.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.883 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -96.08 -66.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 75.42 110.86 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -95.44 -69.5 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 74.21 110.925 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.01 79.0 0.71 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.726 -0.75 . . . . 63.44 112.479 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 75.0 111.121 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.89 0.376 . . . . 75.24 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.24 44.51 96.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.775 -0.726 . . . . 52.55 112.494 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.19 -176.13 3.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 75.22 110.891 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -147.18 137.32 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 73.35 111.117 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.03 81.12 2.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 74.14 110.844 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.77 -18.48 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.34 111.127 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.16 0.23 38.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 74.23 112.444 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.5 38.99 43.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.777 -0.725 . . . . 75.12 112.487 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.86 84.05 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 65.12 111.146 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -136.18 67.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.902 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -90.93 88.3 6.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.893 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.68 151.15 56.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 75.11 111.092 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 91.76 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.641 2.227 . . . . 75.43 112.324 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.67 6.68 46.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 73.42 112.512 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 147.22 50.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.949 0.404 . . . . 74.44 110.915 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -121.24 179.69 4.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.146 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.1 t -103.35 155.37 18.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 63.42 110.88 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' TRP . 72.3 m -150.29 54.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 71.23 110.85 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.534 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 48.9 t90 -35.91 138.58 0.43 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.596 0.713 . . . . 75.44 110.891 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 54.3 Cg_endo -69.73 -37.86 1.83 Allowed 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.691 -1.795 . . . . 65.24 112.354 -0.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 m -67.88 -168.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 72.54 111.115 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.69 167.19 23.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 70.42 110.879 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.46 -100.43 0.54 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 61.43 112.488 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.19 -173.37 3.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 65.23 110.842 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -103.07 -22.08 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.919 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -98.44 -66.96 0.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 73.34 110.859 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -92.58 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.95 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.81 77.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 51.12 112.521 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 71.2 111.121 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.876 0.369 . . . . 75.03 110.85 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.8 57.06 2.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 75.14 112.436 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -142.02 -169.54 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.39 . . . . 60.44 110.852 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.55 133.62 24.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 74.43 111.125 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 p -131.31 61.0 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 72.53 110.906 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.8 t -53.65 -30.83 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 72.54 111.144 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.63 -22.5 74.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 63.33 112.515 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.07 21.27 18.48 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.794 -0.717 . . . . 72.34 112.482 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -125.68 103.82 8.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 73.21 111.156 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.1 34.35 0.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.892 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -78.73 86.04 4.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.934 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.16 158.78 33.44 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.636 0.732 . . . . 72.21 111.098 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 85.34 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.695 2.264 . . . . 71.32 112.357 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.36 4.94 15.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 51.23 112.489 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 m -144.38 157.19 44.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 70.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 p -129.7 170.17 14.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 75.32 111.134 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -91.72 148.5 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 62.12 110.865 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 19' ' ' TRP . 13.6 m -145.35 53.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.892 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.538 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 44.3 t90 -33.81 138.4 0.29 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.548 0.69 . . . . 74.32 110.924 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.538 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.75 -40.03 1.2 Allowed 'Cis proline' 0 C--O 1.232 0.199 0 C-N-CA 122.688 -1.797 . . . . 65.34 112.346 -0.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -67.48 -170.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 74.41 111.154 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -141.13 144.99 35.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.904 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.89 -95.79 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 73.24 112.487 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -148.71 -169.31 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.845 0.355 . . . . 55.23 110.859 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -105.49 -27.75 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 73.54 110.865 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -96.33 -60.85 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 74.32 110.856 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -74.69 -68.86 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 75.44 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 38.47 6.05 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 54.33 112.436 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 74.44 111.095 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.882 0.372 . . . . 64.05 110.894 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.95 37.34 3.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 65.43 112.509 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -146.37 172.01 14.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.939 0.4 . . . . 71.45 110.903 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.6 124.39 25.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.12 111.109 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 1.202 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.9 m -90.27 51.72 2.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.5 110.833 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.1 t -45.78 -44.13 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.3 111.116 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.25 18.47 36.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 75.44 112.463 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.59 53.76 36.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.747 . . . . 44.34 112.492 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 t -149.95 72.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 73.44 111.148 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 1.212 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 31.6 p -150.11 35.18 0.66 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 71.44 110.894 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -73.43 123.56 24.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.896 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.85 159.29 71.96 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.607 0.718 . . . . 74.42 111.143 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 82.64 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 75.33 112.311 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.21 2.16 8.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 71.0 112.527 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.97 158.29 44.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 71.51 110.868 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.74 178.38 5.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 72.12 111.176 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 1.212 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -99.98 151.08 21.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 63.12 110.882 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' TRP . 19.4 m -148.56 56.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 73.13 110.862 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.531 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 37.0 t90 -37.29 138.88 0.55 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.545 0.688 . . . . 74.54 110.878 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.531 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.74 -39.99 1.2 Allowed 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.706 -1.789 . . . . 72.02 112.341 -0.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.81 -170.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.132 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.822 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 20.0 t -139.59 154.01 47.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 72.22 110.867 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.85 -99.35 0.24 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.741 -0.742 . . . . 71.31 112.511 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -149.47 -169.75 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 75.51 110.872 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -101.74 -21.37 14.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 73.22 110.867 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -93.11 -74.75 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 73.03 110.85 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -69.27 -68.76 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.897 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.62 38.38 5.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 61.12 112.515 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 75.13 111.1 -179.929 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.896 0.379 . . . . 61.53 110.927 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.19 59.26 8.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 74.05 112.451 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -137.17 -173.03 3.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 74.5 110.901 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.57 128.24 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 72.11 111.143 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.4 p -124.57 53.47 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 64.41 110.884 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.4 m -52.69 -32.46 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 72.33 111.152 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.84 -25.13 74.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 74.53 112.503 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.53 40.58 3.15 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 75.53 112.496 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -148.83 103.02 3.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 73.43 111.197 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.18 33.69 0.66 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 75.31 110.924 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -80.1 84.29 5.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 70.45 110.912 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.31 158.23 35.86 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.581 0.705 . . . . 74.33 111.163 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 85.23 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 74.0 112.353 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.87 3.71 13.37 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 62.01 112.462 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.1 m -142.75 151.91 41.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 74.42 110.864 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 p -125.94 164.63 20.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 70.33 111.137 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.79 147.56 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.884 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 19' ' ' TRP . 16.0 m -145.26 53.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 71.51 110.835 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.539 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 41.5 t90 -34.24 138.32 0.32 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.542 0.686 . . . . 72.33 110.936 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.73 -40.44 1.1 Allowed 'Cis proline' 0 C--N 1.342 0.199 0 C-N-CA 122.721 -1.783 . . . . 75.22 112.345 -0.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.11 -170.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 72.05 111.144 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.1 t -144.95 142.88 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 72.44 110.897 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.35 -96.23 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.787 -0.72 . . . . 73.4 112.485 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -148.25 -171.4 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 73.53 110.875 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -105.22 -27.49 11.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 71.34 110.844 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -89.77 -70.03 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.31 110.887 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -73.18 -68.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.844 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.39 37.97 4.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 63.42 112.436 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 74.3 111.121 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.877 0.37 . . . . 64.33 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.08 45.95 2.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.727 -0.749 . . . . 70.42 112.491 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -139.18 -176.13 4.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 75.44 110.914 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.5 127.8 17.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.18 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 p -107.13 64.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 65.33 110.849 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.4 t -55.26 -25.79 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 72.52 111.152 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.82 -18.56 67.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 73.15 112.466 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.36 31.8 8.17 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.777 -0.725 . . . . 71.42 112.47 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 t -140.93 105.41 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 75.23 111.157 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 26.77 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 70.34 110.898 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -70.14 102.22 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 75.23 110.886 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.68 158.15 76.22 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.527 0.68 . . . . 72.41 111.149 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 88.68 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.692 2.261 . . . . 73.13 112.319 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.45 2.33 19.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 72.41 112.479 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 146.19 30.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.387 . . . . 62.21 110.849 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 p -122.0 165.47 15.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 75.24 111.176 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.2 t -88.23 143.22 27.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 62.35 110.888 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' TRP . 5.1 t -142.1 53.04 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.35 110.818 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 47.1 t90 -35.97 138.74 0.43 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.538 0.685 . . . . 75.54 110.918 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.73 -37.57 1.93 Allowed 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 -1.785 . . . . 73.45 112.337 -0.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 m -67.31 -170.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 74.33 111.132 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.0 t -149.73 140.78 22.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 72.12 110.894 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.22 -103.92 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.757 -0.735 . . . . 73.33 112.518 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -137.16 -172.32 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.82 0.343 . . . . 74.32 110.846 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -105.63 -25.99 12.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.881 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -57.51 3.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 74.51 110.89 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -101.51 -84.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.915 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.73 54.85 0.13 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 61.14 112.475 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 75.51 111.126 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.6 m . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.914 0.387 . . . . 73.12 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.05 37.52 25.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 71.13 112.49 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.7 -178.2 3.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 73.11 110.88 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.87 151.13 26.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.34 111.12 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 t -150.31 23.26 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.864 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.8 t -51.76 -39.56 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 75.24 111.1 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.53 20.85 47.66 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.78 -0.724 . . . . 72.13 112.485 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.27 19.31 39.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 72.45 112.484 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -113.11 80.39 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 75.1 111.101 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 t -150.21 59.65 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.41 110.913 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -90.43 122.76 33.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.11 110.881 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.63 149.51 37.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.595 0.712 . . . . 74.52 111.168 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 96.49 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 73.34 112.359 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.62 4.55 36.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 73.21 112.461 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.8 t -128.49 144.49 51.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 72.3 110.907 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.48 177.78 4.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 73.51 111.131 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.8 t -101.98 143.83 31.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.876 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 19' ' ' TRP . 54.7 m -141.28 50.75 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 62.32 110.827 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.54 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 39.6 t90 -34.49 138.74 0.32 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.587 0.708 . . . . 75.3 110.934 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.54 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.8 Cg_endo -69.79 -37.5 1.96 Allowed 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.707 -1.789 . . . . 71.11 112.353 -0.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -68.5 -170.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.134 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -135.45 157.04 47.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 74.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.01 -107.15 0.46 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 51.22 112.495 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -147.79 -171.64 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 54.22 110.861 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.44 -34.55 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.881 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -50.79 16.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 74.34 110.874 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -93.88 -69.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 72.34 110.931 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.08 37.01 2.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 74.02 112.503 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.37 . . . . 73.13 111.14 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.902 0.382 . . . . 54.5 110.854 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 128.82 -22.44 5.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 62.04 112.472 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -91.14 175.85 6.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 74.24 110.885 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -109.73 160.18 16.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 74.33 111.108 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.3 t -126.84 35.59 4.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 73.3 110.867 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -46.91 -54.9 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.42 111.146 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.17 -25.02 65.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 73.14 112.495 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.9 26.05 18.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 55.14 112.52 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -147.75 97.89 2.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.354 . . . . 72.05 111.144 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.8 p -150.22 23.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 64.42 110.876 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -51.93 121.77 7.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.93 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.54 159.3 73.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.622 0.725 . . . . 72.52 111.124 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 80.4 0.89 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.712 2.275 . . . . 73.24 112.335 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.4 2.67 6.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 53.05 112.445 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.1 156.94 44.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 74.22 110.868 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -176.42 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.35 111.132 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.0 t -90.14 142.09 28.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.862 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 19' ' ' TRP . 15.2 m -141.35 51.89 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 65.04 110.838 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 34.4 t90 -34.53 138.99 0.32 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 75.3 110.921 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 54.4 Cg_endo -69.65 -39.88 1.23 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.712 -1.787 . . . . 74.33 112.36 -0.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 m -69.45 -169.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 73.42 111.113 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.6 t -130.64 149.22 52.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.52 110.855 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.09 -109.23 0.45 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 71.12 112.508 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -142.44 -170.46 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 75.24 110.891 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -102.02 -34.52 9.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.893 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -55.61 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 70.22 110.896 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -87.72 -68.32 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 65.3 110.913 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 43.72 2.19 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 53.42 112.482 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.6 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 71.41 111.161 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.882 0.372 . . . . 75.34 110.869 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 121.26 23.65 2.61 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.808 -0.711 . . . . 73.24 112.508 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.3 -172.83 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.941 0.4 . . . . 75.11 110.883 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -144.31 127.6 16.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 72.43 111.176 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.3 p -108.33 63.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 75.35 110.845 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.7 t -54.82 -26.3 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 74.21 111.136 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.49 -19.75 65.63 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 71.2 112.518 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.2 30.46 7.8 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 64.44 112.556 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 t -139.63 107.18 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 73.33 111.132 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.54 37.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.876 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -73.81 75.59 1.61 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 72.14 110.866 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.39 154.45 48.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.575 0.702 . . . . 74.1 111.14 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 90.4 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.676 2.25 . . . . 75.12 112.352 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.28 4.83 25.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 61.04 112.472 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 52.2 t -140.19 103.95 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 62.34 110.894 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.29 127.5 36.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 74.51 111.13 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.2 t -52.32 138.02 27.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.852 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 19' ' ' TRP . 15.1 m -144.01 53.5 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 71.31 110.869 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.543 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 53.2 t90 -34.1 138.61 0.3 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.589 0.709 . . . . 75.44 110.882 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.4 Cg_endo -69.78 -39.51 1.32 Allowed 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.673 -1.803 . . . . 61.53 112.314 -0.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.52 -168.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 73.04 111.132 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 21.1 t -150.86 139.2 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 72.24 110.874 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.75 -94.45 0.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 52.34 112.487 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -148.65 -170.3 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 75.31 110.863 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.39 -37.27 4.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 73.01 110.908 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -51.47 13.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 74.14 110.906 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -93.91 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 73.23 110.944 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.76 37.39 1.57 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 63.35 112.478 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 64.42 111.137 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.855 0.359 . . . . 71.34 110.904 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.64 21.04 73.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 73.2 112.504 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -117.92 -172.19 2.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.99 0.424 . . . . 74.51 110.844 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.09 130.09 17.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 70.44 111.15 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.5 p -110.64 59.88 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 75.31 110.86 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -51.28 -36.6 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 73.45 111.134 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.13 -29.11 74.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 73.12 112.547 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.42 37.01 3.16 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 65.42 112.482 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -149.96 109.8 4.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 72.41 111.159 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.0 28.12 0.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 73.32 110.912 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -72.1 81.33 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.874 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.07 158.84 31.56 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.593 0.711 . . . . 73.21 111.154 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 85.02 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.648 2.232 . . . . 74.11 112.352 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.15 3.9 12.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 65.35 112.458 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 154.76 43.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 74.42 110.888 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -127.57 157.07 41.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 62.34 111.139 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.7 t -78.71 145.07 34.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 72.42 110.876 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' TRP . 38.6 m -143.11 53.07 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 72.03 110.819 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.55 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 50.7 t90 -36.6 138.66 0.48 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.577 0.704 . . . . 75.44 110.892 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.55 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.74 -37.39 1.99 Allowed 'Cis proline' 0 C--N 1.342 0.204 0 C-N-CA 122.667 -1.805 . . . . 75.43 112.345 -0.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 m -67.71 -168.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 75.43 111.099 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.2 t -149.45 140.91 23.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 52.45 110.911 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.0 -92.4 0.14 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 62.22 112.486 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -150.78 -171.05 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.326 . . . . 75.52 110.891 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.63 -38.04 4.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 72.15 110.889 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -58.05 3.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 75.01 110.866 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -87.12 -69.3 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 63.34 110.922 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.17 57.7 0.95 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 72.2 112.517 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 71.51 111.14 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 89.9 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.828 0.347 . . . . 61.33 110.867 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.76 46.04 2.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 72.33 112.5 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.9 mp0 -139.82 -177.42 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 72.43 110.914 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.9 124.43 13.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 70.54 111.128 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.7 p -104.97 63.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 73.32 110.865 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.2 t -55.5 -25.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 75.11 111.155 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.07 -17.86 66.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.724 -0.75 . . . . 72.31 112.501 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.02 32.3 7.99 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 64.15 112.529 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -140.46 104.3 4.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 75.32 111.138 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.2 31.24 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 72.42 110.912 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -74.62 84.36 2.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.89 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.44 158.48 36.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.557 0.694 . . . . 72.14 111.146 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 87.63 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.66 2.24 . . . . 64.22 112.374 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.91 3.42 19.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.762 . . . . 50.45 112.497 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.71 151.23 42.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 64.01 110.909 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 p -124.01 160.55 27.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 65.13 111.151 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.1 t -85.39 142.55 29.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 61.4 110.907 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 19' ' ' TRP . 10.9 t -141.36 52.39 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 63.3 110.851 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 46.6 t90 -35.83 138.74 0.42 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.545 0.688 . . . . 64.15 110.941 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.4 Cg_endo -69.85 -36.85 2.19 Favored 'Cis proline' 0 C--O 1.232 0.187 0 C-N-CA 122.659 -1.809 . . . . 74.51 112.321 0.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 m -68.15 -170.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 75.15 111.129 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.3 t -150.96 140.96 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.915 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.83 -103.43 0.24 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.737 . . . . 54.12 112.519 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -139.75 -169.83 2.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.85 0.357 . . . . 74.34 110.812 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -108.06 -26.95 10.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.905 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -48.78 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 74.14 110.857 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -95.87 -68.47 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.929 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.0 32.48 3.52 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 65.23 112.487 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 63.1 111.127 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.896 0.379 . . . . 72.5 110.916 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.17 40.37 97.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 74.12 112.526 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -108.85 -178.85 3.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 74.12 110.934 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.89 143.35 32.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 73.02 111.148 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.72 20.36 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 73.11 110.884 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 p -50.98 -40.39 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 75.33 111.094 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.33 -1.61 69.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 61.23 112.487 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.79 56.49 18.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 73.55 112.483 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -150.37 43.81 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 75.53 111.125 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.1 p -125.91 56.38 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 64.14 110.886 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.3 121.42 32.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.32 110.859 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.67 158.72 64.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.62 0.724 . . . . 75.45 111.138 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 90.6 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.707 2.271 . . . . 74.43 112.332 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.94 1.64 23.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 64.03 112.481 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.57 157.84 32.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.881 0.372 . . . . 64.53 110.877 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.63 -175.16 2.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 74.51 111.143 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.3 t -118.83 142.27 47.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.432 . . . . 75.33 110.877 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 m -139.84 59.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.24 110.88 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.53 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 36.4 t90 -37.79 138.99 0.61 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.581 0.705 . . . . 71.24 110.929 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.74 -40.82 1.02 Allowed 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.71 -1.788 . . . . 74.13 112.334 0.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.74 -177.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 73.41 111.141 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.7 t -134.2 160.94 36.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 61.54 110.918 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.86 -95.93 0.5 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 74.45 112.481 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -149.38 -179.18 6.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 64.02 110.829 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -102.91 -28.37 12.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.33 110.846 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -83.2 -64.57 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 74.15 110.831 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -82.95 -69.03 0.66 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 73.12 110.865 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.15 44.83 2.71 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 50.4 112.511 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 71.24 111.116 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.906 0.384 . . . . 53.23 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.08 68.42 1.67 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 64.42 112.497 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -146.57 -177.29 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 74.33 110.892 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.46 151.15 30.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 72.44 111.162 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.6 t -150.09 28.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 70.12 110.825 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.55 -36.42 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.32 111.136 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.32 -10.59 81.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 73.11 112.478 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.08 7.93 76.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 53.33 112.492 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -111.49 88.66 2.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 74.44 111.204 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.2 t -150.25 47.77 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.908 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -90.16 113.56 25.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.899 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.17 158.62 75.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 72.51 111.125 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 87.63 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.734 2.289 . . . . 72.53 112.351 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.8 3.47 20.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 71.03 112.491 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 m -135.29 149.49 49.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.94 0.4 . . . . 74.34 110.839 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.21 179.36 4.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.178 -0.465 . . . . 70.14 111.11 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -102.7 144.49 31.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 62.32 110.91 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 19' ' ' TRP . 8.6 t -141.6 52.46 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 71.35 110.836 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.524 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 40.8 t90 -34.88 138.75 0.34 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.577 0.703 . . . . 74.42 110.899 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.8 Cg_endo -69.74 -38.51 1.6 Allowed 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.73 -1.779 . . . . 73.41 112.344 -0.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.09 -171.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 75.33 111.126 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.9 t -131.31 151.79 51.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 73.5 110.911 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.69 -97.98 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 72.32 112.533 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -148.03 -169.29 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 74.41 110.846 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -103.76 -17.46 15.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.857 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -100.51 -67.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.21 110.879 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -92.38 -69.65 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 74.15 110.902 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.18 76.49 0.86 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 74.34 112.479 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 73.42 111.133 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.927 0.394 . . . . 55.25 110.905 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.15 46.01 4.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 41.23 112.472 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -144.66 -179.67 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 73.03 110.942 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -145.83 139.15 26.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.171 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 1.431 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -128.05 79.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 64.54 110.913 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.28 -17.02 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 73.24 111.141 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.87 6.76 25.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.69 -0.766 . . . . 73.14 112.494 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.35 56.4 15.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 75.23 112.522 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -148.07 73.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 72.52 111.16 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.804 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 17.5 p -149.06 25.83 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 70.11 110.845 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -66.31 135.0 53.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.888 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.94 159.53 40.08 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.503 0.668 . . . . 75.43 111.196 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 79.9 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.638 2.225 . . . . 64.54 112.355 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.56 -0.22 5.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.757 . . . . 73.21 112.483 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.0 163.48 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.957 0.408 . . . . 72.44 110.849 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -133.04 175.17 9.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 74.12 111.178 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 28.0 t -101.5 155.32 18.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 71.05 110.884 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 19' ' ' TRP . 3.2 t -150.08 57.54 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 75.31 110.852 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.535 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 41.8 t90 -36.67 138.85 0.48 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.536 0.684 . . . . 75.12 110.863 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 54.2 Cg_endo -69.73 -38.83 1.49 Allowed 'Cis proline' 0 C--O 1.231 0.131 0 C-N-CA 122.712 -1.787 . . . . 74.13 112.346 -0.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.4 -169.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.175 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 1.431 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -150.11 155.31 39.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 75.21 110.891 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.06 -90.75 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 72.11 112.457 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -148.82 -174.53 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 73.3 110.905 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -109.89 -25.48 10.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 71.34 110.878 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -88.27 -67.67 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.23 110.888 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -76.07 -69.14 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 75.12 110.927 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.56 38.93 2.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 72.43 112.494 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 73.44 111.129 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.825 0.345 . . . . 72.23 110.869 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.21 43.55 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 74.54 112.449 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -148.77 -173.59 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 73.42 110.912 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.46 130.11 20.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 73.23 111.144 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.2 p -110.83 66.55 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 74.3 110.872 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.58 -27.17 20.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 75.53 111.119 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.35 -14.88 70.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 73.43 112.484 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.74 28.15 19.7 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 75.44 112.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -129.26 98.74 4.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.364 . . . . 64.12 111.186 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.1 20.78 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 73.33 110.862 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -71.38 84.73 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 73.3 110.879 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.22 158.85 34.06 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.557 0.694 . . . . 72.2 111.186 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 80.91 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.674 2.25 . . . . 73.55 112.346 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.03 1.31 6.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 61.05 112.489 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.93 156.54 43.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 72.21 110.871 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.97 168.66 13.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 71.1 111.11 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -92.88 147.27 22.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 71.22 110.837 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 19' ' ' TRP . 33.4 t -144.91 54.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.867 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.542 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 53.0 t90 -36.89 138.6 0.51 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 73.22 110.946 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.81 -37.79 1.86 Allowed 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 -1.811 . . . . 73.42 112.343 -0.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 m -66.09 -170.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 64.42 111.138 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.1 t -144.88 141.55 29.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 75.5 110.9 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.81 -91.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.758 . . . . 70.04 112.47 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -148.15 177.93 8.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 73.52 110.908 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -96.29 -26.28 15.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 74.53 110.89 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.69 -62.55 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 75.53 110.829 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -83.24 -68.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 70.44 110.927 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.2 49.14 0.89 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 60.35 112.469 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 72.33 111.121 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.902 0.382 . . . . 74.21 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.14 31.18 61.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 64.22 112.517 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.91 -169.41 1.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.944 0.402 . . . . 71.32 110.817 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.69 140.76 43.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 75.12 111.112 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.659 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.8 t -143.52 30.69 1.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 75.44 110.852 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.8 t -54.88 -29.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 73.33 111.172 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.73 -3.91 64.0 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.752 -0.737 . . . . 63.4 112.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.29 53.83 19.69 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.733 -0.746 . . . . 70.41 112.453 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -139.75 66.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 74.14 111.167 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.659 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 19.5 m -118.21 58.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 70.01 110.879 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -90.07 64.55 6.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 53.3 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.6 149.96 38.02 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.618 0.723 . . . . 74.25 111.151 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 92.79 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.677 2.251 . . . . 74.02 112.348 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.73 3.44 28.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 70.33 112.456 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 t -132.99 141.09 48.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 72.11 110.898 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.54 -179.69 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 65.3 111.114 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 t -103.09 142.16 34.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 73.45 110.86 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' TRP . 39.2 m -139.79 49.58 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 52.44 110.869 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.535 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 40.9 t90 -35.98 138.8 0.43 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.521 0.676 . . . . 74.12 110.961 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.5 Cg_endo -69.76 -35.28 2.75 Favored 'Cis proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.671 -1.804 . . . . 72.32 112.383 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 m -68.71 -170.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 52.04 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.3 t -132.43 156.93 45.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 62.24 110.89 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.79 -102.27 0.35 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 62.54 112.533 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -148.29 163.07 38.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 65.31 110.845 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -85.27 -25.47 27.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.55 110.904 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -86.27 -62.86 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 72.52 110.911 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -82.34 -69.0 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.952 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.95 49.22 1.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.696 -0.764 . . . . 74.33 112.492 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 73.22 111.118 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.891 0.377 . . . . 64.3 110.91 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.07 38.56 1.66 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 63.31 112.49 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -138.61 -175.04 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 75.23 110.889 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.09 128.47 17.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.42 111.15 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.4 p -108.27 61.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 75.45 110.866 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.0 t -52.56 -28.56 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.14 111.138 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.08 -28.22 70.7 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.723 -0.751 . . . . 71.31 112.477 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.21 27.88 6.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.773 -0.727 . . . . 60.51 112.492 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 t -149.87 119.34 6.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 72.33 111.094 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.41 67.1 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.42 110.904 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -90.18 85.62 6.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.33 110.906 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.89 154.93 41.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.711 . . . . 74.03 111.167 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 87.66 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.699 2.266 . . . . 73.43 112.329 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.86 7.19 29.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 73.43 112.41 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 m -140.15 159.26 42.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 75.33 110.927 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.16 177.42 6.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 75.1 111.095 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -93.78 144.11 25.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 64.23 110.895 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 19' ' ' TRP . 74.7 m -144.26 53.78 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.4 110.904 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.543 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 54.2 t90 -36.46 138.67 0.47 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.53 0.681 . . . . 74.34 110.924 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.5 Cg_endo -69.8 -37.62 1.92 Allowed 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.696 -1.793 . . . . 75.2 112.351 0.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.9 m -67.11 -169.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 74.34 111.127 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.6 t -149.33 141.03 23.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 62.35 110.869 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.92 -101.43 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 75.21 112.485 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -135.38 -170.61 2.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 71.53 110.858 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -106.41 -31.91 8.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.1 110.87 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -82.79 -64.41 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 75.1 110.858 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -81.23 -69.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.4 110.957 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.35 26.54 6.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 74.45 112.51 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 73.21 111.079 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.857 0.361 . . . . 74.51 110.888 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.82 66.58 0.67 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 52.42 112.481 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -141.43 174.34 10.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.419 . . . . 74.22 110.83 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.0 140.43 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 71.44 111.16 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.73 17.54 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 73.45 110.893 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.8 t -49.12 -49.4 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 74.41 111.091 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.85 -25.79 66.26 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.739 -0.743 . . . . 64.33 112.485 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.63 22.06 19.8 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.759 -0.734 . . . . 71.11 112.505 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -149.26 91.41 1.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 72.31 111.106 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p -149.35 30.35 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 73.02 110.905 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -58.97 128.69 38.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 72.32 110.893 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.14 155.42 70.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.556 0.693 . . . . 74.44 111.149 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 96.49 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 74.1 112.331 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.18 -1.19 29.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 75.24 112.512 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.6 m -127.06 143.84 51.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 75.42 110.891 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 p -114.83 134.51 55.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 62.31 111.16 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 t -60.0 136.42 58.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.911 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' TRP . 19.3 m -139.7 54.44 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 72.21 110.841 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.537 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 38.5 t90 -35.93 138.71 0.43 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.485 0.66 . . . . 73.43 110.945 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.537 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.79 -39.91 1.23 Allowed 'Cis proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.672 -1.803 . . . . 74.51 112.363 -0.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -63.7 -175.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.52 111.105 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.5 t -140.73 148.01 40.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.903 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.05 -75.81 0.37 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 51.5 112.482 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -151.87 -171.83 4.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 72.22 110.89 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -117.24 -33.67 4.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 72.11 110.858 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -80.31 -54.84 5.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.476 . . . . 75.4 110.85 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -88.47 -68.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.51 110.93 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.71 18.1 28.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.754 . . . . 73.15 112.484 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.901 0.381 . . . . 75.12 111.081 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 95.8 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.9 0.381 . . . . 73.11 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.04 44.26 5.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 73.42 112.489 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -148.41 175.82 10.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 74.4 110.876 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -143.85 125.12 14.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 75.34 111.17 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p -104.17 61.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 70.35 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -54.24 -26.4 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 72.12 111.158 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.76 -23.33 67.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 72.32 112.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.39 32.43 5.76 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 75.22 112.492 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -147.54 112.02 5.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 71.41 111.173 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 27.04 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 72.53 110.842 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -64.37 95.66 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.907 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.59 158.22 76.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.588 0.709 . . . . 75.11 111.1 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 94.26 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.71 2.273 . . . . 71.42 112.349 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.18 3.9 38.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 62.12 112.546 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.9 m -134.3 133.23 40.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 71.32 110.881 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -117.0 128.83 55.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.14 111.142 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -56.53 141.76 41.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 70.42 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' TRP . 2.8 t -144.35 53.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 73.12 110.832 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.543 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 52.9 t90 -35.79 138.67 0.42 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.558 0.694 . . . . 64.42 110.912 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.1 Cg_endo -69.77 -37.96 1.8 Allowed 'Cis proline' 0 C--N 1.341 0.137 0 C-N-CA 122.713 -1.786 . . . . 73.31 112.315 -0.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 m -67.89 -169.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 73.35 111.149 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 t -151.58 140.9 21.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.844 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.08 -92.25 0.15 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 44.23 112.469 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -148.78 -170.34 3.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 70.51 110.859 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.04 -38.43 3.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 71.25 110.887 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.66 -57.08 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 71.34 110.875 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -84.68 -69.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 74.13 110.89 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.74 44.44 2.47 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.739 -0.743 . . . . 73.44 112.487 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 75.24 111.131 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.864 0.364 . . . . 73.21 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.97 30.17 23.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 64.31 112.501 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -126.4 -175.76 3.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 74.14 110.875 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.16 127.79 16.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 74.22 111.142 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.5 p -108.38 61.8 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 71.53 110.866 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -53.09 -27.54 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.1 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.96 -26.33 69.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.739 . . . . 72.34 112.509 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.33 31.38 5.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 73.21 112.488 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 t -149.84 114.97 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 74.52 111.137 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.68 50.03 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 71.31 110.924 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -81.43 88.35 6.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 71.53 110.862 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.49 157.93 39.98 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.558 0.694 . . . . 73.01 111.183 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 90.11 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.273 . . . . 70.42 112.303 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.38 6.33 33.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 64.41 112.495 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.86 153.4 45.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 73.32 110.919 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -125.37 172.9 9.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 64.3 111.133 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.66 145.32 24.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.902 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 19' ' ' TRP . 46.0 m -144.9 54.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 72.05 110.871 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.553 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 52.5 t90 -36.54 138.85 0.47 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.543 0.687 . . . . 74.32 110.935 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.69 -37.83 1.84 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.722 -1.783 . . . . 60.22 112.35 -0.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 m -67.05 -170.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 74.54 111.123 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.5 t -148.58 141.17 24.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 74.43 110.935 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.4 -97.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 65.42 112.487 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -148.73 -170.22 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 64.52 110.873 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.09 -40.38 3.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.88 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -50.89 22.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 75.25 110.856 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -92.63 -69.22 0.76 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 73.4 110.888 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.89 49.67 1.24 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 63.12 112.512 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 75.45 111.08 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 CA--C 1.526 0.038 0 CA-C-O 120.882 0.372 . . . . 75.11 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.9 43.8 95.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.742 . . . . 72.1 112.473 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -112.43 -168.96 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 74.2 110.923 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.85 132.56 22.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 75.04 111.088 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 p -130.98 62.57 1.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 63.13 110.9 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.3 t -54.28 -30.23 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 73.25 111.153 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.71 -17.78 72.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 61.24 112.492 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.0 16.62 40.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 64.23 112.52 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.59 99.08 7.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 75.32 111.157 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.79 29.89 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 71.35 110.895 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -76.38 88.06 3.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 74.43 110.897 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.37 154.63 46.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.537 0.684 . . . . 71.21 111.182 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 84.53 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.701 2.267 . . . . 75.32 112.315 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.99 0.96 8.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 65.43 112.504 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.87 151.91 36.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 73.44 110.937 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -122.98 173.94 7.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.32 111.145 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.6 t -94.84 148.97 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 72.43 110.877 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 19' ' ' TRP . 4.7 t -144.93 53.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 70.03 110.867 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 44.3 t90 -33.77 138.35 0.29 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.54 0.686 . . . . 75.03 110.949 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.82 -40.44 1.11 Allowed 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 -1.809 . . . . 74.41 112.32 0.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 m -66.99 -170.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 73.11 111.152 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.1 t -138.85 148.35 43.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.45 110.903 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.73 -95.66 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.752 . . . . 62.5 112.505 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -151.31 -171.04 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 73.45 110.878 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -102.91 -22.29 13.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.883 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -96.08 -66.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 75.42 110.86 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -95.44 -69.5 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 74.21 110.925 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.01 79.0 0.71 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.726 -0.75 . . . . 63.44 112.479 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 75.0 111.121 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.89 0.376 . . . . 75.24 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.24 44.51 96.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.775 -0.726 . . . . 52.55 112.494 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.19 -176.13 3.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 75.22 110.891 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -147.18 137.32 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 73.35 111.117 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.03 81.12 2.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 74.14 110.844 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.77 -18.48 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.34 111.127 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.16 0.23 38.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 74.23 112.444 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.5 38.99 43.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.777 -0.725 . . . . 75.12 112.487 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.86 84.05 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 65.12 111.146 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -136.18 67.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.902 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -90.93 88.3 6.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.893 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.68 151.15 56.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 75.11 111.092 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 91.76 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.641 2.227 . . . . 75.43 112.324 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.67 6.68 46.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 73.42 112.512 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 147.22 50.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.949 0.404 . . . . 74.44 110.915 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -121.24 179.69 4.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.146 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.1 t -103.35 155.37 18.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 63.42 110.88 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' TRP . 72.3 m -150.29 54.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 71.23 110.85 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.534 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 48.9 t90 -35.91 138.58 0.43 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.596 0.713 . . . . 75.44 110.891 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 54.3 Cg_endo -69.73 -37.86 1.83 Allowed 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.691 -1.795 . . . . 65.24 112.354 -0.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 m -67.88 -168.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 72.54 111.115 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.69 167.19 23.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 70.42 110.879 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.46 -100.43 0.54 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 61.43 112.488 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.19 -173.37 3.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 65.23 110.842 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -103.07 -22.08 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.919 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -98.44 -66.96 0.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 73.34 110.859 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -92.58 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.95 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.81 77.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 51.12 112.521 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 71.2 111.121 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.876 0.369 . . . . 75.03 110.85 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.8 57.06 2.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 75.14 112.436 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -142.02 -169.54 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.39 . . . . 60.44 110.852 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.55 133.62 24.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 74.43 111.125 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 p -131.31 61.0 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 72.53 110.906 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.8 t -53.65 -30.83 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 72.54 111.144 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.63 -22.5 74.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 63.33 112.515 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.07 21.27 18.48 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.794 -0.717 . . . . 72.34 112.482 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -125.68 103.82 8.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 73.21 111.156 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.1 34.35 0.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.892 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -78.73 86.04 4.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.934 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.16 158.78 33.44 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.636 0.732 . . . . 72.21 111.098 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 85.34 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.695 2.264 . . . . 71.32 112.357 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.36 4.94 15.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 51.23 112.489 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 m -144.38 157.19 44.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 70.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 p -129.7 170.17 14.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 75.32 111.134 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -91.72 148.5 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 62.12 110.865 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 19' ' ' TRP . 13.6 m -145.35 53.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.892 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.538 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 44.3 t90 -33.81 138.4 0.29 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.548 0.69 . . . . 74.32 110.924 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.538 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.75 -40.03 1.2 Allowed 'Cis proline' 0 C--O 1.232 0.199 0 C-N-CA 122.688 -1.797 . . . . 65.34 112.346 -0.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -67.48 -170.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 74.41 111.154 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -141.13 144.99 35.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.904 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.89 -95.79 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 73.24 112.487 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -148.71 -169.31 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.845 0.355 . . . . 55.23 110.859 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -105.49 -27.75 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 73.54 110.865 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -96.33 -60.85 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 74.32 110.856 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -74.69 -68.86 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 75.44 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 38.47 6.05 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 54.33 112.436 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 74.44 111.095 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.882 0.372 . . . . 64.05 110.894 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.95 37.34 3.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 65.43 112.509 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -146.37 172.01 14.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.939 0.4 . . . . 71.45 110.903 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.6 124.39 25.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.12 111.109 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 1.202 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.9 m -90.27 51.72 2.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.5 110.833 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.1 t -45.78 -44.13 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.3 111.116 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.25 18.47 36.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 75.44 112.463 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.59 53.76 36.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.747 . . . . 44.34 112.492 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 t -149.95 72.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 73.44 111.148 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 1.212 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 31.6 p -150.11 35.18 0.66 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 71.44 110.894 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -73.43 123.56 24.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.896 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.85 159.29 71.96 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.607 0.718 . . . . 74.42 111.143 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 82.64 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 75.33 112.311 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.21 2.16 8.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 71.0 112.527 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.97 158.29 44.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 71.51 110.868 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.74 178.38 5.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 72.12 111.176 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 1.212 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -99.98 151.08 21.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 63.12 110.882 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' TRP . 19.4 m -148.56 56.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 73.13 110.862 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.531 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 37.0 t90 -37.29 138.88 0.55 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.545 0.688 . . . . 74.54 110.878 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.531 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.74 -39.99 1.2 Allowed 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.706 -1.789 . . . . 72.02 112.341 -0.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.81 -170.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.132 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.822 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 20.0 t -139.59 154.01 47.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 72.22 110.867 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.85 -99.35 0.24 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.741 -0.742 . . . . 71.31 112.511 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -149.47 -169.75 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 75.51 110.872 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -101.74 -21.37 14.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 73.22 110.867 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -93.11 -74.75 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 73.03 110.85 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -69.27 -68.76 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.897 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.62 38.38 5.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 61.12 112.515 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 75.13 111.1 -179.929 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.896 0.379 . . . . 61.53 110.927 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.19 59.26 8.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 74.05 112.451 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -137.17 -173.03 3.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 74.5 110.901 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.57 128.24 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 72.11 111.143 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.4 p -124.57 53.47 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 64.41 110.884 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.4 m -52.69 -32.46 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 72.33 111.152 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.84 -25.13 74.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 74.53 112.503 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.53 40.58 3.15 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 75.53 112.496 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -148.83 103.02 3.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 73.43 111.197 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.18 33.69 0.66 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 75.31 110.924 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -80.1 84.29 5.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 70.45 110.912 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.31 158.23 35.86 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.581 0.705 . . . . 74.33 111.163 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 85.23 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 74.0 112.353 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.87 3.71 13.37 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 62.01 112.462 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.1 m -142.75 151.91 41.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 74.42 110.864 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 p -125.94 164.63 20.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 70.33 111.137 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.79 147.56 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.884 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 19' ' ' TRP . 16.0 m -145.26 53.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 71.51 110.835 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.539 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 41.5 t90 -34.24 138.32 0.32 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.542 0.686 . . . . 72.33 110.936 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.73 -40.44 1.1 Allowed 'Cis proline' 0 C--N 1.342 0.199 0 C-N-CA 122.721 -1.783 . . . . 75.22 112.345 -0.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.11 -170.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 72.05 111.144 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.1 t -144.95 142.88 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 72.44 110.897 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.35 -96.23 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.787 -0.72 . . . . 73.4 112.485 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -148.25 -171.4 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 73.53 110.875 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -105.22 -27.49 11.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 71.34 110.844 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -89.77 -70.03 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.31 110.887 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -73.18 -68.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.844 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.39 37.97 4.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 63.42 112.436 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 74.3 111.121 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.877 0.37 . . . . 64.33 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.08 45.95 2.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.727 -0.749 . . . . 70.42 112.491 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -139.18 -176.13 4.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 75.44 110.914 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.5 127.8 17.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.18 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 p -107.13 64.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 65.33 110.849 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.4 t -55.26 -25.79 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 72.52 111.152 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.82 -18.56 67.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 73.15 112.466 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.36 31.8 8.17 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.777 -0.725 . . . . 71.42 112.47 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 t -140.93 105.41 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 75.23 111.157 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 26.77 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 70.34 110.898 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -70.14 102.22 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 75.23 110.886 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.68 158.15 76.22 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.527 0.68 . . . . 72.41 111.149 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 88.68 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.692 2.261 . . . . 73.13 112.319 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.45 2.33 19.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 72.41 112.479 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 146.19 30.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.387 . . . . 62.21 110.849 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 p -122.0 165.47 15.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 75.24 111.176 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.2 t -88.23 143.22 27.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 62.35 110.888 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' TRP . 5.1 t -142.1 53.04 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.35 110.818 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.54 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 47.1 t90 -35.97 138.74 0.43 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.538 0.685 . . . . 75.54 110.918 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.73 -37.57 1.93 Allowed 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 -1.785 . . . . 73.45 112.337 -0.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 m -67.31 -170.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 74.33 111.132 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.0 t -149.73 140.78 22.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 72.12 110.894 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.22 -103.92 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.757 -0.735 . . . . 73.33 112.518 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -137.16 -172.32 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.82 0.343 . . . . 74.32 110.846 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -105.63 -25.99 12.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.881 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -57.51 3.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 74.51 110.89 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -101.51 -84.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.915 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.73 54.85 0.13 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 61.14 112.475 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 75.51 111.126 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.6 m . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.914 0.387 . . . . 73.12 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.05 37.52 25.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 71.13 112.49 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.7 -178.2 3.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 73.11 110.88 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.87 151.13 26.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.34 111.12 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 t -150.31 23.26 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.864 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.8 t -51.76 -39.56 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 75.24 111.1 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.53 20.85 47.66 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.78 -0.724 . . . . 72.13 112.485 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.27 19.31 39.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 72.45 112.484 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -113.11 80.39 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 75.1 111.101 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 t -150.21 59.65 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.41 110.913 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -90.43 122.76 33.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.11 110.881 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.63 149.51 37.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.595 0.712 . . . . 74.52 111.168 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 96.49 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 73.34 112.359 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.62 4.55 36.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 73.21 112.461 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.8 t -128.49 144.49 51.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 72.3 110.907 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.48 177.78 4.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 73.51 111.131 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.8 t -101.98 143.83 31.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.876 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 19' ' ' TRP . 54.7 m -141.28 50.75 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 62.32 110.827 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.54 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 39.6 t90 -34.49 138.74 0.32 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.587 0.708 . . . . 75.3 110.934 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.54 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.8 Cg_endo -69.79 -37.5 1.96 Allowed 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.707 -1.789 . . . . 71.11 112.353 -0.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -68.5 -170.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.134 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -135.45 157.04 47.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 74.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.01 -107.15 0.46 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 51.22 112.495 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -147.79 -171.64 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 54.22 110.861 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.44 -34.55 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.881 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -50.79 16.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 74.34 110.874 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -93.88 -69.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 72.34 110.931 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.08 37.01 2.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 74.02 112.503 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.37 . . . . 73.13 111.14 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.902 0.382 . . . . 54.5 110.854 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 128.82 -22.44 5.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 62.04 112.472 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -91.14 175.85 6.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 74.24 110.885 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -109.73 160.18 16.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 74.33 111.108 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.3 t -126.84 35.59 4.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 73.3 110.867 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -46.91 -54.9 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.42 111.146 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.17 -25.02 65.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 73.14 112.495 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.9 26.05 18.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 55.14 112.52 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -147.75 97.89 2.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.354 . . . . 72.05 111.144 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.8 p -150.22 23.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 64.42 110.876 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -51.93 121.77 7.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.93 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.54 159.3 73.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.622 0.725 . . . . 72.52 111.124 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 80.4 0.89 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.712 2.275 . . . . 73.24 112.335 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.4 2.67 6.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 53.05 112.445 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.1 156.94 44.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 74.22 110.868 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -176.42 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.35 111.132 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.0 t -90.14 142.09 28.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.862 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 19' ' ' TRP . 15.2 m -141.35 51.89 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 65.04 110.838 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.556 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 34.4 t90 -34.53 138.99 0.32 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 75.3 110.921 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 54.4 Cg_endo -69.65 -39.88 1.23 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.712 -1.787 . . . . 74.33 112.36 -0.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 m -69.45 -169.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 73.42 111.113 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.6 t -130.64 149.22 52.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.52 110.855 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.09 -109.23 0.45 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 71.12 112.508 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -142.44 -170.46 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 75.24 110.891 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -102.02 -34.52 9.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.893 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -55.61 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 70.22 110.896 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -87.72 -68.32 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 65.3 110.913 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 43.72 2.19 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 53.42 112.482 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.6 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 71.41 111.161 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.882 0.372 . . . . 75.34 110.869 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 121.26 23.65 2.61 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.808 -0.711 . . . . 73.24 112.508 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.3 -172.83 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.941 0.4 . . . . 75.11 110.883 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -144.31 127.6 16.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 72.43 111.176 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.3 p -108.33 63.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 75.35 110.845 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.7 t -54.82 -26.3 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 74.21 111.136 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.49 -19.75 65.63 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 71.2 112.518 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.2 30.46 7.8 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 64.44 112.556 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 t -139.63 107.18 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 73.33 111.132 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.54 37.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.876 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -73.81 75.59 1.61 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 72.14 110.866 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.39 154.45 48.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.575 0.702 . . . . 74.1 111.14 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 90.4 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.676 2.25 . . . . 75.12 112.352 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.28 4.83 25.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 61.04 112.472 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 52.2 t -140.19 103.95 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 62.34 110.894 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.29 127.5 36.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 74.51 111.13 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.2 t -52.32 138.02 27.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.852 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 19' ' ' TRP . 15.1 m -144.01 53.5 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 71.31 110.869 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.543 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 53.2 t90 -34.1 138.61 0.3 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.589 0.709 . . . . 75.44 110.882 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.4 Cg_endo -69.78 -39.51 1.32 Allowed 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.673 -1.803 . . . . 61.53 112.314 -0.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.52 -168.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 73.04 111.132 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 21.1 t -150.86 139.2 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 72.24 110.874 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.75 -94.45 0.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 52.34 112.487 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -148.65 -170.3 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 75.31 110.863 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.39 -37.27 4.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 73.01 110.908 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -51.47 13.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 74.14 110.906 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -93.91 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 73.23 110.944 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.76 37.39 1.57 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 63.35 112.478 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 64.42 111.137 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.855 0.359 . . . . 71.34 110.904 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.64 21.04 73.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 73.2 112.504 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -117.92 -172.19 2.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.99 0.424 . . . . 74.51 110.844 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.09 130.09 17.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 70.44 111.15 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.5 p -110.64 59.88 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 75.31 110.86 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -51.28 -36.6 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 73.45 111.134 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.13 -29.11 74.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 73.12 112.547 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.42 37.01 3.16 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 65.42 112.482 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -149.96 109.8 4.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 72.41 111.159 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.0 28.12 0.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 73.32 110.912 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -72.1 81.33 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.874 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.07 158.84 31.56 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.593 0.711 . . . . 73.21 111.154 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 85.02 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.648 2.232 . . . . 74.11 112.352 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.15 3.9 12.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 65.35 112.458 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 154.76 43.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 74.42 110.888 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -127.57 157.07 41.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 62.34 111.139 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.7 t -78.71 145.07 34.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 72.42 110.876 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' TRP . 38.6 m -143.11 53.07 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 72.03 110.819 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.55 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 50.7 t90 -36.6 138.66 0.48 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.577 0.704 . . . . 75.44 110.892 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.55 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.74 -37.39 1.99 Allowed 'Cis proline' 0 C--N 1.342 0.204 0 C-N-CA 122.667 -1.805 . . . . 75.43 112.345 -0.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 m -67.71 -168.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 75.43 111.099 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.2 t -149.45 140.91 23.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 52.45 110.911 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.0 -92.4 0.14 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 62.22 112.486 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -150.78 -171.05 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.326 . . . . 75.52 110.891 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.63 -38.04 4.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 72.15 110.889 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -58.05 3.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 75.01 110.866 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -87.12 -69.3 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 63.34 110.922 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.17 57.7 0.95 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 72.2 112.517 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 71.51 111.14 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 89.9 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.828 0.347 . . . . 50.119999999999997 110.867 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.76 46.04 2.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 62.119999999999997 112.5 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.9 mp0 -139.82 -177.42 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 72.430000000000007 110.914 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.9 124.43 13.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 63.32 111.128 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.7 p -104.97 63.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 73.319999999999993 110.865 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.2 t -55.5 -25.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 75.109999999999999 111.155 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.07 -17.86 66.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.724 -0.75 . . . . 72.310000000000002 112.501 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.02 32.3 7.99 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 40.439999999999998 112.529 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 9' ' ' THR . 1.8 t -140.46 104.3 4.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 61.219999999999999 111.138 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.2 31.24 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 64.430000000000007 110.912 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -74.62 84.36 2.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 110.89 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.44 158.48 36.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.557 0.694 . . . . 72.030000000000001 111.146 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 87.63 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.66 2.24 . . . . 64.219999999999999 112.374 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.91 3.42 19.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.762 . . . . 50.450000000000003 112.497 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.71 151.23 42.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 64.010000000000005 110.909 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 p -124.01 160.55 27.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 65.129999999999995 111.151 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.1 t -85.39 142.55 29.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 61.399999999999999 110.907 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 19' ' ' TRP . 10.9 t -141.36 52.39 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 63.299999999999997 110.851 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.548 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 46.6 t90 -35.83 138.74 0.42 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.545 0.688 . . . . 64.150000000000006 110.941 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.4 Cg_endo -69.85 -36.85 2.19 Favored 'Cis proline' 0 C--O 1.232 0.187 0 C-N-CA 122.659 -1.809 . . . . 72.200000000000003 112.321 0.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 m -68.15 -170.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 75.150000000000006 111.129 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.3 t -150.96 140.96 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 110.915 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.83 -103.43 0.24 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.737 . . . . 54.119999999999997 112.519 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -139.75 -169.83 2.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.85 0.357 . . . . 74.340000000000003 110.812 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -108.06 -26.95 10.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.905 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -48.78 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 74.140000000000001 110.857 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -95.87 -68.47 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 73.450000000000003 110.929 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.0 32.48 3.52 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 42.109999999999999 112.487 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 29' ' ' VAL . 6.1 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 51.420000000000002 111.127 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.896 0.379 . . . . 71.219999999999999 110.916 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.17 40.37 97.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 54.409999999999997 112.526 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -108.85 -178.85 3.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 74.120000000000005 110.934 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.89 143.35 32.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 111.148 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.72 20.36 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 73.109999999999999 110.884 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 p -50.98 -40.39 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 75.329999999999998 111.094 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.33 -1.61 69.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 43.539999999999999 112.487 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.79 56.49 18.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 73.549999999999997 112.483 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -150.37 43.81 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 75.530000000000001 111.125 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.1 p -125.91 56.38 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 31.23 110.886 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.3 121.42 32.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.32 110.859 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.503 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -125.67 158.72 64.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.62 0.724 . . . . 75.450000000000003 111.138 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.503 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.2 Cg_endo -69.75 90.6 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.707 2.271 . . . . 63.329999999999998 112.332 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.94 1.64 23.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 53.229999999999997 112.481 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.57 157.84 32.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.881 0.372 . . . . 64.530000000000001 110.877 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.63 -175.16 2.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 74.510000000000005 111.143 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.3 t -118.83 142.27 47.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.432 . . . . 74.540000000000006 110.877 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 m -139.84 59.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.239999999999995 110.88 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.542 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 36.4 t90 -37.79 138.99 0.61 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.581 0.705 . . . . 71.239999999999995 110.929 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.74 -40.82 1.02 Allowed 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.71 -1.788 . . . . 74.129999999999995 112.334 0.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.74 -177.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 64.329999999999998 111.141 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.7 t -134.2 160.94 36.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 61.539999999999999 110.918 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.86 -95.93 0.5 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 54.409999999999997 112.481 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -149.38 -179.18 6.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 64.019999999999996 110.829 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -102.91 -28.37 12.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.329999999999998 110.846 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -83.2 -64.57 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 65.030000000000001 110.831 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -82.95 -69.03 0.66 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 110.865 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.15 44.83 2.71 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 25.030000000000001 112.511 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 62.240000000000002 111.116 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.906 0.384 . . . . 52.32 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.08 68.42 1.67 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 51.340000000000003 112.497 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -146.57 -177.29 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 74.329999999999998 110.892 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.46 151.15 30.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 72.439999999999998 111.162 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.6 t -150.09 28.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 61.520000000000003 110.825 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.55 -36.42 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.530000000000001 111.136 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.32 -10.59 81.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 64.219999999999999 112.478 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.08 7.93 76.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 34.229999999999997 112.492 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -111.49 88.66 2.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 74.439999999999998 111.204 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.2 t -150.25 47.77 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 62.009999999999998 110.908 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -90.16 113.56 25.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.899 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.49 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -132.17 158.62 75.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 72.040000000000006 111.125 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.49 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.7 Cg_endo -69.73 87.63 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.734 2.289 . . . . 72.530000000000001 112.351 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.8 3.47 20.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 71.030000000000001 112.491 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 m -135.29 149.49 49.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.94 0.4 . . . . 74.340000000000003 110.839 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.21 179.36 4.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.178 -0.465 . . . . 64.510000000000005 111.11 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -102.7 144.49 31.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 62.32 110.91 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 19' ' ' TRP . 8.6 t -141.6 52.46 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 70.319999999999993 110.836 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.542 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 40.8 t90 -34.88 138.75 0.34 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.577 0.703 . . . . 73.239999999999995 110.899 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.8 Cg_endo -69.74 -38.51 1.6 Allowed 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.73 -1.779 . . . . 64.140000000000001 112.344 -0.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.09 -171.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 64.340000000000003 111.126 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.9 t -131.31 151.79 51.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 73.5 110.911 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.69 -97.98 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 72.319999999999993 112.533 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -148.03 -169.29 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 74.409999999999997 110.846 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -103.76 -17.46 15.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.857 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -100.51 -67.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 65.329999999999998 110.879 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -92.38 -69.65 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 73.010000000000005 110.902 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.18 76.49 0.86 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 53.399999999999999 112.479 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 42.350000000000001 111.133 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.927 0.394 . . . . 55.25 110.905 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.15 46.01 4.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 33.240000000000002 112.472 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -144.66 -179.67 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 63.109999999999999 110.942 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -145.83 139.15 26.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.171 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 1.431 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -128.05 79.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 53.210000000000001 110.913 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.28 -17.02 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 73.239999999999995 111.141 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.87 6.76 25.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.69 -0.766 . . . . 71.150000000000006 112.494 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.35 56.4 15.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 75.230000000000004 112.522 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -148.07 73.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 71.340000000000003 111.16 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.804 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 17.5 p -149.06 25.83 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 70.109999999999999 110.845 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -66.31 135.0 53.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 55.030000000000001 110.888 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.94 159.53 40.08 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.503 0.668 . . . . 65.140000000000001 111.196 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 79.9 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.638 2.225 . . . . 53.210000000000001 112.355 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.56 -0.22 5.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.757 . . . . 73.209999999999994 112.483 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.0 163.48 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.957 0.408 . . . . 44.310000000000002 110.849 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -133.04 175.17 9.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 72.510000000000005 111.178 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 28.0 t -101.5 155.32 18.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 64.099999999999994 110.884 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 19' ' ' TRP . 3.2 t -150.08 57.54 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 62.409999999999997 110.852 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.546 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 41.8 t90 -36.67 138.85 0.48 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.536 0.684 . . . . 72.340000000000003 110.863 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 54.2 Cg_endo -69.73 -38.83 1.49 Allowed 'Cis proline' 0 C--O 1.231 0.131 0 C-N-CA 122.712 -1.787 . . . . 74.019999999999996 112.346 -0.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.4 -169.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 53.109999999999999 111.175 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 1.431 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -150.11 155.31 39.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 75.209999999999994 110.891 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.06 -90.75 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 72.109999999999999 112.457 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -148.82 -174.53 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 73.299999999999997 110.905 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -109.89 -25.48 10.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 71.340000000000003 110.878 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -88.27 -67.67 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.230000000000004 110.888 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -76.07 -69.14 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 75.120000000000005 110.927 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.56 38.93 2.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 72.430000000000007 112.494 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 72.319999999999993 111.129 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.825 0.345 . . . . 72.230000000000004 110.869 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.21 43.55 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 74.540000000000006 112.449 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -148.77 -173.59 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 72.209999999999994 110.912 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.46 130.11 20.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 72.439999999999998 111.144 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.2 p -110.83 66.55 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 74.299999999999997 110.872 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.58 -27.17 20.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 75.530000000000001 111.119 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.35 -14.88 70.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 73.430000000000007 112.484 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.74 28.15 19.7 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 62.340000000000003 112.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 9' ' ' THR . 1.7 t -129.26 98.74 4.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.364 . . . . 64.120000000000005 111.186 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.1 20.78 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.420000000000002 110.862 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -71.38 84.73 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 73.299999999999997 110.879 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.22 158.85 34.06 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.557 0.694 . . . . 64.310000000000002 111.186 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 80.91 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.674 2.25 . . . . 72.099999999999994 112.346 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.03 1.31 6.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 61.049999999999997 112.489 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.93 156.54 43.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 53.43 110.871 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.97 168.66 13.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 53.409999999999997 111.11 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -92.88 147.27 22.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 71.219999999999999 110.837 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 19' ' ' TRP . 33.4 t -144.91 54.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.340000000000003 110.867 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.555 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 53.0 t90 -36.89 138.6 0.51 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 73.219999999999999 110.946 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.555 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.81 -37.79 1.86 Allowed 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 -1.811 . . . . 73.420000000000002 112.343 -0.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 m -66.09 -170.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 45.399999999999999 111.138 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.1 t -144.88 141.55 29.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 62.43 110.9 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.81 -91.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.758 . . . . 70.040000000000006 112.47 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -148.15 177.93 8.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 73.519999999999996 110.908 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -96.29 -26.28 15.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 74.530000000000001 110.89 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.69 -62.55 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 75.530000000000001 110.829 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -83.24 -68.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 62.310000000000002 110.927 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.2 49.14 0.89 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 60.350000000000001 112.469 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 71.209999999999994 111.121 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.902 0.382 . . . . 71.200000000000003 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.14 31.18 61.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 64.219999999999999 112.517 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.91 -169.41 1.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.944 0.402 . . . . 71.319999999999993 110.817 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.69 140.76 43.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 75.120000000000005 111.112 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.659 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.8 t -143.52 30.69 1.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 75.439999999999998 110.852 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.8 t -54.88 -29.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 73.329999999999998 111.172 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.73 -3.91 64.0 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.752 -0.737 . . . . 62.229999999999997 112.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.29 53.83 19.69 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.733 -0.746 . . . . 70.409999999999997 112.453 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -139.75 66.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 74.140000000000001 111.167 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.659 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 19.5 m -118.21 58.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 70.010000000000005 110.879 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -90.07 64.55 6.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 53.299999999999997 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.638 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -104.6 149.96 38.02 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.618 0.723 . . . . 73.319999999999993 111.151 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.638 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.8 Cg_endo -69.74 92.79 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.677 2.251 . . . . 74.019999999999996 112.348 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.73 3.44 28.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 70.329999999999998 112.456 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 t -132.99 141.09 48.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 71.200000000000003 110.898 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -112.54 -179.69 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 53.149999999999999 111.114 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' H ' HG22 ' A' ' 16' ' ' THR . 34.1 t -103.09 142.16 34.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 73.450000000000003 110.86 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' TRP . 39.2 m -139.79 49.58 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 52.439999999999998 110.869 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.547 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 40.9 t90 -35.98 138.8 0.43 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.521 0.676 . . . . 74.120000000000005 110.961 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.5 Cg_endo -69.76 -35.28 2.75 Favored 'Cis proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.671 -1.804 . . . . 72.319999999999993 112.383 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 m -68.71 -170.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 44.109999999999999 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.3 t -132.43 156.93 45.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 62.240000000000002 110.89 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.79 -102.27 0.35 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 61.149999999999999 112.533 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -148.29 163.07 38.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 65.310000000000002 110.845 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -85.27 -25.47 27.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.549999999999997 110.904 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -86.27 -62.86 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 72.519999999999996 110.911 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -82.34 -69.0 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 110.952 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.95 49.22 1.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.696 -0.764 . . . . 74.329999999999998 112.492 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 73.219999999999999 111.118 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.891 0.377 . . . . 45.340000000000003 110.91 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.07 38.56 1.66 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 60.130000000000003 112.49 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -138.61 -175.04 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 65.230000000000004 110.889 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.09 128.47 17.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 65.409999999999997 111.15 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.4 p -108.27 61.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 75.450000000000003 110.866 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.0 t -52.56 -28.56 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 41.219999999999999 111.138 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.08 -28.22 70.7 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.723 -0.751 . . . . 54.450000000000003 112.477 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.21 27.88 6.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.773 -0.727 . . . . 60.509999999999998 112.492 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 t -149.87 119.34 6.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 72.329999999999998 111.094 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.41 67.1 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 54.200000000000003 110.904 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -90.18 85.62 6.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 72.319999999999993 110.906 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.89 154.93 41.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.711 . . . . 64.150000000000006 111.167 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 87.66 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.699 2.266 . . . . 73.430000000000007 112.329 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.86 7.19 29.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 73.430000000000007 112.41 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 m -140.15 159.26 42.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 71.310000000000002 110.927 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -128.16 177.42 6.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 72.409999999999997 111.095 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.416 ' H ' HG22 ' A' ' 16' ' ' THR . 42.2 t -93.78 144.11 25.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 64.230000000000004 110.895 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 19' ' ' TRP . 74.7 m -144.26 53.78 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.400000000000006 110.904 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.551 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 54.2 t90 -36.46 138.67 0.47 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.53 0.681 . . . . 74.340000000000003 110.924 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.5 Cg_endo -69.8 -37.62 1.92 Allowed 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.696 -1.793 . . . . 74.530000000000001 112.351 0.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.9 m -67.11 -169.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 74.150000000000006 111.127 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.6 t -149.33 141.03 23.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 62.350000000000001 110.869 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.92 -101.43 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 32.439999999999998 112.485 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -135.38 -170.61 2.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 71.530000000000001 110.858 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -106.41 -31.91 8.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 72.420000000000002 110.87 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -82.79 -64.41 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 65.230000000000004 110.858 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -81.23 -69.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.400000000000006 110.957 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.35 26.54 6.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 52.229999999999997 112.51 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 72.439999999999998 111.079 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.857 0.361 . . . . 74.150000000000006 110.888 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.82 66.58 0.67 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 21.239999999999998 112.481 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -141.43 174.34 10.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.419 . . . . 74.219999999999999 110.83 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.0 140.43 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 71.439999999999998 111.16 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.73 17.54 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 73.450000000000003 110.893 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.8 t -49.12 -49.4 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 74.409999999999997 111.091 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.85 -25.79 66.26 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.739 -0.743 . . . . 64.329999999999998 112.485 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.63 22.06 19.8 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.759 -0.734 . . . . 71.109999999999999 112.505 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -149.26 91.41 1.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 72.310000000000002 111.106 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p -149.35 30.35 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 73.019999999999996 110.905 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -58.97 128.69 38.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.893 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.574 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -140.14 155.42 70.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.556 0.693 . . . . 72.430000000000007 111.149 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.2 Cg_endo -69.78 96.49 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 74.099999999999994 112.331 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.18 -1.19 29.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 45.439999999999998 112.512 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.6 m -127.06 143.84 51.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 75.420000000000002 110.891 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 p -114.83 134.51 55.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 55.109999999999999 111.16 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 t -60.0 136.42 58.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 110.911 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' TRP . 19.3 m -139.7 54.44 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 52.340000000000003 110.841 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.547 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 38.5 t90 -35.93 138.71 0.43 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.485 0.66 . . . . 73.430000000000007 110.945 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.79 -39.91 1.23 Allowed 'Cis proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.672 -1.803 . . . . 64.329999999999998 112.363 -0.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -63.7 -175.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 111.105 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.5 t -140.73 148.01 40.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 62.299999999999997 110.903 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.05 -75.81 0.37 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 51.5 112.482 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -151.87 -171.83 4.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 43.340000000000003 110.89 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -117.24 -33.67 4.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 72.109999999999999 110.858 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -80.31 -54.84 5.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.476 . . . . 71.439999999999998 110.85 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -88.47 -68.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.430000000000007 110.93 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.71 18.1 28.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.754 . . . . 73.150000000000006 112.484 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.901 0.381 . . . . 63.450000000000003 111.081 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 95.8 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.9 0.381 . . . . 73.109999999999999 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.04 44.26 5.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 54.020000000000003 112.489 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -148.41 175.82 10.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 74.400000000000006 110.876 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -143.85 125.12 14.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 111.17 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p -104.17 61.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 61.210000000000001 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -54.24 -26.4 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 54.399999999999999 111.158 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.76 -23.33 67.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 72.319999999999993 112.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.39 32.43 5.76 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 75.219999999999999 112.492 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -147.54 112.02 5.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 71.409999999999997 111.173 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 27.04 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 72.530000000000001 110.842 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -64.37 95.66 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.907 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.5 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -132.59 158.22 76.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.588 0.709 . . . . 75.109999999999999 111.1 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.5 Cg_endo -69.81 94.26 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.71 2.273 . . . . 61.520000000000003 112.349 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.18 3.9 38.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 61.409999999999997 112.546 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.9 m -134.3 133.23 40.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 71.319999999999993 110.881 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -117.0 128.83 55.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.140000000000001 111.142 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -56.53 141.76 41.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 70.420000000000002 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' TRP . 2.8 t -144.35 53.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 73.109999999999999 110.832 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.551 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 52.9 t90 -35.79 138.67 0.42 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.558 0.694 . . . . 64.420000000000002 110.912 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.1 Cg_endo -69.77 -37.96 1.8 Allowed 'Cis proline' 0 C--N 1.341 0.137 0 C-N-CA 122.713 -1.786 . . . . 73.310000000000002 112.315 -0.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 m -67.89 -169.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 44.520000000000003 111.149 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 t -151.58 140.9 21.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 110.844 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.08 -92.25 0.15 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 44.229999999999997 112.469 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -148.78 -170.34 3.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 63.219999999999999 110.859 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.04 -38.43 3.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 71.25 110.887 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.66 -57.08 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 71.239999999999995 110.875 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -84.68 -69.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 74.129999999999995 110.89 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.74 44.44 2.47 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.739 -0.743 . . . . 51.240000000000002 112.487 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 55.409999999999997 111.131 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.864 0.364 . . . . 73.209999999999994 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.97 30.17 23.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 51.5 112.501 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -126.4 -175.76 3.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 74.140000000000001 110.875 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.16 127.79 16.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 74.219999999999999 111.142 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.5 p -108.38 61.8 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 71.530000000000001 110.866 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -53.09 -27.54 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.099999999999994 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.96 -26.33 69.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.739 . . . . 71.120000000000005 112.509 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.33 31.38 5.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 73.209999999999994 112.488 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 t -149.84 114.97 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 74.030000000000001 111.137 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.68 50.03 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 61.43 110.924 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -81.43 88.35 6.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 71.530000000000001 110.862 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.49 157.93 39.98 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.558 0.694 . . . . 73.010000000000005 111.183 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 90.11 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.273 . . . . 70.420000000000002 112.303 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.38 6.33 33.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 64.409999999999997 112.495 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.86 153.4 45.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 73.319999999999993 110.919 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -125.37 172.9 9.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 42.350000000000001 111.133 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.66 145.32 24.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 72.230000000000004 110.902 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 19' ' ' TRP . 46.0 m -144.9 54.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 72.049999999999997 110.871 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.555 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 52.5 t90 -36.54 138.85 0.47 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.543 0.687 . . . . 63.420000000000002 110.935 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.555 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.69 -37.83 1.84 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.722 -1.783 . . . . 51.520000000000003 112.35 -0.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 m -67.05 -170.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.319999999999993 111.123 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.5 t -148.58 141.17 24.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 110.935 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.4 -97.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 44.329999999999998 112.487 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -148.73 -170.22 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 60.329999999999998 110.873 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.09 -40.38 3.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 110.88 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -50.89 22.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 72.439999999999998 110.856 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -92.63 -69.22 0.76 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 110.888 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.89 49.67 1.24 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 44.130000000000003 112.512 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 73.530000000000001 111.08 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 CA--C 1.526 0.038 0 CA-C-O 120.882 0.372 . . . . 75.109999999999999 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.9 43.8 95.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.742 . . . . 72.099999999999994 112.473 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -112.43 -168.96 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 72.329999999999998 110.923 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.498 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -143.85 132.56 22.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 75.040000000000006 111.088 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 p -130.98 62.57 1.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 54.119999999999997 110.9 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.3 t -54.28 -30.23 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 63.43 111.153 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.71 -17.78 72.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 52.310000000000002 112.492 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.0 16.62 40.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 64.230000000000004 112.52 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.59 99.08 7.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 75.319999999999993 111.157 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.79 29.89 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 64.209999999999994 110.895 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -76.38 88.06 3.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 74.230000000000004 110.897 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.556 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -114.37 154.63 46.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.537 0.684 . . . . 63.530000000000001 111.182 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.556 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.3 Cg_endo -69.77 84.53 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.701 2.267 . . . . 75.319999999999993 112.315 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.99 0.96 8.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 65.430000000000007 112.504 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.87 151.91 36.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 73.439999999999998 110.937 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -122.98 173.94 7.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.319999999999993 111.145 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.6 t -94.84 148.97 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 62.549999999999997 110.877 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 19' ' ' TRP . 4.7 t -144.93 53.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 70.030000000000001 110.867 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.559 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 44.3 t90 -33.77 138.35 0.29 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.54 0.686 . . . . 75.030000000000001 110.949 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.82 -40.44 1.11 Allowed 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 -1.809 . . . . 74.409999999999997 112.32 0.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 4' ' ' THR . 14.9 m -66.99 -170.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 111.152 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.1 t -138.85 148.35 43.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.450000000000003 110.903 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.73 -95.66 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.752 . . . . 62.32 112.505 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -151.31 -171.04 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 63.310000000000002 110.878 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -102.91 -22.29 13.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 110.883 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -96.08 -66.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 75.420000000000002 110.86 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -95.44 -69.5 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 51.25 110.925 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.01 79.0 0.71 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.726 -0.75 . . . . 63.439999999999998 112.479 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 75.0 111.121 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.89 0.376 . . . . 75.239999999999995 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.24 44.51 96.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.775 -0.726 . . . . 30.420000000000002 112.494 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.19 -176.13 3.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 75.219999999999999 110.891 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -147.18 137.32 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 73.349999999999994 111.117 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.03 81.12 2.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 73.510000000000005 110.844 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.77 -18.48 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 71.530000000000001 111.127 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.16 0.23 38.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 74.230000000000004 112.444 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.5 38.99 43.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.777 -0.725 . . . . 75.120000000000005 112.487 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.86 84.05 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 61.109999999999999 111.146 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -136.18 67.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 41.100000000000001 110.902 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -90.93 88.3 6.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 72.019999999999996 110.893 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.595 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -121.68 151.15 56.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 75.109999999999999 111.092 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.595 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.7 Cg_endo -69.75 91.76 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.641 2.227 . . . . 70.530000000000001 112.324 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.67 6.68 46.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 72.430000000000007 112.512 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 147.22 50.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.949 0.404 . . . . 74.439999999999998 110.915 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -121.24 179.69 4.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 61.109999999999999 111.146 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.1 t -103.35 155.37 18.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 42.149999999999999 110.88 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' TRP . 72.3 m -150.29 54.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 71.230000000000004 110.85 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.545 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 48.9 t90 -35.91 138.58 0.43 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.596 0.713 . . . . 75.439999999999998 110.891 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 54.3 Cg_endo -69.73 -37.86 1.83 Allowed 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.691 -1.795 . . . . 53.439999999999998 112.354 -0.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 m -67.88 -168.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 72.540000000000006 111.115 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.69 167.19 23.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 45.439999999999998 110.879 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.46 -100.43 0.54 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 61.43 112.488 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.19 -173.37 3.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 65.230000000000004 110.842 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -103.07 -22.08 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.919 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -98.44 -66.96 0.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 73.019999999999996 110.859 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -92.58 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 75.230000000000004 110.95 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.81 77.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 51.119999999999997 112.521 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 71.140000000000001 111.121 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.876 0.369 . . . . 52.32 110.85 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.8 57.06 2.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 72.109999999999999 112.436 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -142.02 -169.54 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.39 . . . . 60.439999999999998 110.852 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -143.55 133.62 24.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 111.125 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 p -131.31 61.0 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 72.530000000000001 110.906 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.8 t -53.65 -30.83 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 72.540000000000006 111.144 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.63 -22.5 74.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 53.100000000000001 112.515 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.07 21.27 18.48 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.794 -0.717 . . . . 72.340000000000003 112.482 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 9' ' ' THR . 1.8 t -125.68 103.82 8.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 73.209999999999994 111.156 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.1 34.35 0.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 53.420000000000002 110.892 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -78.73 86.04 4.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.239999999999995 110.934 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.16 158.78 33.44 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.636 0.732 . . . . 72.209999999999994 111.098 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 85.34 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.695 2.264 . . . . 61.109999999999999 112.357 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.36 4.94 15.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 51.229999999999997 112.489 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 m -144.38 157.19 44.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 70.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 p -129.7 170.17 14.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 72.099999999999994 111.134 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -91.72 148.5 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 62.119999999999997 110.865 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 19' ' ' TRP . 13.6 m -145.35 53.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.892 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.553 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 44.3 t90 -33.81 138.4 0.29 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.548 0.69 . . . . 74.319999999999993 110.924 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.75 -40.03 1.2 Allowed 'Cis proline' 0 C--O 1.232 0.199 0 C-N-CA 122.688 -1.797 . . . . 65.340000000000003 112.346 -0.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.523 ' HA ' HG22 ' A' ' 4' ' ' THR . 13.9 m -67.48 -170.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 74.409999999999997 111.154 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -141.13 144.99 35.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 60.399999999999999 110.904 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.89 -95.79 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 40.219999999999999 112.487 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -148.71 -169.31 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.845 0.355 . . . . 55.229999999999997 110.859 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -105.49 -27.75 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 70.120000000000005 110.865 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -96.33 -60.85 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 72.25 110.856 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -74.69 -68.86 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 75.439999999999998 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 38.47 6.05 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 54.329999999999998 112.436 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 74.439999999999998 111.095 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.882 0.372 . . . . 64.049999999999997 110.894 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.95 37.34 3.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 65.430000000000007 112.509 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -146.37 172.01 14.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.939 0.4 . . . . 71.450000000000003 110.903 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.6 124.39 25.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 72.450000000000003 111.109 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 1.202 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.9 m -90.27 51.72 2.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.5 110.833 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.1 t -45.78 -44.13 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.299999999999997 111.116 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.25 18.47 36.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 75.439999999999998 112.463 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.59 53.76 36.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.747 . . . . 24.43 112.492 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 t -149.95 72.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 62.100000000000001 111.148 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 1.212 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 31.6 p -150.11 35.18 0.66 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 61.329999999999998 110.894 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -73.43 123.56 24.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 72.430000000000007 110.896 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.85 159.29 71.96 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.607 0.718 . . . . 63.299999999999997 111.143 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 82.64 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 71.319999999999993 112.311 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.21 2.16 8.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 55.420000000000002 112.527 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.97 158.29 44.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 63.43 110.868 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -122.74 178.38 5.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 65.540000000000006 111.176 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 1.212 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -99.98 151.08 21.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 50.030000000000001 110.882 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' TRP . 19.4 m -148.56 56.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 71.439999999999998 110.862 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.543 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 37.0 t90 -37.29 138.88 0.55 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.545 0.688 . . . . 74.540000000000006 110.878 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.74 -39.99 1.2 Allowed 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.706 -1.789 . . . . 70.239999999999995 112.341 -0.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.81 -170.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 111.132 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.822 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 20.0 t -139.59 154.01 47.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 72.219999999999999 110.867 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.85 -99.35 0.24 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.741 -0.742 . . . . 71.310000000000002 112.511 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -149.47 -169.75 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 75.420000000000002 110.872 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -101.74 -21.37 14.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 73.219999999999999 110.867 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -93.11 -74.75 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 73.030000000000001 110.85 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -69.27 -68.76 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 74.109999999999999 110.897 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.62 38.38 5.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 54.130000000000003 112.515 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 75.129999999999995 111.1 -179.929 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.896 0.379 . . . . 61.530000000000001 110.927 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.19 59.26 8.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 71.319999999999993 112.451 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -137.17 -173.03 3.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 74.420000000000002 110.901 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -143.57 128.24 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 61.119999999999997 111.143 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.4 p -124.57 53.47 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 64.409999999999997 110.884 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.4 m -52.69 -32.46 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 63.299999999999997 111.152 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.84 -25.13 74.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 70.340000000000003 112.503 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.53 40.58 3.15 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 75.530000000000001 112.496 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 1.8 t -148.83 103.02 3.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 73.430000000000007 111.197 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.18 33.69 0.66 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 54.450000000000003 110.924 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -80.1 84.29 5.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 70.450000000000003 110.912 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.31 158.23 35.86 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.581 0.705 . . . . 74.329999999999998 111.163 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 85.23 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 73.420000000000002 112.353 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.87 3.71 13.37 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 62.009999999999998 112.462 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.1 m -142.75 151.91 41.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 110.864 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 p -125.94 164.63 20.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 70.329999999999998 111.137 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.79 147.56 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.340000000000003 110.884 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 19' ' ' TRP . 16.0 m -145.26 53.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 62.25 110.835 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.557 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 41.5 t90 -34.24 138.32 0.32 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.542 0.686 . . . . 63.340000000000003 110.936 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.73 -40.44 1.1 Allowed 'Cis proline' 0 C--N 1.342 0.199 0 C-N-CA 122.721 -1.783 . . . . 71.120000000000005 112.345 -0.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.471 ' HA ' HG22 ' A' ' 4' ' ' THR . 13.2 m -67.11 -170.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 71.439999999999998 111.144 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.1 t -144.95 142.88 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 63.420000000000002 110.897 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.35 -96.23 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.787 -0.72 . . . . 61.539999999999999 112.485 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -148.25 -171.4 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 73.530000000000001 110.875 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -105.22 -27.49 11.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 71.340000000000003 110.844 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -89.77 -70.03 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.200000000000003 110.887 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -73.18 -68.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 74.349999999999994 110.844 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.39 37.97 4.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 43.450000000000003 112.436 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 74.299999999999997 111.121 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.877 0.37 . . . . 63.299999999999997 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.08 45.95 2.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.727 -0.749 . . . . 64.530000000000001 112.491 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -139.18 -176.13 4.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 70.140000000000001 110.914 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.5 127.8 17.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 72.430000000000007 111.18 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 p -107.13 64.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 65.329999999999998 110.849 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.4 t -55.26 -25.79 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 72.519999999999996 111.152 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.82 -18.56 67.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 53.25 112.466 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.36 31.8 8.17 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.777 -0.725 . . . . 71.420000000000002 112.47 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 1.9 t -140.93 105.41 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 74.140000000000001 111.157 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 26.77 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 70.340000000000003 110.898 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -70.14 102.22 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 75.230000000000004 110.886 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.411 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -133.68 158.15 76.22 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.527 0.68 . . . . 70.420000000000002 111.149 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.9 Cg_endo -69.79 88.68 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.692 2.261 . . . . 73.129999999999995 112.319 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.45 2.33 19.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 72.409999999999997 112.479 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 146.19 30.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.387 . . . . 52.0 110.849 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 p -122.0 165.47 15.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 75.239999999999995 111.176 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.2 t -88.23 143.22 27.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 54.100000000000001 110.888 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' TRP . 5.1 t -142.1 53.04 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.349999999999994 110.818 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.549 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 47.1 t90 -35.97 138.74 0.43 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.538 0.685 . . . . 74.219999999999999 110.918 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.549 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.73 -37.57 1.93 Allowed 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 -1.785 . . . . 73.450000000000003 112.337 -0.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 m -67.31 -170.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 73.230000000000004 111.132 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.0 t -149.73 140.78 22.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 72.120000000000005 110.894 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.22 -103.92 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.757 -0.735 . . . . 73.329999999999998 112.518 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -137.16 -172.32 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.82 0.343 . . . . 74.319999999999993 110.846 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -105.63 -25.99 12.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 63.229999999999997 110.881 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -57.51 3.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 74.510000000000005 110.89 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -101.51 -84.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.140000000000001 110.915 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.73 54.85 0.13 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 61.140000000000001 112.475 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 73.340000000000003 111.126 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.6 m . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.914 0.387 . . . . 64.400000000000006 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.05 37.52 25.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 71.129999999999995 112.49 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.7 -178.2 3.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 73.109999999999999 110.88 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.87 151.13 26.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 72.299999999999997 111.12 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 t -150.31 23.26 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 33.240000000000002 110.864 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.8 t -51.76 -39.56 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 75.239999999999995 111.1 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.53 20.85 47.66 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.78 -0.724 . . . . 72.129999999999995 112.485 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.27 19.31 39.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 15.15 112.484 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -113.11 80.39 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 71.439999999999998 111.101 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 t -150.21 59.65 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 110.913 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -90.43 122.76 33.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.109999999999999 110.881 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.641 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -146.63 149.51 37.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.595 0.712 . . . . 74.519999999999996 111.168 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.0 Cg_endo -69.73 96.49 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 73.340000000000003 112.359 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.62 4.55 36.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 72.340000000000003 112.461 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.8 t -128.49 144.49 51.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 72.299999999999997 110.907 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.48 177.78 4.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 111.131 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.8 t -101.98 143.83 31.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.876 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 19' ' ' TRP . 54.7 m -141.28 50.75 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.229999999999997 110.827 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.552 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 39.6 t90 -34.49 138.74 0.32 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.587 0.708 . . . . 75.299999999999997 110.934 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.552 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.8 Cg_endo -69.79 -37.5 1.96 Allowed 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.707 -1.789 . . . . 63.409999999999997 112.353 -0.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -68.5 -170.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 75.420000000000002 111.134 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -135.45 157.04 47.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 74.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.01 -107.15 0.46 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 51.109999999999999 112.495 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -147.79 -171.64 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 54.219999999999999 110.861 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.44 -34.55 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.881 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -50.79 16.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 74.340000000000003 110.874 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -93.88 -69.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 72.340000000000003 110.931 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.08 37.01 2.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 74.019999999999996 112.503 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.37 . . . . 64.209999999999994 111.14 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.902 0.382 . . . . 54.5 110.854 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 128.82 -22.44 5.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 62.039999999999999 112.472 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -91.14 175.85 6.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 74.239999999999995 110.885 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.597 ' OG1' HG23 ' A' ' 6' ' ' VAL . 1.8 t -109.73 160.18 16.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 111.108 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.3 t -126.84 35.59 4.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 110.867 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.597 HG23 ' OG1' ' A' ' 4' ' ' THR . 60.0 t -46.91 -54.9 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.420000000000002 111.146 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.17 -25.02 65.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 63.030000000000001 112.495 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.9 26.05 18.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 55.140000000000001 112.52 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -147.75 97.89 2.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.354 . . . . 72.049999999999997 111.144 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.8 p -150.22 23.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 62.109999999999999 110.876 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -51.93 121.77 7.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.129999999999995 110.93 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.54 159.3 73.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.622 0.725 . . . . 65.209999999999994 111.124 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 80.4 0.89 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.712 2.275 . . . . 70.099999999999994 112.335 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.4 2.67 6.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 51.119999999999997 112.445 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.1 156.94 44.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 74.219999999999999 110.868 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -176.42 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.349999999999994 111.132 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.0 t -90.14 142.09 28.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 71.409999999999997 110.862 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 19' ' ' TRP . 15.2 m -141.35 51.89 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 65.040000000000006 110.838 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.57 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 34.4 t90 -34.53 138.99 0.32 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 75.299999999999997 110.921 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.57 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 54.4 Cg_endo -69.65 -39.88 1.23 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.712 -1.787 . . . . 74.329999999999998 112.36 -0.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 m -69.45 -169.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 65.450000000000003 111.113 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.6 t -130.64 149.22 52.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.519999999999996 110.855 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.09 -109.23 0.45 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 64.140000000000001 112.508 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -142.44 -170.46 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 75.239999999999995 110.891 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -102.02 -34.52 9.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.893 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -55.61 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 63.340000000000003 110.896 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -87.72 -68.32 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 65.299999999999997 110.913 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 43.72 2.19 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 22.43 112.482 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.6 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 55.399999999999999 111.161 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.882 0.372 . . . . 61.549999999999997 110.869 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 121.26 23.65 2.61 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.808 -0.711 . . . . 73.239999999999995 112.508 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.3 -172.83 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.941 0.4 . . . . 51.240000000000002 110.883 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -144.31 127.6 16.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 63.549999999999997 111.176 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.3 p -108.33 63.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 75.349999999999994 110.845 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.7 t -54.82 -26.3 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 64.540000000000006 111.136 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.49 -19.75 65.63 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 71.200000000000003 112.518 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.2 30.46 7.8 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 64.019999999999996 112.556 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 9' ' ' THR . 2.2 t -139.63 107.18 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 65.200000000000003 111.132 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.54 37.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 72.420000000000002 110.876 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -73.81 75.59 1.61 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 72.140000000000001 110.866 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.561 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -116.39 154.45 48.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.575 0.702 . . . . 53.030000000000001 111.14 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.561 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.2 Cg_endo -69.75 90.4 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.676 2.25 . . . . 75.120000000000005 112.352 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.28 4.83 25.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 53.340000000000003 112.472 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 52.2 t -140.19 103.95 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 32.149999999999999 110.894 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.29 127.5 36.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 42.200000000000003 111.13 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.2 t -52.32 138.02 27.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 72.530000000000001 110.852 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 19' ' ' TRP . 15.1 m -144.01 53.5 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 71.310000000000002 110.869 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.553 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 53.2 t90 -34.1 138.61 0.3 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.589 0.709 . . . . 63.149999999999999 110.882 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.4 Cg_endo -69.78 -39.51 1.32 Allowed 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.673 -1.803 . . . . 61.530000000000001 112.314 -0.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.52 -168.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 61.409999999999997 111.132 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 21.1 t -150.86 139.2 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 43.340000000000003 110.874 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.75 -94.45 0.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 52.340000000000003 112.487 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -148.65 -170.3 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 74.219999999999999 110.863 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.39 -37.27 4.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 73.010000000000005 110.908 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -51.47 13.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 73.239999999999995 110.906 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -93.91 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 73.230000000000004 110.944 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.76 37.39 1.57 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 31.41 112.478 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 52.210000000000001 111.137 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.855 0.359 . . . . 71.340000000000003 110.904 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.64 21.04 73.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 61.399999999999999 112.504 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -117.92 -172.19 2.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.99 0.424 . . . . 74.510000000000005 110.844 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.09 130.09 17.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 43.100000000000001 111.15 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.5 p -110.64 59.88 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 63.219999999999999 110.86 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -51.28 -36.6 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 70.430000000000007 111.134 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.13 -29.11 74.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 73.120000000000005 112.547 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.42 37.01 3.16 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 65.420000000000002 112.482 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -149.96 109.8 4.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 63.009999999999998 111.159 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.0 28.12 0.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 73.319999999999993 110.912 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -72.1 81.33 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 74.230000000000004 110.874 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.07 158.84 31.56 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.593 0.711 . . . . 54.229999999999997 111.154 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 85.02 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.648 2.232 . . . . 40.340000000000003 112.352 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.15 3.9 12.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 65.349999999999994 112.458 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 154.76 43.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 74.230000000000004 110.888 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -127.57 157.07 41.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 62.340000000000003 111.139 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.7 t -78.71 145.07 34.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 72.420000000000002 110.876 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' TRP . 38.6 m -143.11 53.07 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 71.219999999999999 110.819 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 50.7 t90 -36.6 138.66 0.48 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.577 0.704 . . . . 75.439999999999998 110.892 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.565 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.74 -37.39 1.99 Allowed 'Cis proline' 0 C--N 1.342 0.204 0 C-N-CA 122.667 -1.805 . . . . 65.450000000000003 112.345 -0.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 m -67.71 -168.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 75.430000000000007 111.099 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.2 t -149.45 140.91 23.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 52.450000000000003 110.911 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.0 -92.4 0.14 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 62.219999999999999 112.486 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -150.78 -171.05 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.326 . . . . 75.519999999999996 110.891 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.63 -38.04 4.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 72.150000000000006 110.889 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -58.05 3.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 73.219999999999999 110.866 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -87.12 -69.3 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 63.340000000000003 110.922 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.17 57.7 0.95 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 53.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 71.510000000000005 111.14 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 89.9 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.828 0.347 . . . . 50.119999999999997 110.867 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.76 46.04 2.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 62.119999999999997 112.5 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.9 mp0 -139.82 -177.42 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 72.430000000000007 110.914 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.9 124.43 13.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 63.32 111.128 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.7 p -104.97 63.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 73.319999999999993 110.865 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.2 t -55.5 -25.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 75.109999999999999 111.155 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.07 -17.86 66.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.724 -0.75 . . . . 72.310000000000002 112.501 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.02 32.3 7.99 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 40.439999999999998 112.529 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 9' ' ' THR . 1.8 t -140.46 104.3 4.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 61.219999999999999 111.138 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.2 31.24 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 64.430000000000007 110.912 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -74.62 84.36 2.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 110.89 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.44 158.48 36.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.557 0.694 . . . . 72.030000000000001 111.146 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 87.63 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.66 2.24 . . . . 64.219999999999999 112.374 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.91 3.42 19.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.762 . . . . 50.450000000000003 112.497 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.71 151.23 42.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 64.010000000000005 110.909 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 p -124.01 160.55 27.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 65.129999999999995 111.151 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.1 t -85.39 142.55 29.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 61.399999999999999 110.907 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 19' ' ' TRP . 10.9 t -141.36 52.39 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 63.299999999999997 110.851 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.548 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 46.6 t90 -35.83 138.74 0.42 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.545 0.688 . . . . 64.150000000000006 110.941 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.4 Cg_endo -69.85 -36.85 2.19 Favored 'Cis proline' 0 C--O 1.232 0.187 0 C-N-CA 122.659 -1.809 . . . . 72.200000000000003 112.321 0.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 m -68.15 -170.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 75.150000000000006 111.129 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.3 t -150.96 140.96 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 110.915 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.83 -103.43 0.24 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.737 . . . . 54.119999999999997 112.519 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -139.75 -169.83 2.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.85 0.357 . . . . 74.340000000000003 110.812 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -108.06 -26.95 10.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.905 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -48.78 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 74.140000000000001 110.857 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -95.87 -68.47 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 73.450000000000003 110.929 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.0 32.48 3.52 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 42.109999999999999 112.487 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 29' ' ' VAL . 6.1 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 51.420000000000002 111.127 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.896 0.379 . . . . 71.219999999999999 110.916 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.17 40.37 97.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 54.409999999999997 112.526 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -108.85 -178.85 3.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 74.120000000000005 110.934 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.89 143.35 32.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 111.148 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.72 20.36 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 73.109999999999999 110.884 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 p -50.98 -40.39 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 75.329999999999998 111.094 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.33 -1.61 69.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 43.539999999999999 112.487 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.79 56.49 18.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 73.549999999999997 112.483 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -150.37 43.81 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 75.530000000000001 111.125 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.1 p -125.91 56.38 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 31.23 110.886 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.3 121.42 32.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.32 110.859 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.503 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -125.67 158.72 64.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.62 0.724 . . . . 75.450000000000003 111.138 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.503 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.2 Cg_endo -69.75 90.6 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.707 2.271 . . . . 63.329999999999998 112.332 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.94 1.64 23.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 53.229999999999997 112.481 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.57 157.84 32.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.881 0.372 . . . . 64.530000000000001 110.877 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.63 -175.16 2.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 74.510000000000005 111.143 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.3 t -118.83 142.27 47.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.432 . . . . 74.540000000000006 110.877 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 m -139.84 59.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.239999999999995 110.88 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.542 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 36.4 t90 -37.79 138.99 0.61 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.581 0.705 . . . . 71.239999999999995 110.929 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.74 -40.82 1.02 Allowed 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.71 -1.788 . . . . 74.129999999999995 112.334 0.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.74 -177.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 64.329999999999998 111.141 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.7 t -134.2 160.94 36.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 61.539999999999999 110.918 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.86 -95.93 0.5 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 54.409999999999997 112.481 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -149.38 -179.18 6.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 64.019999999999996 110.829 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -102.91 -28.37 12.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.329999999999998 110.846 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -83.2 -64.57 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 65.030000000000001 110.831 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -82.95 -69.03 0.66 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 110.865 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.15 44.83 2.71 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 25.030000000000001 112.511 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 62.240000000000002 111.116 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.906 0.384 . . . . 52.32 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.08 68.42 1.67 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 51.340000000000003 112.497 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -146.57 -177.29 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 74.329999999999998 110.892 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.46 151.15 30.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 72.439999999999998 111.162 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.6 t -150.09 28.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 61.520000000000003 110.825 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.55 -36.42 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.530000000000001 111.136 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.32 -10.59 81.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 64.219999999999999 112.478 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.08 7.93 76.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 34.229999999999997 112.492 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -111.49 88.66 2.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 74.439999999999998 111.204 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.2 t -150.25 47.77 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 62.009999999999998 110.908 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -90.16 113.56 25.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.899 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.49 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -132.17 158.62 75.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 72.040000000000006 111.125 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.49 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.7 Cg_endo -69.73 87.63 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.734 2.289 . . . . 72.530000000000001 112.351 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.8 3.47 20.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 71.030000000000001 112.491 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 m -135.29 149.49 49.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.94 0.4 . . . . 74.340000000000003 110.839 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.21 179.36 4.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.178 -0.465 . . . . 64.510000000000005 111.11 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -102.7 144.49 31.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 62.32 110.91 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 19' ' ' TRP . 8.6 t -141.6 52.46 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 70.319999999999993 110.836 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.542 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 40.8 t90 -34.88 138.75 0.34 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.577 0.703 . . . . 73.239999999999995 110.899 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.8 Cg_endo -69.74 -38.51 1.6 Allowed 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.73 -1.779 . . . . 64.140000000000001 112.344 -0.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.09 -171.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 64.340000000000003 111.126 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.9 t -131.31 151.79 51.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 73.5 110.911 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.69 -97.98 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 72.319999999999993 112.533 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -148.03 -169.29 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 74.409999999999997 110.846 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -103.76 -17.46 15.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.857 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -100.51 -67.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 65.329999999999998 110.879 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -92.38 -69.65 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 73.010000000000005 110.902 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.18 76.49 0.86 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 53.399999999999999 112.479 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 42.350000000000001 111.133 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.927 0.394 . . . . 55.25 110.905 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.15 46.01 4.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 33.240000000000002 112.472 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -144.66 -179.67 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 63.109999999999999 110.942 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -145.83 139.15 26.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.171 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 1.431 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -128.05 79.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 53.210000000000001 110.913 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.28 -17.02 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 73.239999999999995 111.141 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.87 6.76 25.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.69 -0.766 . . . . 71.150000000000006 112.494 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.35 56.4 15.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 75.230000000000004 112.522 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -148.07 73.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 71.340000000000003 111.16 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.804 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 17.5 p -149.06 25.83 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 70.109999999999999 110.845 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -66.31 135.0 53.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 55.030000000000001 110.888 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.94 159.53 40.08 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.503 0.668 . . . . 65.140000000000001 111.196 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 79.9 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.638 2.225 . . . . 53.210000000000001 112.355 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.56 -0.22 5.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.757 . . . . 73.209999999999994 112.483 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.0 163.48 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.957 0.408 . . . . 44.310000000000002 110.849 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -133.04 175.17 9.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 72.510000000000005 111.178 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 28.0 t -101.5 155.32 18.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 64.099999999999994 110.884 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 19' ' ' TRP . 3.2 t -150.08 57.54 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 62.409999999999997 110.852 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.546 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 41.8 t90 -36.67 138.85 0.48 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.536 0.684 . . . . 72.340000000000003 110.863 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 54.2 Cg_endo -69.73 -38.83 1.49 Allowed 'Cis proline' 0 C--O 1.231 0.131 0 C-N-CA 122.712 -1.787 . . . . 74.019999999999996 112.346 -0.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.4 -169.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 53.109999999999999 111.175 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 1.431 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -150.11 155.31 39.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 75.209999999999994 110.891 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.06 -90.75 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 72.109999999999999 112.457 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -148.82 -174.53 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 73.299999999999997 110.905 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -109.89 -25.48 10.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 71.340000000000003 110.878 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -88.27 -67.67 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.230000000000004 110.888 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -76.07 -69.14 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 75.120000000000005 110.927 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.56 38.93 2.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 72.430000000000007 112.494 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 72.319999999999993 111.129 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.825 0.345 . . . . 72.230000000000004 110.869 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.21 43.55 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 74.540000000000006 112.449 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -148.77 -173.59 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 72.209999999999994 110.912 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.46 130.11 20.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 72.439999999999998 111.144 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.2 p -110.83 66.55 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 74.299999999999997 110.872 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.58 -27.17 20.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 75.530000000000001 111.119 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.35 -14.88 70.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 73.430000000000007 112.484 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.74 28.15 19.7 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 62.340000000000003 112.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 9' ' ' THR . 1.7 t -129.26 98.74 4.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.364 . . . . 64.120000000000005 111.186 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.1 20.78 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.420000000000002 110.862 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -71.38 84.73 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 73.299999999999997 110.879 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.22 158.85 34.06 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.557 0.694 . . . . 64.310000000000002 111.186 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 80.91 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.674 2.25 . . . . 72.099999999999994 112.346 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.03 1.31 6.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 61.049999999999997 112.489 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.93 156.54 43.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 53.43 110.871 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.97 168.66 13.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 53.409999999999997 111.11 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -92.88 147.27 22.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 71.219999999999999 110.837 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 19' ' ' TRP . 33.4 t -144.91 54.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.340000000000003 110.867 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.555 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 53.0 t90 -36.89 138.6 0.51 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 73.219999999999999 110.946 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.555 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.81 -37.79 1.86 Allowed 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 -1.811 . . . . 73.420000000000002 112.343 -0.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 m -66.09 -170.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 45.399999999999999 111.138 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.1 t -144.88 141.55 29.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 62.43 110.9 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.81 -91.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.758 . . . . 70.040000000000006 112.47 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -148.15 177.93 8.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 73.519999999999996 110.908 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -96.29 -26.28 15.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 74.530000000000001 110.89 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.69 -62.55 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 75.530000000000001 110.829 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -83.24 -68.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 62.310000000000002 110.927 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.2 49.14 0.89 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 60.350000000000001 112.469 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 71.209999999999994 111.121 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.902 0.382 . . . . 71.200000000000003 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.14 31.18 61.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 64.219999999999999 112.517 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.91 -169.41 1.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.944 0.402 . . . . 71.319999999999993 110.817 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.69 140.76 43.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 75.120000000000005 111.112 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.659 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.8 t -143.52 30.69 1.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 75.439999999999998 110.852 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.8 t -54.88 -29.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 73.329999999999998 111.172 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.73 -3.91 64.0 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.752 -0.737 . . . . 62.229999999999997 112.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.29 53.83 19.69 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.733 -0.746 . . . . 70.409999999999997 112.453 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -139.75 66.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 74.140000000000001 111.167 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.659 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 19.5 m -118.21 58.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 70.010000000000005 110.879 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -90.07 64.55 6.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 53.299999999999997 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.638 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -104.6 149.96 38.02 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.618 0.723 . . . . 73.319999999999993 111.151 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.638 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.8 Cg_endo -69.74 92.79 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.677 2.251 . . . . 74.019999999999996 112.348 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.73 3.44 28.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 70.329999999999998 112.456 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 t -132.99 141.09 48.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 71.200000000000003 110.898 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -112.54 -179.69 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 53.149999999999999 111.114 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' H ' HG22 ' A' ' 16' ' ' THR . 34.1 t -103.09 142.16 34.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 73.450000000000003 110.86 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' TRP . 39.2 m -139.79 49.58 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 52.439999999999998 110.869 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.547 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 40.9 t90 -35.98 138.8 0.43 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.521 0.676 . . . . 74.120000000000005 110.961 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.5 Cg_endo -69.76 -35.28 2.75 Favored 'Cis proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.671 -1.804 . . . . 72.319999999999993 112.383 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 m -68.71 -170.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 44.109999999999999 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.3 t -132.43 156.93 45.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 62.240000000000002 110.89 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.79 -102.27 0.35 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 61.149999999999999 112.533 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -148.29 163.07 38.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 65.310000000000002 110.845 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -85.27 -25.47 27.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.549999999999997 110.904 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -86.27 -62.86 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 72.519999999999996 110.911 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -82.34 -69.0 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 110.952 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.95 49.22 1.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.696 -0.764 . . . . 74.329999999999998 112.492 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 73.219999999999999 111.118 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.891 0.377 . . . . 45.340000000000003 110.91 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.07 38.56 1.66 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 60.130000000000003 112.49 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -138.61 -175.04 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 65.230000000000004 110.889 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.09 128.47 17.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 65.409999999999997 111.15 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.4 p -108.27 61.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 75.450000000000003 110.866 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.0 t -52.56 -28.56 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 41.219999999999999 111.138 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.08 -28.22 70.7 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.723 -0.751 . . . . 54.450000000000003 112.477 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.21 27.88 6.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.773 -0.727 . . . . 60.509999999999998 112.492 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 t -149.87 119.34 6.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 72.329999999999998 111.094 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.41 67.1 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 54.200000000000003 110.904 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -90.18 85.62 6.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 72.319999999999993 110.906 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.89 154.93 41.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.711 . . . . 64.150000000000006 111.167 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 87.66 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.699 2.266 . . . . 73.430000000000007 112.329 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.86 7.19 29.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 73.430000000000007 112.41 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 m -140.15 159.26 42.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 71.310000000000002 110.927 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -128.16 177.42 6.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 72.409999999999997 111.095 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.416 ' H ' HG22 ' A' ' 16' ' ' THR . 42.2 t -93.78 144.11 25.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 64.230000000000004 110.895 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 19' ' ' TRP . 74.7 m -144.26 53.78 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.400000000000006 110.904 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.551 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 54.2 t90 -36.46 138.67 0.47 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.53 0.681 . . . . 74.340000000000003 110.924 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.5 Cg_endo -69.8 -37.62 1.92 Allowed 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.696 -1.793 . . . . 74.530000000000001 112.351 0.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.9 m -67.11 -169.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 74.150000000000006 111.127 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.6 t -149.33 141.03 23.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 62.350000000000001 110.869 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.92 -101.43 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 32.439999999999998 112.485 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -135.38 -170.61 2.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 71.530000000000001 110.858 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -106.41 -31.91 8.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 72.420000000000002 110.87 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -82.79 -64.41 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 65.230000000000004 110.858 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -81.23 -69.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.400000000000006 110.957 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.35 26.54 6.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 52.229999999999997 112.51 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 72.439999999999998 111.079 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.857 0.361 . . . . 74.150000000000006 110.888 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.82 66.58 0.67 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 21.239999999999998 112.481 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -141.43 174.34 10.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.419 . . . . 74.219999999999999 110.83 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.0 140.43 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 71.439999999999998 111.16 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.73 17.54 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 73.450000000000003 110.893 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.8 t -49.12 -49.4 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 74.409999999999997 111.091 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.85 -25.79 66.26 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.739 -0.743 . . . . 64.329999999999998 112.485 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.63 22.06 19.8 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.759 -0.734 . . . . 71.109999999999999 112.505 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -149.26 91.41 1.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 72.310000000000002 111.106 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p -149.35 30.35 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 73.019999999999996 110.905 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -58.97 128.69 38.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.893 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.574 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -140.14 155.42 70.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.556 0.693 . . . . 72.430000000000007 111.149 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.2 Cg_endo -69.78 96.49 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 74.099999999999994 112.331 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.18 -1.19 29.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 45.439999999999998 112.512 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.6 m -127.06 143.84 51.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 75.420000000000002 110.891 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 p -114.83 134.51 55.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 55.109999999999999 111.16 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 t -60.0 136.42 58.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 110.911 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' TRP . 19.3 m -139.7 54.44 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 52.340000000000003 110.841 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.547 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 38.5 t90 -35.93 138.71 0.43 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.485 0.66 . . . . 73.430000000000007 110.945 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.79 -39.91 1.23 Allowed 'Cis proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.672 -1.803 . . . . 64.329999999999998 112.363 -0.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -63.7 -175.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 111.105 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.5 t -140.73 148.01 40.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 62.299999999999997 110.903 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.05 -75.81 0.37 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 51.5 112.482 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -151.87 -171.83 4.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 43.340000000000003 110.89 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -117.24 -33.67 4.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 72.109999999999999 110.858 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -80.31 -54.84 5.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.476 . . . . 71.439999999999998 110.85 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -88.47 -68.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.430000000000007 110.93 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.71 18.1 28.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.754 . . . . 73.150000000000006 112.484 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.901 0.381 . . . . 63.450000000000003 111.081 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 95.8 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.9 0.381 . . . . 73.109999999999999 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.04 44.26 5.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 54.020000000000003 112.489 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -148.41 175.82 10.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 74.400000000000006 110.876 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -143.85 125.12 14.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 111.17 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p -104.17 61.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 61.210000000000001 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -54.24 -26.4 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 54.399999999999999 111.158 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.76 -23.33 67.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 72.319999999999993 112.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.39 32.43 5.76 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 75.219999999999999 112.492 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -147.54 112.02 5.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 71.409999999999997 111.173 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 27.04 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 72.530000000000001 110.842 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -64.37 95.66 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.907 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.5 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -132.59 158.22 76.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.588 0.709 . . . . 75.109999999999999 111.1 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.5 Cg_endo -69.81 94.26 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.71 2.273 . . . . 61.520000000000003 112.349 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.18 3.9 38.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 61.409999999999997 112.546 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.9 m -134.3 133.23 40.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 71.319999999999993 110.881 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -117.0 128.83 55.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.140000000000001 111.142 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -56.53 141.76 41.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 70.420000000000002 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' TRP . 2.8 t -144.35 53.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 73.109999999999999 110.832 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.551 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 52.9 t90 -35.79 138.67 0.42 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.558 0.694 . . . . 64.420000000000002 110.912 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.1 Cg_endo -69.77 -37.96 1.8 Allowed 'Cis proline' 0 C--N 1.341 0.137 0 C-N-CA 122.713 -1.786 . . . . 73.310000000000002 112.315 -0.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 m -67.89 -169.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 44.520000000000003 111.149 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 t -151.58 140.9 21.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 110.844 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.08 -92.25 0.15 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 44.229999999999997 112.469 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -148.78 -170.34 3.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 63.219999999999999 110.859 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.04 -38.43 3.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 71.25 110.887 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.66 -57.08 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 71.239999999999995 110.875 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -84.68 -69.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 74.129999999999995 110.89 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.74 44.44 2.47 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.739 -0.743 . . . . 51.240000000000002 112.487 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 55.409999999999997 111.131 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.864 0.364 . . . . 73.209999999999994 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.97 30.17 23.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 51.5 112.501 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -126.4 -175.76 3.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 74.140000000000001 110.875 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.16 127.79 16.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 74.219999999999999 111.142 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.5 p -108.38 61.8 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 71.530000000000001 110.866 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -53.09 -27.54 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.099999999999994 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.96 -26.33 69.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.739 . . . . 71.120000000000005 112.509 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.33 31.38 5.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 73.209999999999994 112.488 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 t -149.84 114.97 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 74.030000000000001 111.137 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.68 50.03 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 61.43 110.924 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -81.43 88.35 6.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 71.530000000000001 110.862 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.49 157.93 39.98 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.558 0.694 . . . . 73.010000000000005 111.183 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 90.11 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.273 . . . . 70.420000000000002 112.303 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.38 6.33 33.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 64.409999999999997 112.495 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.86 153.4 45.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 73.319999999999993 110.919 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -125.37 172.9 9.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 42.350000000000001 111.133 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.66 145.32 24.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 72.230000000000004 110.902 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 19' ' ' TRP . 46.0 m -144.9 54.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 72.049999999999997 110.871 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.555 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 52.5 t90 -36.54 138.85 0.47 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.543 0.687 . . . . 63.420000000000002 110.935 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.555 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.69 -37.83 1.84 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.722 -1.783 . . . . 51.520000000000003 112.35 -0.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 m -67.05 -170.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.319999999999993 111.123 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.5 t -148.58 141.17 24.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 110.935 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.4 -97.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 44.329999999999998 112.487 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -148.73 -170.22 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 60.329999999999998 110.873 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.09 -40.38 3.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 110.88 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -50.89 22.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 72.439999999999998 110.856 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -92.63 -69.22 0.76 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 110.888 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.89 49.67 1.24 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 44.130000000000003 112.512 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 73.530000000000001 111.08 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 CA--C 1.526 0.038 0 CA-C-O 120.882 0.372 . . . . 75.109999999999999 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.9 43.8 95.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.742 . . . . 72.099999999999994 112.473 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -112.43 -168.96 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 72.329999999999998 110.923 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.498 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -143.85 132.56 22.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 75.040000000000006 111.088 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 p -130.98 62.57 1.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 54.119999999999997 110.9 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.3 t -54.28 -30.23 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 63.43 111.153 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.71 -17.78 72.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 52.310000000000002 112.492 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.0 16.62 40.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 64.230000000000004 112.52 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.59 99.08 7.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 75.319999999999993 111.157 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.79 29.89 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 64.209999999999994 110.895 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -76.38 88.06 3.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 74.230000000000004 110.897 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.556 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -114.37 154.63 46.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.537 0.684 . . . . 63.530000000000001 111.182 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.556 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.3 Cg_endo -69.77 84.53 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.701 2.267 . . . . 75.319999999999993 112.315 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.99 0.96 8.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 65.430000000000007 112.504 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.87 151.91 36.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 73.439999999999998 110.937 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -122.98 173.94 7.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.319999999999993 111.145 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.6 t -94.84 148.97 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 62.549999999999997 110.877 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 19' ' ' TRP . 4.7 t -144.93 53.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 70.030000000000001 110.867 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.559 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 44.3 t90 -33.77 138.35 0.29 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.54 0.686 . . . . 75.030000000000001 110.949 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.82 -40.44 1.11 Allowed 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 -1.809 . . . . 74.409999999999997 112.32 0.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 4' ' ' THR . 14.9 m -66.99 -170.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 111.152 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.1 t -138.85 148.35 43.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.450000000000003 110.903 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.73 -95.66 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.752 . . . . 62.32 112.505 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -151.31 -171.04 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 63.310000000000002 110.878 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -102.91 -22.29 13.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 110.883 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -96.08 -66.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 75.420000000000002 110.86 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -95.44 -69.5 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 51.25 110.925 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.01 79.0 0.71 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.726 -0.75 . . . . 63.439999999999998 112.479 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 75.0 111.121 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.89 0.376 . . . . 75.239999999999995 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.24 44.51 96.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.775 -0.726 . . . . 30.420000000000002 112.494 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.19 -176.13 3.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 75.219999999999999 110.891 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -147.18 137.32 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 73.349999999999994 111.117 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.03 81.12 2.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 73.510000000000005 110.844 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.77 -18.48 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 71.530000000000001 111.127 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.16 0.23 38.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 74.230000000000004 112.444 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.5 38.99 43.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.777 -0.725 . . . . 75.120000000000005 112.487 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.86 84.05 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 61.109999999999999 111.146 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -136.18 67.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 41.100000000000001 110.902 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -90.93 88.3 6.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 72.019999999999996 110.893 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.595 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -121.68 151.15 56.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 75.109999999999999 111.092 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.595 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.7 Cg_endo -69.75 91.76 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.641 2.227 . . . . 70.530000000000001 112.324 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.67 6.68 46.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 72.430000000000007 112.512 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 147.22 50.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.949 0.404 . . . . 74.439999999999998 110.915 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -121.24 179.69 4.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 61.109999999999999 111.146 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.1 t -103.35 155.37 18.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 42.149999999999999 110.88 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' TRP . 72.3 m -150.29 54.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 71.230000000000004 110.85 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.545 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 48.9 t90 -35.91 138.58 0.43 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.596 0.713 . . . . 75.439999999999998 110.891 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 54.3 Cg_endo -69.73 -37.86 1.83 Allowed 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.691 -1.795 . . . . 53.439999999999998 112.354 -0.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 m -67.88 -168.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 72.540000000000006 111.115 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.69 167.19 23.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 45.439999999999998 110.879 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.46 -100.43 0.54 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 61.43 112.488 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.19 -173.37 3.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 65.230000000000004 110.842 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -103.07 -22.08 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.919 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -98.44 -66.96 0.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 73.019999999999996 110.859 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -92.58 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 75.230000000000004 110.95 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.81 77.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 51.119999999999997 112.521 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 71.140000000000001 111.121 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.876 0.369 . . . . 52.32 110.85 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.8 57.06 2.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 72.109999999999999 112.436 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -142.02 -169.54 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.39 . . . . 60.439999999999998 110.852 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -143.55 133.62 24.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 111.125 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 p -131.31 61.0 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 72.530000000000001 110.906 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.8 t -53.65 -30.83 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 72.540000000000006 111.144 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.63 -22.5 74.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 53.100000000000001 112.515 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.07 21.27 18.48 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.794 -0.717 . . . . 72.340000000000003 112.482 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 9' ' ' THR . 1.8 t -125.68 103.82 8.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 73.209999999999994 111.156 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.1 34.35 0.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 53.420000000000002 110.892 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -78.73 86.04 4.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.239999999999995 110.934 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.16 158.78 33.44 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.636 0.732 . . . . 72.209999999999994 111.098 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 85.34 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.695 2.264 . . . . 61.109999999999999 112.357 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.36 4.94 15.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 51.229999999999997 112.489 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 m -144.38 157.19 44.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 70.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 p -129.7 170.17 14.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 72.099999999999994 111.134 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -91.72 148.5 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 62.119999999999997 110.865 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 19' ' ' TRP . 13.6 m -145.35 53.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.892 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.553 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 44.3 t90 -33.81 138.4 0.29 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.548 0.69 . . . . 74.319999999999993 110.924 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.75 -40.03 1.2 Allowed 'Cis proline' 0 C--O 1.232 0.199 0 C-N-CA 122.688 -1.797 . . . . 65.340000000000003 112.346 -0.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' HA ' HG22 ' A' ' 4' ' ' THR . 13.9 m -67.48 -170.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 74.409999999999997 111.154 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -141.13 144.99 35.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 60.399999999999999 110.904 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.89 -95.79 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 40.219999999999999 112.487 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -148.71 -169.31 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.845 0.355 . . . . 55.229999999999997 110.859 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -105.49 -27.75 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 70.120000000000005 110.865 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -96.33 -60.85 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 72.25 110.856 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -74.69 -68.86 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 75.439999999999998 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 38.47 6.05 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 54.329999999999998 112.436 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 74.439999999999998 111.095 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.882 0.372 . . . . 64.049999999999997 110.894 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.95 37.34 3.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 65.430000000000007 112.509 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -146.37 172.01 14.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.939 0.4 . . . . 71.450000000000003 110.903 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.6 124.39 25.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 72.450000000000003 111.109 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 1.202 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.9 m -90.27 51.72 2.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.5 110.833 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.1 t -45.78 -44.13 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.299999999999997 111.116 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.25 18.47 36.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 75.439999999999998 112.463 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.59 53.76 36.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.747 . . . . 24.43 112.492 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 t -149.95 72.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 62.100000000000001 111.148 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 1.212 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 31.6 p -150.11 35.18 0.66 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 61.329999999999998 110.894 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -73.43 123.56 24.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 72.430000000000007 110.896 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.85 159.29 71.96 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.607 0.718 . . . . 63.299999999999997 111.143 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 82.64 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 71.319999999999993 112.311 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.21 2.16 8.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 55.420000000000002 112.527 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.97 158.29 44.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 63.43 110.868 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -122.74 178.38 5.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 65.540000000000006 111.176 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 1.212 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -99.98 151.08 21.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 50.030000000000001 110.882 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' TRP . 19.4 m -148.56 56.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 71.439999999999998 110.862 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.543 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 37.0 t90 -37.29 138.88 0.55 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.545 0.688 . . . . 74.540000000000006 110.878 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.74 -39.99 1.2 Allowed 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.706 -1.789 . . . . 70.239999999999995 112.341 -0.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.81 -170.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 111.132 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.822 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 20.0 t -139.59 154.01 47.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 72.219999999999999 110.867 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.85 -99.35 0.24 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.741 -0.742 . . . . 71.310000000000002 112.511 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -149.47 -169.75 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 75.420000000000002 110.872 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -101.74 -21.37 14.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 73.219999999999999 110.867 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -93.11 -74.75 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 73.030000000000001 110.85 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -69.27 -68.76 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 74.109999999999999 110.897 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.62 38.38 5.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 54.130000000000003 112.515 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 75.129999999999995 111.1 -179.929 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.896 0.379 . . . . 61.530000000000001 110.927 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.19 59.26 8.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 71.319999999999993 112.451 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -137.17 -173.03 3.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 74.420000000000002 110.901 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -143.57 128.24 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 61.119999999999997 111.143 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.4 p -124.57 53.47 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 64.409999999999997 110.884 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.4 m -52.69 -32.46 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 63.299999999999997 111.152 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.84 -25.13 74.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 70.340000000000003 112.503 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.53 40.58 3.15 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 75.530000000000001 112.496 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 1.8 t -148.83 103.02 3.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 73.430000000000007 111.197 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.18 33.69 0.66 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 54.450000000000003 110.924 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -80.1 84.29 5.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 70.450000000000003 110.912 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.31 158.23 35.86 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.581 0.705 . . . . 74.329999999999998 111.163 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 85.23 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 73.420000000000002 112.353 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.87 3.71 13.37 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 62.009999999999998 112.462 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.1 m -142.75 151.91 41.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 110.864 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 p -125.94 164.63 20.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 70.329999999999998 111.137 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.79 147.56 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.340000000000003 110.884 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 19' ' ' TRP . 16.0 m -145.26 53.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 62.25 110.835 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.557 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 41.5 t90 -34.24 138.32 0.32 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.542 0.686 . . . . 63.340000000000003 110.936 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.73 -40.44 1.1 Allowed 'Cis proline' 0 C--N 1.342 0.199 0 C-N-CA 122.721 -1.783 . . . . 71.120000000000005 112.345 -0.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' HA ' HG22 ' A' ' 4' ' ' THR . 13.2 m -67.11 -170.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 71.439999999999998 111.144 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.1 t -144.95 142.88 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 63.420000000000002 110.897 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.35 -96.23 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.787 -0.72 . . . . 61.539999999999999 112.485 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -148.25 -171.4 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 73.530000000000001 110.875 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -105.22 -27.49 11.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 71.340000000000003 110.844 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -89.77 -70.03 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.200000000000003 110.887 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -73.18 -68.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 74.349999999999994 110.844 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.39 37.97 4.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 43.450000000000003 112.436 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 74.299999999999997 111.121 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.877 0.37 . . . . 63.299999999999997 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.08 45.95 2.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.727 -0.749 . . . . 64.530000000000001 112.491 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -139.18 -176.13 4.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 70.140000000000001 110.914 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.5 127.8 17.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 72.430000000000007 111.18 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 p -107.13 64.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 65.329999999999998 110.849 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.4 t -55.26 -25.79 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 72.519999999999996 111.152 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.82 -18.56 67.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 53.25 112.466 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.36 31.8 8.17 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.777 -0.725 . . . . 71.420000000000002 112.47 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 1.9 t -140.93 105.41 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 74.140000000000001 111.157 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 26.77 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 70.340000000000003 110.898 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -70.14 102.22 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 75.230000000000004 110.886 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.411 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -133.68 158.15 76.22 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.527 0.68 . . . . 70.420000000000002 111.149 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.9 Cg_endo -69.79 88.68 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.692 2.261 . . . . 73.129999999999995 112.319 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.45 2.33 19.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 72.409999999999997 112.479 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 146.19 30.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.387 . . . . 52.0 110.849 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 p -122.0 165.47 15.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 75.239999999999995 111.176 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.2 t -88.23 143.22 27.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 54.100000000000001 110.888 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' TRP . 5.1 t -142.1 53.04 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.349999999999994 110.818 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.549 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 47.1 t90 -35.97 138.74 0.43 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.538 0.685 . . . . 74.219999999999999 110.918 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.549 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.73 -37.57 1.93 Allowed 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 -1.785 . . . . 73.450000000000003 112.337 -0.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 m -67.31 -170.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 73.230000000000004 111.132 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.0 t -149.73 140.78 22.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 72.120000000000005 110.894 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.22 -103.92 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.757 -0.735 . . . . 73.329999999999998 112.518 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -137.16 -172.32 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.82 0.343 . . . . 74.319999999999993 110.846 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -105.63 -25.99 12.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 63.229999999999997 110.881 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -57.51 3.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 74.510000000000005 110.89 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -101.51 -84.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.140000000000001 110.915 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.73 54.85 0.13 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 61.140000000000001 112.475 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 73.340000000000003 111.126 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.6 m . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.914 0.387 . . . . 64.400000000000006 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.05 37.52 25.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 71.129999999999995 112.49 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.7 -178.2 3.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 73.109999999999999 110.88 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.87 151.13 26.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 72.299999999999997 111.12 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 t -150.31 23.26 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 33.240000000000002 110.864 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.8 t -51.76 -39.56 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 75.239999999999995 111.1 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.53 20.85 47.66 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.78 -0.724 . . . . 72.129999999999995 112.485 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.27 19.31 39.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 15.15 112.484 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -113.11 80.39 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 71.439999999999998 111.101 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 t -150.21 59.65 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 110.913 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -90.43 122.76 33.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.109999999999999 110.881 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.641 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -146.63 149.51 37.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.595 0.712 . . . . 74.519999999999996 111.168 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.0 Cg_endo -69.73 96.49 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 73.340000000000003 112.359 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.62 4.55 36.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 72.340000000000003 112.461 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.8 t -128.49 144.49 51.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 72.299999999999997 110.907 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.48 177.78 4.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 111.131 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.8 t -101.98 143.83 31.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.876 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 19' ' ' TRP . 54.7 m -141.28 50.75 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.229999999999997 110.827 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.552 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 39.6 t90 -34.49 138.74 0.32 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.587 0.708 . . . . 75.299999999999997 110.934 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.552 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.8 Cg_endo -69.79 -37.5 1.96 Allowed 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.707 -1.789 . . . . 63.409999999999997 112.353 -0.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -68.5 -170.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 75.420000000000002 111.134 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -135.45 157.04 47.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 74.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.01 -107.15 0.46 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 51.109999999999999 112.495 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -147.79 -171.64 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 54.219999999999999 110.861 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.44 -34.55 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.881 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -50.79 16.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 74.340000000000003 110.874 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -93.88 -69.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 72.340000000000003 110.931 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.08 37.01 2.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 74.019999999999996 112.503 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.37 . . . . 64.209999999999994 111.14 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.902 0.382 . . . . 54.5 110.854 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 128.82 -22.44 5.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 62.039999999999999 112.472 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -91.14 175.85 6.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 74.239999999999995 110.885 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.597 ' OG1' HG23 ' A' ' 6' ' ' VAL . 1.8 t -109.73 160.18 16.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 111.108 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.3 t -126.84 35.59 4.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 110.867 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.597 HG23 ' OG1' ' A' ' 4' ' ' THR . 60.0 t -46.91 -54.9 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.420000000000002 111.146 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.17 -25.02 65.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 63.030000000000001 112.495 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.9 26.05 18.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 55.140000000000001 112.52 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -147.75 97.89 2.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.354 . . . . 72.049999999999997 111.144 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.8 p -150.22 23.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 62.109999999999999 110.876 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -51.93 121.77 7.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.129999999999995 110.93 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.54 159.3 73.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.622 0.725 . . . . 65.209999999999994 111.124 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 80.4 0.89 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.712 2.275 . . . . 70.099999999999994 112.335 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.4 2.67 6.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 51.119999999999997 112.445 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.1 156.94 44.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 74.219999999999999 110.868 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -176.42 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.349999999999994 111.132 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.0 t -90.14 142.09 28.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 71.409999999999997 110.862 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 19' ' ' TRP . 15.2 m -141.35 51.89 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 65.040000000000006 110.838 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.57 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 34.4 t90 -34.53 138.99 0.32 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 75.299999999999997 110.921 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.57 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 54.4 Cg_endo -69.65 -39.88 1.23 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.712 -1.787 . . . . 74.329999999999998 112.36 -0.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 m -69.45 -169.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 65.450000000000003 111.113 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.6 t -130.64 149.22 52.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.519999999999996 110.855 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.09 -109.23 0.45 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 64.140000000000001 112.508 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -142.44 -170.46 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 75.239999999999995 110.891 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -102.02 -34.52 9.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.893 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -55.61 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 63.340000000000003 110.896 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -87.72 -68.32 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 65.299999999999997 110.913 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 43.72 2.19 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 22.43 112.482 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.6 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 55.399999999999999 111.161 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.882 0.372 . . . . 61.549999999999997 110.869 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 121.26 23.65 2.61 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.808 -0.711 . . . . 73.239999999999995 112.508 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.3 -172.83 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.941 0.4 . . . . 51.240000000000002 110.883 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -144.31 127.6 16.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 63.549999999999997 111.176 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.3 p -108.33 63.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 75.349999999999994 110.845 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.7 t -54.82 -26.3 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 64.540000000000006 111.136 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.49 -19.75 65.63 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 71.200000000000003 112.518 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.2 30.46 7.8 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 64.019999999999996 112.556 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 9' ' ' THR . 2.2 t -139.63 107.18 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 65.200000000000003 111.132 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.54 37.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 72.420000000000002 110.876 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -73.81 75.59 1.61 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 72.140000000000001 110.866 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.561 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -116.39 154.45 48.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.575 0.702 . . . . 53.030000000000001 111.14 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.561 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.2 Cg_endo -69.75 90.4 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.676 2.25 . . . . 75.120000000000005 112.352 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.28 4.83 25.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 53.340000000000003 112.472 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 52.2 t -140.19 103.95 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 32.149999999999999 110.894 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.29 127.5 36.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 42.200000000000003 111.13 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.2 t -52.32 138.02 27.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 72.530000000000001 110.852 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 19' ' ' TRP . 15.1 m -144.01 53.5 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 71.310000000000002 110.869 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.553 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 53.2 t90 -34.1 138.61 0.3 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.589 0.709 . . . . 63.149999999999999 110.882 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.4 Cg_endo -69.78 -39.51 1.32 Allowed 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.673 -1.803 . . . . 61.530000000000001 112.314 -0.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.52 -168.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 61.409999999999997 111.132 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 21.1 t -150.86 139.2 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 43.340000000000003 110.874 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.75 -94.45 0.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 52.340000000000003 112.487 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -148.65 -170.3 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 74.219999999999999 110.863 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.39 -37.27 4.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 73.010000000000005 110.908 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -51.47 13.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 73.239999999999995 110.906 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -93.91 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 73.230000000000004 110.944 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.76 37.39 1.57 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 31.41 112.478 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 52.210000000000001 111.137 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.855 0.359 . . . . 71.340000000000003 110.904 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.64 21.04 73.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 61.399999999999999 112.504 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -117.92 -172.19 2.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.99 0.424 . . . . 74.510000000000005 110.844 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.09 130.09 17.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 43.100000000000001 111.15 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.5 p -110.64 59.88 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 63.219999999999999 110.86 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -51.28 -36.6 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 70.430000000000007 111.134 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.13 -29.11 74.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 73.120000000000005 112.547 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.42 37.01 3.16 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 65.420000000000002 112.482 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -149.96 109.8 4.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 63.009999999999998 111.159 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.0 28.12 0.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 73.319999999999993 110.912 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -72.1 81.33 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 74.230000000000004 110.874 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.07 158.84 31.56 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.593 0.711 . . . . 54.229999999999997 111.154 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 85.02 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.648 2.232 . . . . 40.340000000000003 112.352 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.15 3.9 12.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 65.349999999999994 112.458 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 154.76 43.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 74.230000000000004 110.888 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -127.57 157.07 41.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 62.340000000000003 111.139 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.7 t -78.71 145.07 34.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 72.420000000000002 110.876 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' TRP . 38.6 m -143.11 53.07 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 71.219999999999999 110.819 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 50.7 t90 -36.6 138.66 0.48 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.577 0.704 . . . . 75.439999999999998 110.892 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.565 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.74 -37.39 1.99 Allowed 'Cis proline' 0 C--N 1.342 0.204 0 C-N-CA 122.667 -1.805 . . . . 65.450000000000003 112.345 -0.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 m -67.71 -168.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 75.430000000000007 111.099 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.2 t -149.45 140.91 23.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 52.450000000000003 110.911 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.0 -92.4 0.14 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 62.219999999999999 112.486 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -150.78 -171.05 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.326 . . . . 75.519999999999996 110.891 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.63 -38.04 4.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 72.150000000000006 110.889 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -58.05 3.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 73.219999999999999 110.866 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -87.12 -69.3 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 63.340000000000003 110.922 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.17 57.7 0.95 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 53.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 71.510000000000005 111.14 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 89.9 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.828 0.347 . . . . 50.12 110.867 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.76 46.04 2.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 62.12 112.5 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.9 mp0 -139.82 -177.42 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 72.43 110.914 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.9 124.43 13.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 63.32 111.128 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.7 p -104.97 63.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 73.32 110.865 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.2 t -55.5 -25.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 75.11 111.155 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.07 -17.86 66.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.724 -0.75 . . . . 72.31 112.501 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.02 32.3 7.99 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 40.44 112.529 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 9' ' ' THR . 1.8 t -140.46 104.3 4.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 61.22 111.138 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.2 31.24 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 64.43 110.912 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -74.62 84.36 2.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.89 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.44 158.48 36.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.557 0.694 . . . . 72.03 111.146 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 87.63 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.66 2.24 . . . . 64.22 112.374 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.91 3.42 19.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.762 . . . . 50.45 112.497 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.71 151.23 42.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 64.01 110.909 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 p -124.01 160.55 27.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 65.13 111.151 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.1 t -85.39 142.55 29.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 61.4 110.907 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 19' ' ' TRP . 10.9 t -141.36 52.39 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 63.3 110.851 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.548 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 46.6 t90 -35.83 138.74 0.42 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.545 0.688 . . . . 64.15 110.941 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.4 Cg_endo -69.85 -36.85 2.19 Favored 'Cis proline' 0 C--O 1.232 0.187 0 C-N-CA 122.659 -1.809 . . . . 72.2 112.321 0.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 m -68.15 -170.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 75.15 111.129 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.3 t -150.96 140.96 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.915 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.83 -103.43 0.24 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.737 . . . . 54.12 112.519 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -139.75 -169.83 2.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.85 0.357 . . . . 74.34 110.812 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -108.06 -26.95 10.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.905 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -48.78 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 74.14 110.857 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -95.87 -68.47 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.929 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.0 32.48 3.52 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 42.11 112.487 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 29' ' ' VAL . 6.1 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 51.42 111.127 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.896 0.379 . . . . 71.22 110.916 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.17 40.37 97.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 54.41 112.526 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -108.85 -178.85 3.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 74.12 110.934 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.89 143.35 32.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 73.02 111.148 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.72 20.36 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 73.11 110.884 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 p -50.98 -40.39 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 75.33 111.094 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.33 -1.61 69.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 43.54 112.487 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.79 56.49 18.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 73.55 112.483 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -150.37 43.81 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 75.53 111.125 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.1 p -125.91 56.38 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 31.23 110.886 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.3 121.42 32.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.32 110.859 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.503 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -125.67 158.72 64.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.62 0.724 . . . . 75.45 111.138 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.503 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.2 Cg_endo -69.75 90.6 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.707 2.271 . . . . 63.33 112.332 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.94 1.64 23.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 53.23 112.481 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.57 157.84 32.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.881 0.372 . . . . 64.53 110.877 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.63 -175.16 2.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 74.51 111.143 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.3 t -118.83 142.27 47.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.432 . . . . 74.54 110.877 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 m -139.84 59.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.24 110.88 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.542 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 36.4 t90 -37.79 138.99 0.61 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.581 0.705 . . . . 71.24 110.929 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.74 -40.82 1.02 Allowed 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.71 -1.788 . . . . 74.13 112.334 0.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.74 -177.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 64.33 111.141 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.7 t -134.2 160.94 36.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 61.54 110.918 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.86 -95.93 0.5 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 54.41 112.481 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -149.38 -179.18 6.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 64.02 110.829 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -102.91 -28.37 12.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.33 110.846 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -83.2 -64.57 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 65.03 110.831 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -82.95 -69.03 0.66 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 73.12 110.865 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.15 44.83 2.71 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 25.03 112.511 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 62.24 111.116 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.906 0.384 . . . . 52.32 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.08 68.42 1.67 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 51.34 112.497 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -146.57 -177.29 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 74.33 110.892 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.46 151.15 30.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 72.44 111.162 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.6 t -150.09 28.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 61.52 110.825 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.55 -36.42 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.53 111.136 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.32 -10.59 81.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 64.22 112.478 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.08 7.93 76.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 34.23 112.492 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -111.49 88.66 2.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 74.44 111.204 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.2 t -150.25 47.77 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 62.01 110.908 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -90.16 113.56 25.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.899 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.49 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -132.17 158.62 75.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 72.04 111.125 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.49 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.7 Cg_endo -69.73 87.63 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.734 2.289 . . . . 72.53 112.351 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.8 3.47 20.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 71.03 112.491 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 m -135.29 149.49 49.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.94 0.4 . . . . 74.34 110.839 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.21 179.36 4.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.178 -0.465 . . . . 64.51 111.11 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -102.7 144.49 31.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 62.32 110.91 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 19' ' ' TRP . 8.6 t -141.6 52.46 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 70.32 110.836 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.542 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 40.8 t90 -34.88 138.75 0.34 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.577 0.703 . . . . 73.24 110.899 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.8 Cg_endo -69.74 -38.51 1.6 Allowed 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.73 -1.779 . . . . 64.14 112.344 -0.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.09 -171.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 64.34 111.126 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.9 t -131.31 151.79 51.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 73.5 110.911 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.69 -97.98 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 72.32 112.533 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -148.03 -169.29 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 74.41 110.846 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -103.76 -17.46 15.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.14 110.857 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -100.51 -67.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 65.33 110.879 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -92.38 -69.65 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 73.01 110.902 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.18 76.49 0.86 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 53.4 112.479 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 42.35 111.133 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.927 0.394 . . . . 55.25 110.905 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.15 46.01 4.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 33.24 112.472 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -144.66 -179.67 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 63.11 110.942 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -145.83 139.15 26.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.171 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 1.431 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -128.05 79.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 53.21 110.913 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.28 -17.02 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 73.24 111.141 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.87 6.76 25.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.69 -0.766 . . . . 71.15 112.494 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.35 56.4 15.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 75.23 112.522 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -148.07 73.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 71.34 111.16 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.804 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 17.5 p -149.06 25.83 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 70.11 110.845 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -66.31 135.0 53.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 55.03 110.888 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.94 159.53 40.08 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.503 0.668 . . . . 65.14 111.196 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 79.9 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.638 2.225 . . . . 53.21 112.355 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.56 -0.22 5.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.757 . . . . 73.21 112.483 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.0 163.48 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.957 0.408 . . . . 44.31 110.849 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -133.04 175.17 9.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 72.51 111.178 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 28.0 t -101.5 155.32 18.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 64.1 110.884 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 19' ' ' TRP . 3.2 t -150.08 57.54 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 62.41 110.852 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.546 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 41.8 t90 -36.67 138.85 0.48 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.536 0.684 . . . . 72.34 110.863 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 54.2 Cg_endo -69.73 -38.83 1.49 Allowed 'Cis proline' 0 C--O 1.231 0.131 0 C-N-CA 122.712 -1.787 . . . . 74.02 112.346 -0.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.4 -169.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 53.11 111.175 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 1.431 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -150.11 155.31 39.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 75.21 110.891 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.06 -90.75 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 72.11 112.457 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -148.82 -174.53 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 73.3 110.905 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -109.89 -25.48 10.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 71.34 110.878 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -88.27 -67.67 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.23 110.888 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -76.07 -69.14 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 75.12 110.927 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.56 38.93 2.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 72.43 112.494 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 72.32 111.129 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.825 0.345 . . . . 72.23 110.869 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.21 43.55 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 74.54 112.449 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -148.77 -173.59 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 72.21 110.912 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.46 130.11 20.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 72.44 111.144 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.2 p -110.83 66.55 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 74.3 110.872 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.58 -27.17 20.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 75.53 111.119 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.35 -14.88 70.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 73.43 112.484 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.74 28.15 19.7 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 62.34 112.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 9' ' ' THR . 1.7 t -129.26 98.74 4.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.364 . . . . 64.12 111.186 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.1 20.78 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.42 110.862 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -71.38 84.73 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 73.3 110.879 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.22 158.85 34.06 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.557 0.694 . . . . 64.31 111.186 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 80.91 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.674 2.25 . . . . 72.1 112.346 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.03 1.31 6.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 61.05 112.489 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.93 156.54 43.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 53.43 110.871 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.97 168.66 13.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 53.41 111.11 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -92.88 147.27 22.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 71.22 110.837 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 19' ' ' TRP . 33.4 t -144.91 54.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.867 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.555 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 53.0 t90 -36.89 138.6 0.51 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 73.22 110.946 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.555 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.81 -37.79 1.86 Allowed 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 -1.811 . . . . 73.42 112.343 -0.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 m -66.09 -170.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 45.4 111.138 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.1 t -144.88 141.55 29.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 62.43 110.9 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.81 -91.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.758 . . . . 70.04 112.47 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -148.15 177.93 8.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 73.52 110.908 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -96.29 -26.28 15.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 74.53 110.89 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.69 -62.55 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 75.53 110.829 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -83.24 -68.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 62.31 110.927 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.2 49.14 0.89 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 60.35 112.469 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 71.21 111.121 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.902 0.382 . . . . 71.2 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.14 31.18 61.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 64.22 112.517 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.91 -169.41 1.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.944 0.402 . . . . 71.32 110.817 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.69 140.76 43.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 75.12 111.112 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.659 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.8 t -143.52 30.69 1.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 75.44 110.852 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.8 t -54.88 -29.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 73.33 111.172 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.73 -3.91 64.0 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.752 -0.737 . . . . 62.23 112.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.29 53.83 19.69 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.733 -0.746 . . . . 70.41 112.453 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -139.75 66.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 74.14 111.167 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.659 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 19.5 m -118.21 58.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 70.01 110.879 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -90.07 64.55 6.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 53.3 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.638 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -104.6 149.96 38.02 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.618 0.723 . . . . 73.32 111.151 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.638 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.8 Cg_endo -69.74 92.79 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.677 2.251 . . . . 74.02 112.348 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.73 3.44 28.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 70.33 112.456 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 t -132.99 141.09 48.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 71.2 110.898 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -112.54 -179.69 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 53.15 111.114 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' H ' HG22 ' A' ' 16' ' ' THR . 34.1 t -103.09 142.16 34.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 73.45 110.86 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' TRP . 39.2 m -139.79 49.58 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 52.44 110.869 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.547 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 40.9 t90 -35.98 138.8 0.43 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.521 0.676 . . . . 74.12 110.961 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.5 Cg_endo -69.76 -35.28 2.75 Favored 'Cis proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.671 -1.804 . . . . 72.32 112.383 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 m -68.71 -170.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 44.11 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.3 t -132.43 156.93 45.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 62.24 110.89 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.79 -102.27 0.35 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 61.15 112.533 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -148.29 163.07 38.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 65.31 110.845 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -85.27 -25.47 27.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.55 110.904 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -86.27 -62.86 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 72.52 110.911 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -82.34 -69.0 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 71.44 110.952 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.95 49.22 1.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.696 -0.764 . . . . 74.33 112.492 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 73.22 111.118 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.891 0.377 . . . . 45.34 110.91 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.07 38.56 1.66 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 60.13 112.49 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -138.61 -175.04 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 65.23 110.889 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.09 128.47 17.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 65.41 111.15 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.4 p -108.27 61.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 75.45 110.866 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.0 t -52.56 -28.56 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 41.22 111.138 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.08 -28.22 70.7 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.723 -0.751 . . . . 54.45 112.477 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.21 27.88 6.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.773 -0.727 . . . . 60.51 112.492 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 t -149.87 119.34 6.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 72.33 111.094 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.41 67.1 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 54.2 110.904 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -90.18 85.62 6.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.906 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.89 154.93 41.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.711 . . . . 64.15 111.167 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 87.66 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.699 2.266 . . . . 73.43 112.329 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.86 7.19 29.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 73.43 112.41 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 m -140.15 159.26 42.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 71.31 110.927 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -128.16 177.42 6.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 72.41 111.095 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.416 ' H ' HG22 ' A' ' 16' ' ' THR . 42.2 t -93.78 144.11 25.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 64.23 110.895 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 19' ' ' TRP . 74.7 m -144.26 53.78 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.4 110.904 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.551 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 54.2 t90 -36.46 138.67 0.47 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.53 0.681 . . . . 74.34 110.924 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.5 Cg_endo -69.8 -37.62 1.92 Allowed 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.696 -1.793 . . . . 74.53 112.351 0.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.9 m -67.11 -169.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 74.15 111.127 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.6 t -149.33 141.03 23.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 62.35 110.869 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.92 -101.43 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 32.44 112.485 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -135.38 -170.61 2.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 71.53 110.858 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -106.41 -31.91 8.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.87 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -82.79 -64.41 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 65.23 110.858 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -81.23 -69.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.4 110.957 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.35 26.54 6.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 52.23 112.51 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 72.44 111.079 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.857 0.361 . . . . 74.15 110.888 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.82 66.58 0.67 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 21.24 112.481 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -141.43 174.34 10.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.419 . . . . 74.22 110.83 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.0 140.43 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 71.44 111.16 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.73 17.54 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 73.45 110.893 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.8 t -49.12 -49.4 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 74.41 111.091 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.85 -25.79 66.26 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.739 -0.743 . . . . 64.33 112.485 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.63 22.06 19.8 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.759 -0.734 . . . . 71.11 112.505 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -149.26 91.41 1.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 72.31 111.106 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p -149.35 30.35 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 73.02 110.905 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -58.97 128.69 38.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 72.32 110.893 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.574 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -140.14 155.42 70.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.556 0.693 . . . . 72.43 111.149 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.2 Cg_endo -69.78 96.49 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 74.1 112.331 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.18 -1.19 29.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 45.44 112.512 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.6 m -127.06 143.84 51.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 75.42 110.891 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 p -114.83 134.51 55.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 55.11 111.16 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 t -60.0 136.42 58.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.911 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' TRP . 19.3 m -139.7 54.44 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 52.34 110.841 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.547 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 38.5 t90 -35.93 138.71 0.43 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.485 0.66 . . . . 73.43 110.945 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.79 -39.91 1.23 Allowed 'Cis proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.672 -1.803 . . . . 64.33 112.363 -0.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -63.7 -175.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.31 111.105 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.5 t -140.73 148.01 40.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 62.3 110.903 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.05 -75.81 0.37 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 51.5 112.482 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -151.87 -171.83 4.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 43.34 110.89 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -117.24 -33.67 4.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 72.11 110.858 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -80.31 -54.84 5.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.476 . . . . 71.44 110.85 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -88.47 -68.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.93 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.71 18.1 28.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.754 . . . . 73.15 112.484 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.901 0.381 . . . . 63.45 111.081 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 95.8 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.9 0.381 . . . . 73.11 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.04 44.26 5.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 54.02 112.489 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -148.41 175.82 10.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 74.4 110.876 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -143.85 125.12 14.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 75.34 111.17 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p -104.17 61.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 61.21 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -54.24 -26.4 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 54.4 111.158 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.76 -23.33 67.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 72.32 112.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.39 32.43 5.76 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 75.22 112.492 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -147.54 112.02 5.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 71.41 111.173 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 27.04 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 72.53 110.842 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -64.37 95.66 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.907 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.5 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -132.59 158.22 76.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.588 0.709 . . . . 75.11 111.1 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.5 Cg_endo -69.81 94.26 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.71 2.273 . . . . 61.52 112.349 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.18 3.9 38.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 61.41 112.546 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.9 m -134.3 133.23 40.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 71.32 110.881 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -117.0 128.83 55.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.14 111.142 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -56.53 141.76 41.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 70.42 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' TRP . 2.8 t -144.35 53.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 73.11 110.832 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.551 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 52.9 t90 -35.79 138.67 0.42 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.558 0.694 . . . . 64.42 110.912 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.1 Cg_endo -69.77 -37.96 1.8 Allowed 'Cis proline' 0 C--N 1.341 0.137 0 C-N-CA 122.713 -1.786 . . . . 73.31 112.315 -0.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 m -67.89 -169.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 44.52 111.149 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 t -151.58 140.9 21.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.844 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.08 -92.25 0.15 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 44.23 112.469 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -148.78 -170.34 3.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 63.22 110.859 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.04 -38.43 3.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 71.25 110.887 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.66 -57.08 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 71.24 110.875 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -84.68 -69.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 74.13 110.89 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.74 44.44 2.47 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.739 -0.743 . . . . 51.24 112.487 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 55.41 111.131 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.864 0.364 . . . . 73.21 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.97 30.17 23.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 51.5 112.501 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -126.4 -175.76 3.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 74.14 110.875 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.16 127.79 16.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 74.22 111.142 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.5 p -108.38 61.8 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 71.53 110.866 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -53.09 -27.54 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.1 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.96 -26.33 69.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.739 . . . . 71.12 112.509 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.33 31.38 5.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 73.21 112.488 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 t -149.84 114.97 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 74.03 111.137 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.68 50.03 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 61.43 110.924 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -81.43 88.35 6.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 71.53 110.862 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.49 157.93 39.98 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.558 0.694 . . . . 73.01 111.183 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 90.11 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.273 . . . . 70.42 112.303 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.38 6.33 33.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 64.41 112.495 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.86 153.4 45.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 73.32 110.919 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -125.37 172.9 9.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 42.35 111.133 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.66 145.32 24.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 72.23 110.902 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 19' ' ' TRP . 46.0 m -144.9 54.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 72.05 110.871 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.555 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 52.5 t90 -36.54 138.85 0.47 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.543 0.687 . . . . 63.42 110.935 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.555 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.69 -37.83 1.84 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.722 -1.783 . . . . 51.52 112.35 -0.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 m -67.05 -170.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.32 111.123 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.5 t -148.58 141.17 24.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 74.43 110.935 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.4 -97.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 44.33 112.487 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -148.73 -170.22 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 60.33 110.873 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.09 -40.38 3.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.88 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -50.89 22.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 72.44 110.856 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -92.63 -69.22 0.76 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 73.4 110.888 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.89 49.67 1.24 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 44.13 112.512 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 73.53 111.08 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 CA--C 1.526 0.038 0 CA-C-O 120.882 0.372 . . . . 75.11 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.9 43.8 95.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.742 . . . . 72.1 112.473 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -112.43 -168.96 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 72.33 110.923 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.498 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -143.85 132.56 22.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 75.04 111.088 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 p -130.98 62.57 1.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 54.12 110.9 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.3 t -54.28 -30.23 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 63.43 111.153 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.71 -17.78 72.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 52.31 112.492 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.0 16.62 40.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 64.23 112.52 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.59 99.08 7.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 75.32 111.157 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.79 29.89 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 64.21 110.895 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -76.38 88.06 3.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 74.23 110.897 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.556 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -114.37 154.63 46.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.537 0.684 . . . . 63.53 111.182 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.556 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.3 Cg_endo -69.77 84.53 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.701 2.267 . . . . 75.32 112.315 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.99 0.96 8.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 65.43 112.504 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.87 151.91 36.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 73.44 110.937 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -122.98 173.94 7.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.32 111.145 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.6 t -94.84 148.97 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 62.55 110.877 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 19' ' ' TRP . 4.7 t -144.93 53.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 70.03 110.867 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.559 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 44.3 t90 -33.77 138.35 0.29 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.54 0.686 . . . . 75.03 110.949 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.82 -40.44 1.11 Allowed 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 -1.809 . . . . 74.41 112.32 0.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 4' ' ' THR . 14.9 m -66.99 -170.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 72.11 111.152 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.1 t -138.85 148.35 43.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.45 110.903 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.73 -95.66 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.752 . . . . 62.32 112.505 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -151.31 -171.04 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 63.31 110.878 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -102.91 -22.29 13.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.883 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -96.08 -66.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 75.42 110.86 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -95.44 -69.5 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 51.25 110.925 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.01 79.0 0.71 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.726 -0.75 . . . . 63.44 112.479 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 75.0 111.121 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.89 0.376 . . . . 75.24 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.24 44.51 96.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.775 -0.726 . . . . 30.42 112.494 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.19 -176.13 3.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 75.22 110.891 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -147.18 137.32 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 73.35 111.117 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.03 81.12 2.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 73.51 110.844 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.77 -18.48 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 71.53 111.127 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.16 0.23 38.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 74.23 112.444 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.5 38.99 43.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.777 -0.725 . . . . 75.12 112.487 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.86 84.05 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 61.11 111.146 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -136.18 67.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 41.1 110.902 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -90.93 88.3 6.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 72.02 110.893 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.595 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -121.68 151.15 56.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 75.11 111.092 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.595 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.7 Cg_endo -69.75 91.76 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.641 2.227 . . . . 70.53 112.324 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.67 6.68 46.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 72.43 112.512 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 147.22 50.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.949 0.404 . . . . 74.44 110.915 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -121.24 179.69 4.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 61.11 111.146 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.1 t -103.35 155.37 18.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 42.15 110.88 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' TRP . 72.3 m -150.29 54.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 71.23 110.85 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.545 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 48.9 t90 -35.91 138.58 0.43 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.596 0.713 . . . . 75.44 110.891 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 54.3 Cg_endo -69.73 -37.86 1.83 Allowed 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.691 -1.795 . . . . 53.44 112.354 -0.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 m -67.88 -168.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 72.54 111.115 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.69 167.19 23.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 45.44 110.879 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.46 -100.43 0.54 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 61.43 112.488 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.19 -173.37 3.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 65.23 110.842 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -103.07 -22.08 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.919 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -98.44 -66.96 0.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 73.02 110.859 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -92.58 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.95 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.81 77.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 51.12 112.521 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 71.14 111.121 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.876 0.369 . . . . 52.32 110.85 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.8 57.06 2.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 72.11 112.436 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -142.02 -169.54 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.39 . . . . 60.44 110.852 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -143.55 133.62 24.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 74.43 111.125 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 p -131.31 61.0 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 72.53 110.906 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.8 t -53.65 -30.83 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 72.54 111.144 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.63 -22.5 74.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 53.1 112.515 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.07 21.27 18.48 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.794 -0.717 . . . . 72.34 112.482 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 9' ' ' THR . 1.8 t -125.68 103.82 8.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 73.21 111.156 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.1 34.35 0.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 53.42 110.892 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -78.73 86.04 4.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.934 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.16 158.78 33.44 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.636 0.732 . . . . 72.21 111.098 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 85.34 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.695 2.264 . . . . 61.11 112.357 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.36 4.94 15.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 51.23 112.489 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 m -144.38 157.19 44.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 70.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 p -129.7 170.17 14.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 72.1 111.134 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -91.72 148.5 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 62.12 110.865 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 19' ' ' TRP . 13.6 m -145.35 53.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.892 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.553 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 44.3 t90 -33.81 138.4 0.29 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.548 0.69 . . . . 74.32 110.924 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.75 -40.03 1.2 Allowed 'Cis proline' 0 C--O 1.232 0.199 0 C-N-CA 122.688 -1.797 . . . . 65.34 112.346 -0.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.523 ' HA ' HG22 ' A' ' 4' ' ' THR . 13.9 m -67.48 -170.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 74.41 111.154 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -141.13 144.99 35.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 60.4 110.904 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.89 -95.79 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 40.22 112.487 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -148.71 -169.31 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.845 0.355 . . . . 55.23 110.859 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -105.49 -27.75 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 70.12 110.865 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -96.33 -60.85 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 72.25 110.856 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -74.69 -68.86 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 75.44 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 38.47 6.05 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 54.33 112.436 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 74.44 111.095 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.882 0.372 . . . . 64.05 110.894 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.95 37.34 3.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 65.43 112.509 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -146.37 172.01 14.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.939 0.4 . . . . 71.45 110.903 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.6 124.39 25.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 72.45 111.109 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 1.202 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.9 m -90.27 51.72 2.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.5 110.833 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.1 t -45.78 -44.13 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.3 111.116 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.25 18.47 36.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 75.44 112.463 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.59 53.76 36.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.747 . . . . 24.43 112.492 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 t -149.95 72.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 62.1 111.148 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 1.212 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 31.6 p -150.11 35.18 0.66 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 61.33 110.894 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -73.43 123.56 24.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.896 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.85 159.29 71.96 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.607 0.718 . . . . 63.3 111.143 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 82.64 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 71.32 112.311 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.21 2.16 8.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 55.42 112.527 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.97 158.29 44.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 63.43 110.868 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -122.74 178.38 5.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 65.54 111.176 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 1.212 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -99.98 151.08 21.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 50.03 110.882 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' TRP . 19.4 m -148.56 56.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 71.44 110.862 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.543 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 37.0 t90 -37.29 138.88 0.55 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.545 0.688 . . . . 74.54 110.878 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.74 -39.99 1.2 Allowed 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.706 -1.789 . . . . 70.24 112.341 -0.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.81 -170.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.132 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.822 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 20.0 t -139.59 154.01 47.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 72.22 110.867 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.85 -99.35 0.24 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.741 -0.742 . . . . 71.31 112.511 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -149.47 -169.75 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 75.42 110.872 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -101.74 -21.37 14.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 73.22 110.867 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -93.11 -74.75 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 73.03 110.85 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -69.27 -68.76 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.897 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.62 38.38 5.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 54.13 112.515 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 75.13 111.1 -179.929 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.896 0.379 . . . . 61.53 110.927 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.19 59.26 8.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 71.32 112.451 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -137.17 -173.03 3.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 74.42 110.901 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -143.57 128.24 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 61.12 111.143 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.4 p -124.57 53.47 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 64.41 110.884 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.4 m -52.69 -32.46 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 63.3 111.152 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.84 -25.13 74.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 70.34 112.503 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.53 40.58 3.15 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 75.53 112.496 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 1.8 t -148.83 103.02 3.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 73.43 111.197 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.18 33.69 0.66 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 54.45 110.924 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -80.1 84.29 5.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 70.45 110.912 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.31 158.23 35.86 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.581 0.705 . . . . 74.33 111.163 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 85.23 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 73.42 112.353 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.87 3.71 13.37 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 62.01 112.462 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.1 m -142.75 151.91 41.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 74.42 110.864 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 p -125.94 164.63 20.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 70.33 111.137 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.79 147.56 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.884 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 19' ' ' TRP . 16.0 m -145.26 53.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 62.25 110.835 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.557 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 41.5 t90 -34.24 138.32 0.32 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.542 0.686 . . . . 63.34 110.936 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.73 -40.44 1.1 Allowed 'Cis proline' 0 C--N 1.342 0.199 0 C-N-CA 122.721 -1.783 . . . . 71.12 112.345 -0.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.471 ' HA ' HG22 ' A' ' 4' ' ' THR . 13.2 m -67.11 -170.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 71.44 111.144 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.1 t -144.95 142.88 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 63.42 110.897 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.35 -96.23 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.787 -0.72 . . . . 61.54 112.485 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -148.25 -171.4 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 73.53 110.875 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -105.22 -27.49 11.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 71.34 110.844 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -89.77 -70.03 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.887 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -73.18 -68.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.844 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.39 37.97 4.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 43.45 112.436 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 74.3 111.121 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.877 0.37 . . . . 63.3 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.08 45.95 2.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.727 -0.749 . . . . 64.53 112.491 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -139.18 -176.13 4.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 70.14 110.914 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.5 127.8 17.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 72.43 111.18 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 p -107.13 64.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 65.33 110.849 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.4 t -55.26 -25.79 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 72.52 111.152 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.82 -18.56 67.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 53.25 112.466 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.36 31.8 8.17 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.777 -0.725 . . . . 71.42 112.47 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 1.9 t -140.93 105.41 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 74.14 111.157 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 26.77 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 70.34 110.898 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -70.14 102.22 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 75.23 110.886 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.411 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -133.68 158.15 76.22 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.527 0.68 . . . . 70.42 111.149 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.9 Cg_endo -69.79 88.68 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.692 2.261 . . . . 73.13 112.319 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.45 2.33 19.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 72.41 112.479 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 146.19 30.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.387 . . . . 52.0 110.849 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 p -122.0 165.47 15.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 75.24 111.176 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.2 t -88.23 143.22 27.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 54.1 110.888 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' TRP . 5.1 t -142.1 53.04 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.35 110.818 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.549 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 47.1 t90 -35.97 138.74 0.43 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.538 0.685 . . . . 74.22 110.918 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.549 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.73 -37.57 1.93 Allowed 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 -1.785 . . . . 73.45 112.337 -0.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 m -67.31 -170.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 73.23 111.132 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.0 t -149.73 140.78 22.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 72.12 110.894 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.22 -103.92 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.757 -0.735 . . . . 73.33 112.518 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -137.16 -172.32 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.82 0.343 . . . . 74.32 110.846 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -105.63 -25.99 12.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 63.23 110.881 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -57.51 3.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 74.51 110.89 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -101.51 -84.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.915 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.73 54.85 0.13 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 61.14 112.475 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 73.34 111.126 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.6 m . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.914 0.387 . . . . 64.4 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.05 37.52 25.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 71.13 112.49 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.7 -178.2 3.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 73.11 110.88 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.87 151.13 26.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 72.3 111.12 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 t -150.31 23.26 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 33.24 110.864 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.8 t -51.76 -39.56 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 75.24 111.1 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.53 20.85 47.66 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.78 -0.724 . . . . 72.13 112.485 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.27 19.31 39.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 15.15 112.484 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -113.11 80.39 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 71.44 111.101 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 t -150.21 59.65 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.913 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -90.43 122.76 33.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.11 110.881 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.641 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -146.63 149.51 37.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.595 0.712 . . . . 74.52 111.168 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.0 Cg_endo -69.73 96.49 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 73.34 112.359 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.62 4.55 36.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 72.34 112.461 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.8 t -128.49 144.49 51.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 72.3 110.907 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.48 177.78 4.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 73.51 111.131 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.8 t -101.98 143.83 31.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.876 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 19' ' ' TRP . 54.7 m -141.28 50.75 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.23 110.827 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.552 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 39.6 t90 -34.49 138.74 0.32 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.587 0.708 . . . . 75.3 110.934 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.552 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.8 Cg_endo -69.79 -37.5 1.96 Allowed 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.707 -1.789 . . . . 63.41 112.353 -0.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -68.5 -170.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.134 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -135.45 157.04 47.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 74.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.01 -107.15 0.46 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 51.11 112.495 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -147.79 -171.64 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 54.22 110.861 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.44 -34.55 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.881 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -50.79 16.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 74.34 110.874 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -93.88 -69.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 72.34 110.931 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.08 37.01 2.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 74.02 112.503 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.37 . . . . 64.21 111.14 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.902 0.382 . . . . 54.5 110.854 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 128.82 -22.44 5.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 62.04 112.472 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -91.14 175.85 6.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 74.24 110.885 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.597 ' OG1' HG23 ' A' ' 6' ' ' VAL . 1.8 t -109.73 160.18 16.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 74.33 111.108 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.3 t -126.84 35.59 4.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 73.3 110.867 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.597 HG23 ' OG1' ' A' ' 4' ' ' THR . 60.0 t -46.91 -54.9 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.42 111.146 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.17 -25.02 65.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 63.03 112.495 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.9 26.05 18.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 55.14 112.52 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -147.75 97.89 2.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.354 . . . . 72.05 111.144 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.8 p -150.22 23.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 62.11 110.876 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -51.93 121.77 7.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.93 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.54 159.3 73.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.622 0.725 . . . . 65.21 111.124 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 80.4 0.89 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.712 2.275 . . . . 70.1 112.335 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.4 2.67 6.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 51.12 112.445 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.1 156.94 44.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 74.22 110.868 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -176.42 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.35 111.132 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.0 t -90.14 142.09 28.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.862 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 19' ' ' TRP . 15.2 m -141.35 51.89 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 65.04 110.838 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.57 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 34.4 t90 -34.53 138.99 0.32 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 75.3 110.921 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.57 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 54.4 Cg_endo -69.65 -39.88 1.23 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.712 -1.787 . . . . 74.33 112.36 -0.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 m -69.45 -169.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 65.45 111.113 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.6 t -130.64 149.22 52.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.52 110.855 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.09 -109.23 0.45 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 64.14 112.508 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -142.44 -170.46 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 75.24 110.891 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -102.02 -34.52 9.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.893 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -55.61 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 63.34 110.896 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -87.72 -68.32 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 65.3 110.913 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 43.72 2.19 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 22.43 112.482 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.6 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 55.4 111.161 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.882 0.372 . . . . 61.55 110.869 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 121.26 23.65 2.61 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.808 -0.711 . . . . 73.24 112.508 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.3 -172.83 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.941 0.4 . . . . 51.24 110.883 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -144.31 127.6 16.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 63.55 111.176 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.3 p -108.33 63.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 75.35 110.845 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.7 t -54.82 -26.3 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 64.54 111.136 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.49 -19.75 65.63 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 71.2 112.518 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.2 30.46 7.8 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 64.02 112.556 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 9' ' ' THR . 2.2 t -139.63 107.18 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 65.2 111.132 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.54 37.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 72.42 110.876 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -73.81 75.59 1.61 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 72.14 110.866 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.561 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -116.39 154.45 48.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.575 0.702 . . . . 53.03 111.14 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.561 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.2 Cg_endo -69.75 90.4 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.676 2.25 . . . . 75.12 112.352 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.28 4.83 25.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 53.34 112.472 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 52.2 t -140.19 103.95 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 32.15 110.894 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.29 127.5 36.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 42.2 111.13 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.2 t -52.32 138.02 27.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.852 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 19' ' ' TRP . 15.1 m -144.01 53.5 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 71.31 110.869 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.553 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 53.2 t90 -34.1 138.61 0.3 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.589 0.709 . . . . 63.15 110.882 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.4 Cg_endo -69.78 -39.51 1.32 Allowed 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.673 -1.803 . . . . 61.53 112.314 -0.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.52 -168.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 61.41 111.132 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 21.1 t -150.86 139.2 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 43.34 110.874 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.75 -94.45 0.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 52.34 112.487 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -148.65 -170.3 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 74.22 110.863 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.39 -37.27 4.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 73.01 110.908 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -51.47 13.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 73.24 110.906 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -93.91 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 73.23 110.944 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.76 37.39 1.57 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 31.41 112.478 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 52.21 111.137 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.855 0.359 . . . . 71.34 110.904 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.64 21.04 73.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 61.4 112.504 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -117.92 -172.19 2.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.99 0.424 . . . . 74.51 110.844 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.09 130.09 17.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 43.1 111.15 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.5 p -110.64 59.88 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 63.22 110.86 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -51.28 -36.6 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 70.43 111.134 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.13 -29.11 74.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 73.12 112.547 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.42 37.01 3.16 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 65.42 112.482 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -149.96 109.8 4.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 63.01 111.159 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.0 28.12 0.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 73.32 110.912 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -72.1 81.33 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.874 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.07 158.84 31.56 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.593 0.711 . . . . 54.23 111.154 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 85.02 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.648 2.232 . . . . 40.34 112.352 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.15 3.9 12.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 65.35 112.458 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 154.76 43.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 74.23 110.888 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -127.57 157.07 41.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 62.34 111.139 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.7 t -78.71 145.07 34.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 72.42 110.876 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' TRP . 38.6 m -143.11 53.07 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 71.22 110.819 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 50.7 t90 -36.6 138.66 0.48 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.577 0.704 . . . . 75.44 110.892 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.565 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.74 -37.39 1.99 Allowed 'Cis proline' 0 C--N 1.342 0.204 0 C-N-CA 122.667 -1.805 . . . . 65.45 112.345 -0.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 m -67.71 -168.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 75.43 111.099 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.2 t -149.45 140.91 23.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 52.45 110.911 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.0 -92.4 0.14 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 62.22 112.486 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -150.78 -171.05 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.326 . . . . 75.52 110.891 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.63 -38.04 4.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 72.15 110.889 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -58.05 3.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 73.22 110.866 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -87.12 -69.3 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 63.34 110.922 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.17 57.7 0.95 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 53.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 71.51 111.14 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 89.9 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.828 0.347 . . . . 50.12 110.867 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.76 46.04 2.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 62.12 112.5 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.9 mp0 -139.82 -177.42 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 72.43 110.914 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.9 124.43 13.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 63.32 111.128 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.7 p -104.97 63.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 73.32 110.865 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.2 t -55.5 -25.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 75.11 111.155 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.07 -17.86 66.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.724 -0.75 . . . . 72.31 112.501 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.02 32.3 7.99 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 40.44 112.529 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 9' ' ' THR . 1.8 t -140.46 104.3 4.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 61.22 111.138 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.2 31.24 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 64.43 110.912 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -74.62 84.36 2.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.89 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.44 158.48 36.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.557 0.694 . . . . 72.03 111.146 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 87.63 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.66 2.24 . . . . 64.22 112.374 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.91 3.42 19.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.762 . . . . 50.45 112.497 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.71 151.23 42.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 64.01 110.909 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.9 p -124.01 160.55 27.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 65.13 111.151 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.1 t -85.39 142.55 29.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 61.4 110.907 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 19' ' ' TRP . 10.9 t -141.36 52.39 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 63.3 110.851 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.548 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 46.6 t90 -35.83 138.74 0.42 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.545 0.688 . . . . 64.15 110.941 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.4 Cg_endo -69.85 -36.85 2.19 Favored 'Cis proline' 0 C--O 1.232 0.187 0 C-N-CA 122.659 -1.809 . . . . 72.2 112.321 0.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 m -68.15 -170.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 75.15 111.129 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.3 t -150.96 140.96 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.915 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.83 -103.43 0.24 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.737 . . . . 54.12 112.519 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -139.75 -169.83 2.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.85 0.357 . . . . 74.34 110.812 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -108.06 -26.95 10.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.905 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -48.78 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 74.14 110.857 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -95.87 -68.47 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.929 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.0 32.48 3.52 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 42.11 112.487 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 29' ' ' VAL . 6.1 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 51.42 111.127 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.896 0.379 . . . . 71.22 110.916 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.17 40.37 97.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 54.41 112.526 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -108.85 -178.85 3.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 74.12 110.934 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.89 143.35 32.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 73.02 111.148 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.72 20.36 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 73.11 110.884 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 p -50.98 -40.39 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 75.33 111.094 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.33 -1.61 69.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 43.54 112.487 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.79 56.49 18.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 73.55 112.483 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -150.37 43.81 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 75.53 111.125 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.1 p -125.91 56.38 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 31.23 110.886 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.3 121.42 32.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 63.32 110.859 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.503 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -125.67 158.72 64.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.62 0.724 . . . . 75.45 111.138 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.503 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.2 Cg_endo -69.75 90.6 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.707 2.271 . . . . 63.33 112.332 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.94 1.64 23.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 53.23 112.481 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.57 157.84 32.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.881 0.372 . . . . 64.53 110.877 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.63 -175.16 2.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 74.51 111.143 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.3 t -118.83 142.27 47.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.432 . . . . 74.54 110.877 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 m -139.84 59.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.24 110.88 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.542 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 36.4 t90 -37.79 138.99 0.61 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.581 0.705 . . . . 71.24 110.929 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.74 -40.82 1.02 Allowed 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.71 -1.788 . . . . 74.13 112.334 0.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.74 -177.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 64.33 111.141 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.7 t -134.2 160.94 36.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 61.54 110.918 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.86 -95.93 0.5 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 54.41 112.481 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -149.38 -179.18 6.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 64.02 110.829 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -102.91 -28.37 12.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.33 110.846 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -83.2 -64.57 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 65.03 110.831 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -82.95 -69.03 0.66 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 73.12 110.865 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.15 44.83 2.71 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 25.03 112.511 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 62.24 111.116 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.906 0.384 . . . . 52.32 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.08 68.42 1.67 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 51.34 112.497 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -146.57 -177.29 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 74.33 110.892 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.46 151.15 30.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 72.44 111.162 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.6 t -150.09 28.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 61.52 110.825 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.55 -36.42 28.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.53 111.136 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.32 -10.59 81.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 64.22 112.478 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.08 7.93 76.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 34.23 112.492 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -111.49 88.66 2.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 74.44 111.204 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.2 t -150.25 47.77 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 62.01 110.908 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -90.16 113.56 25.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.899 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.49 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -132.17 158.62 75.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 72.04 111.125 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.49 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.7 Cg_endo -69.73 87.63 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.734 2.289 . . . . 72.53 112.351 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.8 3.47 20.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 71.03 112.491 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 m -135.29 149.49 49.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.94 0.4 . . . . 74.34 110.839 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.21 179.36 4.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.178 -0.465 . . . . 64.51 111.11 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.6 t -102.7 144.49 31.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 62.32 110.91 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 19' ' ' TRP . 8.6 t -141.6 52.46 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 70.32 110.836 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.542 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 40.8 t90 -34.88 138.75 0.34 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.577 0.703 . . . . 73.24 110.899 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.8 Cg_endo -69.74 -38.51 1.6 Allowed 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 122.73 -1.779 . . . . 64.14 112.344 -0.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.09 -171.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 64.34 111.126 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.9 t -131.31 151.79 51.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 73.5 110.911 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.69 -97.98 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 72.32 112.533 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -148.03 -169.29 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 74.41 110.846 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -103.76 -17.46 15.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.14 110.857 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -100.51 -67.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 65.33 110.879 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -92.38 -69.65 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 73.01 110.902 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.18 76.49 0.86 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 53.4 112.479 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 42.35 111.133 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.927 0.394 . . . . 55.25 110.905 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.15 46.01 4.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 33.24 112.472 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -144.66 -179.67 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 63.11 110.942 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -145.83 139.15 26.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.171 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 1.431 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -128.05 79.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 53.21 110.913 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.28 -17.02 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 73.24 111.141 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -112.87 6.76 25.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.69 -0.766 . . . . 71.15 112.494 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.35 56.4 15.74 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 75.23 112.522 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -148.07 73.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 71.34 111.16 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.804 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 17.5 p -149.06 25.83 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 70.11 110.845 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -66.31 135.0 53.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 55.03 110.888 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.94 159.53 40.08 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.503 0.668 . . . . 65.14 111.196 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 79.9 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.638 2.225 . . . . 53.21 112.355 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.56 -0.22 5.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.757 . . . . 73.21 112.483 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.0 163.48 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.957 0.408 . . . . 44.31 110.849 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -133.04 175.17 9.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 72.51 111.178 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 28.0 t -101.5 155.32 18.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 64.1 110.884 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 19' ' ' TRP . 3.2 t -150.08 57.54 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 62.41 110.852 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.546 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 41.8 t90 -36.67 138.85 0.48 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.536 0.684 . . . . 72.34 110.863 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 54.2 Cg_endo -69.73 -38.83 1.49 Allowed 'Cis proline' 0 C--O 1.231 0.131 0 C-N-CA 122.712 -1.787 . . . . 74.02 112.346 -0.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.4 -169.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 53.11 111.175 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 1.431 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -150.11 155.31 39.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 75.21 110.891 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.06 -90.75 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 72.11 112.457 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -148.82 -174.53 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 73.3 110.905 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -109.89 -25.48 10.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 71.34 110.878 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -88.27 -67.67 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.23 110.888 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -76.07 -69.14 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 75.12 110.927 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.56 38.93 2.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 72.43 112.494 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 72.32 111.129 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.825 0.345 . . . . 72.23 110.869 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.21 43.55 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 74.54 112.449 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -148.77 -173.59 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 72.21 110.912 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.46 130.11 20.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 72.44 111.144 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.2 p -110.83 66.55 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 74.3 110.872 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.58 -27.17 20.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 75.53 111.119 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.35 -14.88 70.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 73.43 112.484 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.74 28.15 19.7 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 62.34 112.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 9' ' ' THR . 1.7 t -129.26 98.74 4.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.364 . . . . 64.12 111.186 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.1 20.78 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.42 110.862 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -71.38 84.73 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 73.3 110.879 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.22 158.85 34.06 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.557 0.694 . . . . 64.31 111.186 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 80.91 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.674 2.25 . . . . 72.1 112.346 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.03 1.31 6.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 61.05 112.489 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.93 156.54 43.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 53.43 110.871 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.97 168.66 13.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 53.41 111.11 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -92.88 147.27 22.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 71.22 110.837 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 19' ' ' TRP . 33.4 t -144.91 54.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.867 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.555 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 53.0 t90 -36.89 138.6 0.51 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 73.22 110.946 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.555 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.81 -37.79 1.86 Allowed 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 -1.811 . . . . 73.42 112.343 -0.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 m -66.09 -170.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 45.4 111.138 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.1 t -144.88 141.55 29.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 62.43 110.9 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.81 -91.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.758 . . . . 70.04 112.47 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -148.15 177.93 8.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 73.52 110.908 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -96.29 -26.28 15.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 74.53 110.89 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.69 -62.55 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 75.53 110.829 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -83.24 -68.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 62.31 110.927 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.2 49.14 0.89 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 60.35 112.469 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 71.21 111.121 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.902 0.382 . . . . 71.2 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.14 31.18 61.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 64.22 112.517 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.91 -169.41 1.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.944 0.402 . . . . 71.32 110.817 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.69 140.76 43.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 75.12 111.112 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.659 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.8 t -143.52 30.69 1.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 75.44 110.852 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.8 t -54.88 -29.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 73.33 111.172 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.73 -3.91 64.0 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.752 -0.737 . . . . 62.23 112.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.29 53.83 19.69 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.733 -0.746 . . . . 70.41 112.453 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -139.75 66.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 74.14 111.167 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.659 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 19.5 m -118.21 58.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 70.01 110.879 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -90.07 64.55 6.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 53.3 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.638 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -104.6 149.96 38.02 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.618 0.723 . . . . 73.32 111.151 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.638 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.8 Cg_endo -69.74 92.79 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.677 2.251 . . . . 74.02 112.348 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.73 3.44 28.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 70.33 112.456 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 t -132.99 141.09 48.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 71.2 110.898 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -112.54 -179.69 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 53.15 111.114 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' H ' HG22 ' A' ' 16' ' ' THR . 34.1 t -103.09 142.16 34.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 73.45 110.86 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' TRP . 39.2 m -139.79 49.58 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 52.44 110.869 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.547 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 40.9 t90 -35.98 138.8 0.43 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.521 0.676 . . . . 74.12 110.961 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.5 Cg_endo -69.76 -35.28 2.75 Favored 'Cis proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.671 -1.804 . . . . 72.32 112.383 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 m -68.71 -170.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 44.11 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.3 t -132.43 156.93 45.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 62.24 110.89 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.79 -102.27 0.35 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 61.15 112.533 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -148.29 163.07 38.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 65.31 110.845 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -85.27 -25.47 27.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.55 110.904 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -86.27 -62.86 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 72.52 110.911 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -82.34 -69.0 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 71.44 110.952 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.95 49.22 1.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.696 -0.764 . . . . 74.33 112.492 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 73.22 111.118 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.891 0.377 . . . . 45.34 110.91 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.07 38.56 1.66 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 60.13 112.49 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -138.61 -175.04 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 65.23 110.889 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.09 128.47 17.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 65.41 111.15 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.4 p -108.27 61.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 75.45 110.866 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.0 t -52.56 -28.56 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 41.22 111.138 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.08 -28.22 70.7 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.723 -0.751 . . . . 54.45 112.477 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.21 27.88 6.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.773 -0.727 . . . . 60.51 112.492 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 t -149.87 119.34 6.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 72.33 111.094 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.41 67.1 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 54.2 110.904 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -90.18 85.62 6.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.906 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.89 154.93 41.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.711 . . . . 64.15 111.167 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 87.66 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.699 2.266 . . . . 73.43 112.329 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.86 7.19 29.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 73.43 112.41 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 m -140.15 159.26 42.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 71.31 110.927 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -128.16 177.42 6.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 72.41 111.095 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.416 ' H ' HG22 ' A' ' 16' ' ' THR . 42.2 t -93.78 144.11 25.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 64.23 110.895 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 19' ' ' TRP . 74.7 m -144.26 53.78 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.4 110.904 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.551 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 54.2 t90 -36.46 138.67 0.47 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.53 0.681 . . . . 74.34 110.924 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.5 Cg_endo -69.8 -37.62 1.92 Allowed 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.696 -1.793 . . . . 74.53 112.351 0.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.9 m -67.11 -169.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 74.15 111.127 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.6 t -149.33 141.03 23.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 62.35 110.869 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.92 -101.43 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 32.44 112.485 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -135.38 -170.61 2.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 71.53 110.858 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -106.41 -31.91 8.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.87 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -82.79 -64.41 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 65.23 110.858 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -81.23 -69.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.4 110.957 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.35 26.54 6.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 52.23 112.51 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 72.44 111.079 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.857 0.361 . . . . 74.15 110.888 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.82 66.58 0.67 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 21.24 112.481 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -141.43 174.34 10.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.419 . . . . 74.22 110.83 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.0 140.43 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 71.44 111.16 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.73 17.54 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 73.45 110.893 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.8 t -49.12 -49.4 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 74.41 111.091 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.85 -25.79 66.26 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.739 -0.743 . . . . 64.33 112.485 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.63 22.06 19.8 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.759 -0.734 . . . . 71.11 112.505 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -149.26 91.41 1.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 72.31 111.106 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p -149.35 30.35 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 73.02 110.905 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -58.97 128.69 38.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 72.32 110.893 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.574 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -140.14 155.42 70.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.556 0.693 . . . . 72.43 111.149 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.2 Cg_endo -69.78 96.49 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 74.1 112.331 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.18 -1.19 29.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 45.44 112.512 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.6 m -127.06 143.84 51.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 75.42 110.891 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 p -114.83 134.51 55.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 55.11 111.16 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 t -60.0 136.42 58.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.911 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' TRP . 19.3 m -139.7 54.44 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 52.34 110.841 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.547 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 38.5 t90 -35.93 138.71 0.43 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.485 0.66 . . . . 73.43 110.945 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.79 -39.91 1.23 Allowed 'Cis proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.672 -1.803 . . . . 64.33 112.363 -0.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -63.7 -175.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.31 111.105 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.5 t -140.73 148.01 40.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 62.3 110.903 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.05 -75.81 0.37 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 51.5 112.482 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -151.87 -171.83 4.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 43.34 110.89 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -117.24 -33.67 4.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 72.11 110.858 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -80.31 -54.84 5.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.476 . . . . 71.44 110.85 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -88.47 -68.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.93 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.71 18.1 28.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.754 . . . . 73.15 112.484 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.901 0.381 . . . . 63.45 111.081 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 95.8 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.9 0.381 . . . . 73.11 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.04 44.26 5.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 54.02 112.489 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -148.41 175.82 10.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 74.4 110.876 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -143.85 125.12 14.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 75.34 111.17 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p -104.17 61.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 61.21 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -54.24 -26.4 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 54.4 111.158 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.76 -23.33 67.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 72.32 112.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.39 32.43 5.76 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 75.22 112.492 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -147.54 112.02 5.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 71.41 111.173 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 27.04 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 72.53 110.842 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -64.37 95.66 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.907 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.5 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -132.59 158.22 76.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.588 0.709 . . . . 75.11 111.1 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.5 Cg_endo -69.81 94.26 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.71 2.273 . . . . 61.52 112.349 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.18 3.9 38.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 61.41 112.546 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.9 m -134.3 133.23 40.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 71.32 110.881 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -117.0 128.83 55.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.14 111.142 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -56.53 141.76 41.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 70.42 110.881 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' TRP . 2.8 t -144.35 53.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 73.11 110.832 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.551 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 52.9 t90 -35.79 138.67 0.42 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.558 0.694 . . . . 64.42 110.912 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.1 Cg_endo -69.77 -37.96 1.8 Allowed 'Cis proline' 0 C--N 1.341 0.137 0 C-N-CA 122.713 -1.786 . . . . 73.31 112.315 -0.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 m -67.89 -169.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 44.52 111.149 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 t -151.58 140.9 21.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.844 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.08 -92.25 0.15 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 44.23 112.469 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -148.78 -170.34 3.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 63.22 110.859 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.04 -38.43 3.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 71.25 110.887 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.66 -57.08 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 71.24 110.875 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -84.68 -69.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 74.13 110.89 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.74 44.44 2.47 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.739 -0.743 . . . . 51.24 112.487 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 55.41 111.131 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.864 0.364 . . . . 73.21 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.97 30.17 23.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 51.5 112.501 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -126.4 -175.76 3.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 74.14 110.875 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.16 127.79 16.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 74.22 111.142 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.5 p -108.38 61.8 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 71.53 110.866 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -53.09 -27.54 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.1 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.96 -26.33 69.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.739 . . . . 71.12 112.509 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.33 31.38 5.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 73.21 112.488 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 t -149.84 114.97 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 74.03 111.137 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.68 50.03 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 61.43 110.924 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -81.43 88.35 6.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 71.53 110.862 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.49 157.93 39.98 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.558 0.694 . . . . 73.01 111.183 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 90.11 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.273 . . . . 70.42 112.303 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.38 6.33 33.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 64.41 112.495 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.86 153.4 45.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 73.32 110.919 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -125.37 172.9 9.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 42.35 111.133 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.66 145.32 24.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 72.23 110.902 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 19' ' ' TRP . 46.0 m -144.9 54.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 72.05 110.871 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.555 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 52.5 t90 -36.54 138.85 0.47 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.543 0.687 . . . . 63.42 110.935 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.555 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.69 -37.83 1.84 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.722 -1.783 . . . . 51.52 112.35 -0.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 m -67.05 -170.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.32 111.123 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.5 t -148.58 141.17 24.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 74.43 110.935 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.4 -97.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 44.33 112.487 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -148.73 -170.22 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 60.33 110.873 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.09 -40.38 3.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.88 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -50.89 22.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 72.44 110.856 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -92.63 -69.22 0.76 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 73.4 110.888 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.89 49.67 1.24 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 44.13 112.512 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 73.53 111.08 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 CA--C 1.526 0.038 0 CA-C-O 120.882 0.372 . . . . 75.11 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.9 43.8 95.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.742 . . . . 72.1 112.473 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -112.43 -168.96 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 72.33 110.923 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.498 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -143.85 132.56 22.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 75.04 111.088 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 p -130.98 62.57 1.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 54.12 110.9 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.3 t -54.28 -30.23 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 63.43 111.153 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.71 -17.78 72.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 52.31 112.492 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.0 16.62 40.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 64.23 112.52 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.59 99.08 7.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 75.32 111.157 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.79 29.89 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 64.21 110.895 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -76.38 88.06 3.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 74.23 110.897 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.556 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -114.37 154.63 46.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.537 0.684 . . . . 63.53 111.182 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.556 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.3 Cg_endo -69.77 84.53 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.701 2.267 . . . . 75.32 112.315 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.99 0.96 8.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 65.43 112.504 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.87 151.91 36.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 73.44 110.937 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -122.98 173.94 7.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.32 111.145 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.6 t -94.84 148.97 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 62.55 110.877 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 19' ' ' TRP . 4.7 t -144.93 53.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 70.03 110.867 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.559 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 44.3 t90 -33.77 138.35 0.29 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.54 0.686 . . . . 75.03 110.949 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.82 -40.44 1.11 Allowed 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 -1.809 . . . . 74.41 112.32 0.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' HA ' HG22 ' A' ' 4' ' ' THR . 14.9 m -66.99 -170.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 72.11 111.152 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.1 t -138.85 148.35 43.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.45 110.903 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.73 -95.66 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.752 . . . . 62.32 112.505 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -151.31 -171.04 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 63.31 110.878 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -102.91 -22.29 13.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.883 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -96.08 -66.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 75.42 110.86 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -95.44 -69.5 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 51.25 110.925 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.01 79.0 0.71 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.726 -0.75 . . . . 63.44 112.479 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 75.0 111.121 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.89 0.376 . . . . 75.24 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.24 44.51 96.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.775 -0.726 . . . . 30.42 112.494 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.19 -176.13 3.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 75.22 110.891 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -147.18 137.32 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 73.35 111.117 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.03 81.12 2.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 73.51 110.844 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.77 -18.48 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 71.53 111.127 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.16 0.23 38.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 74.23 112.444 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.5 38.99 43.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.777 -0.725 . . . . 75.12 112.487 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.86 84.05 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 61.11 111.146 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -136.18 67.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 41.1 110.902 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -90.93 88.3 6.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 72.02 110.893 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.595 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -121.68 151.15 56.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.604 0.716 . . . . 75.11 111.092 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.595 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.7 Cg_endo -69.75 91.76 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.641 2.227 . . . . 70.53 112.324 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.67 6.68 46.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 72.43 112.512 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 147.22 50.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.949 0.404 . . . . 74.44 110.915 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -121.24 179.69 4.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 61.11 111.146 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.1 t -103.35 155.37 18.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 42.15 110.88 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' TRP . 72.3 m -150.29 54.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 71.23 110.85 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.545 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 48.9 t90 -35.91 138.58 0.43 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.596 0.713 . . . . 75.44 110.891 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 54.3 Cg_endo -69.73 -37.86 1.83 Allowed 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.691 -1.795 . . . . 53.44 112.354 -0.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 m -67.88 -168.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 72.54 111.115 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -144.69 167.19 23.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 45.44 110.879 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.46 -100.43 0.54 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 61.43 112.488 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.19 -173.37 3.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 65.23 110.842 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -103.07 -22.08 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.919 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -98.44 -66.96 0.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 73.02 110.859 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -92.58 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.95 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.81 77.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 51.12 112.521 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 71.14 111.121 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.876 0.369 . . . . 52.32 110.85 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.8 57.06 2.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 72.11 112.436 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -142.02 -169.54 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.39 . . . . 60.44 110.852 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -143.55 133.62 24.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 74.43 111.125 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 p -131.31 61.0 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 72.53 110.906 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.8 t -53.65 -30.83 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 72.54 111.144 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.63 -22.5 74.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 53.1 112.515 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.07 21.27 18.48 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.794 -0.717 . . . . 72.34 112.482 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 9' ' ' THR . 1.8 t -125.68 103.82 8.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 73.21 111.156 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.1 34.35 0.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 53.42 110.892 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -78.73 86.04 4.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.934 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.16 158.78 33.44 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.636 0.732 . . . . 72.21 111.098 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 85.34 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.695 2.264 . . . . 61.11 112.357 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.36 4.94 15.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 51.23 112.489 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 m -144.38 157.19 44.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 70.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 p -129.7 170.17 14.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 72.1 111.134 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -91.72 148.5 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 62.12 110.865 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 19' ' ' TRP . 13.6 m -145.35 53.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.892 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.553 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 44.3 t90 -33.81 138.4 0.29 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.548 0.69 . . . . 74.32 110.924 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.75 -40.03 1.2 Allowed 'Cis proline' 0 C--O 1.232 0.199 0 C-N-CA 122.688 -1.797 . . . . 65.34 112.346 -0.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' HA ' HG22 ' A' ' 4' ' ' THR . 13.9 m -67.48 -170.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 74.41 111.154 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -141.13 144.99 35.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 60.4 110.904 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.89 -95.79 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 40.22 112.487 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -148.71 -169.31 3.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.845 0.355 . . . . 55.23 110.859 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -105.49 -27.75 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 70.12 110.865 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -96.33 -60.85 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 72.25 110.856 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -74.69 -68.86 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 75.44 110.908 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 38.47 6.05 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 54.33 112.436 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 74.44 111.095 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.882 0.372 . . . . 64.05 110.894 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.95 37.34 3.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 65.43 112.509 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -146.37 172.01 14.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.939 0.4 . . . . 71.45 110.903 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.6 124.39 25.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 72.45 111.109 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 1.202 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.9 m -90.27 51.72 2.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.5 110.833 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.1 t -45.78 -44.13 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.3 111.116 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.25 18.47 36.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 75.44 112.463 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.59 53.76 36.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.73 -0.747 . . . . 24.43 112.492 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 t -149.95 72.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 62.1 111.148 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 1.212 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 31.6 p -150.11 35.18 0.66 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 61.33 110.894 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -73.43 123.56 24.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.896 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.85 159.29 71.96 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.607 0.718 . . . . 63.3 111.143 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 82.64 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 71.32 112.311 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.21 2.16 8.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 55.42 112.527 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.97 158.29 44.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 63.43 110.868 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -122.74 178.38 5.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 65.54 111.176 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 1.212 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -99.98 151.08 21.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 50.03 110.882 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' TRP . 19.4 m -148.56 56.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 71.44 110.862 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.543 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 37.0 t90 -37.29 138.88 0.55 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.545 0.688 . . . . 74.54 110.878 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.74 -39.99 1.2 Allowed 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.706 -1.789 . . . . 70.24 112.341 -0.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.81 -170.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.132 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.822 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 20.0 t -139.59 154.01 47.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 72.22 110.867 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.85 -99.35 0.24 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.741 -0.742 . . . . 71.31 112.511 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -149.47 -169.75 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 75.42 110.872 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -101.74 -21.37 14.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 73.22 110.867 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -93.11 -74.75 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 73.03 110.85 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -69.27 -68.76 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.897 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.62 38.38 5.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 54.13 112.515 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 75.13 111.1 -179.929 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.896 0.379 . . . . 61.53 110.927 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.19 59.26 8.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 71.32 112.451 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -137.17 -173.03 3.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 74.42 110.901 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -143.57 128.24 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 61.12 111.143 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.4 p -124.57 53.47 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 64.41 110.884 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.4 m -52.69 -32.46 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 63.3 111.152 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.84 -25.13 74.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 70.34 112.503 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.53 40.58 3.15 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 75.53 112.496 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 1.8 t -148.83 103.02 3.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 73.43 111.197 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.18 33.69 0.66 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 54.45 110.924 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -80.1 84.29 5.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 70.45 110.912 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.31 158.23 35.86 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.581 0.705 . . . . 74.33 111.163 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 85.23 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 73.42 112.353 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.87 3.71 13.37 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 62.01 112.462 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.1 m -142.75 151.91 41.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 74.42 110.864 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 p -125.94 164.63 20.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 70.33 111.137 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.79 147.56 24.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.884 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 19' ' ' TRP . 16.0 m -145.26 53.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 62.25 110.835 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.557 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 41.5 t90 -34.24 138.32 0.32 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.542 0.686 . . . . 63.34 110.936 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.7 Cg_endo -69.73 -40.44 1.1 Allowed 'Cis proline' 0 C--N 1.342 0.199 0 C-N-CA 122.721 -1.783 . . . . 71.12 112.345 -0.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' HA ' HG22 ' A' ' 4' ' ' THR . 13.2 m -67.11 -170.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 71.44 111.144 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.1 t -144.95 142.88 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 63.42 110.897 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.35 -96.23 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.787 -0.72 . . . . 61.54 112.485 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -148.25 -171.4 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 73.53 110.875 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -105.22 -27.49 11.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 71.34 110.844 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -89.77 -70.03 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.887 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -73.18 -68.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.844 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.39 37.97 4.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 43.45 112.436 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 74.3 111.121 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.877 0.37 . . . . 63.3 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.08 45.95 2.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.727 -0.749 . . . . 64.53 112.491 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -139.18 -176.13 4.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 70.14 110.914 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.5 127.8 17.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 72.43 111.18 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 p -107.13 64.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 65.33 110.849 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.4 t -55.26 -25.79 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 72.52 111.152 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.82 -18.56 67.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 53.25 112.466 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.36 31.8 8.17 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.777 -0.725 . . . . 71.42 112.47 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 9' ' ' THR . 1.9 t -140.93 105.41 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 74.14 111.157 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 26.77 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 70.34 110.898 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -70.14 102.22 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 75.23 110.886 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.411 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -133.68 158.15 76.22 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.527 0.68 . . . . 70.42 111.149 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HD2' HG22 ' A' ' 12' ' ' THR . 53.9 Cg_endo -69.79 88.68 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.692 2.261 . . . . 73.13 112.319 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.45 2.33 19.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 72.41 112.479 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 146.19 30.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.387 . . . . 52.0 110.849 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 p -122.0 165.47 15.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 75.24 111.176 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.2 t -88.23 143.22 27.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 54.1 110.888 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' TRP . 5.1 t -142.1 53.04 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.35 110.818 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.549 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 47.1 t90 -35.97 138.74 0.43 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.538 0.685 . . . . 74.22 110.918 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.549 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.6 Cg_endo -69.73 -37.57 1.93 Allowed 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 -1.785 . . . . 73.45 112.337 -0.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.6 m -67.31 -170.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 73.23 111.132 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.0 t -149.73 140.78 22.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 72.12 110.894 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.22 -103.92 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.757 -0.735 . . . . 73.33 112.518 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -137.16 -172.32 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.82 0.343 . . . . 74.32 110.846 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -105.63 -25.99 12.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 63.23 110.881 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -57.51 3.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 74.51 110.89 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -101.51 -84.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.915 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.73 54.85 0.13 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 61.14 112.475 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 73.34 111.126 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.6 m . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.914 0.387 . . . . 64.4 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.05 37.52 25.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 71.13 112.49 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.7 -178.2 3.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 73.11 110.88 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.87 151.13 26.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 72.3 111.12 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 t -150.31 23.26 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 33.24 110.864 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.8 t -51.76 -39.56 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 75.24 111.1 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.53 20.85 47.66 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.78 -0.724 . . . . 72.13 112.485 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.27 19.31 39.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 15.15 112.484 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -113.11 80.39 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 71.44 111.101 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 t -150.21 59.65 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.913 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -90.43 122.76 33.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.11 110.881 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.641 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -146.63 149.51 37.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.595 0.712 . . . . 74.52 111.168 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.0 Cg_endo -69.73 96.49 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 73.34 112.359 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.62 4.55 36.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 72.34 112.461 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.8 t -128.49 144.49 51.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 72.3 110.907 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.48 177.78 4.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 73.51 111.131 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.8 t -101.98 143.83 31.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.876 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 19' ' ' TRP . 54.7 m -141.28 50.75 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.23 110.827 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.552 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 39.6 t90 -34.49 138.74 0.32 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.587 0.708 . . . . 75.3 110.934 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.552 ' C ' ' HA ' ' A' ' 19' ' ' TRP . 53.8 Cg_endo -69.79 -37.5 1.96 Allowed 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.707 -1.789 . . . . 63.41 112.353 -0.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -68.5 -170.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.134 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -135.45 157.04 47.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 74.0 110.861 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.01 -107.15 0.46 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 51.11 112.495 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -147.79 -171.64 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 54.22 110.861 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.44 -34.55 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.881 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -50.79 16.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 74.34 110.874 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -93.88 -69.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 72.34 110.931 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.08 37.01 2.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 74.02 112.503 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.37 . . . . 64.21 111.14 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.902 0.382 . . . . 54.5 110.854 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 128.82 -22.44 5.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 62.04 112.472 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -91.14 175.85 6.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 74.24 110.885 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.597 ' OG1' HG23 ' A' ' 6' ' ' VAL . 1.8 t -109.73 160.18 16.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 74.33 111.108 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.3 t -126.84 35.59 4.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 73.3 110.867 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.597 HG23 ' OG1' ' A' ' 4' ' ' THR . 60.0 t -46.91 -54.9 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.42 111.146 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.17 -25.02 65.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 63.03 112.495 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.9 26.05 18.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 55.14 112.52 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -147.75 97.89 2.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.354 . . . . 72.05 111.144 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.8 p -150.22 23.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 62.11 110.876 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -51.93 121.77 7.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.93 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.54 159.3 73.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.622 0.725 . . . . 65.21 111.124 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 80.4 0.89 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.712 2.275 . . . . 70.1 112.335 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.4 2.67 6.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 51.12 112.445 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.1 156.94 44.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 74.22 110.868 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -176.42 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.35 111.132 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.0 t -90.14 142.09 28.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.862 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 19' ' ' TRP . 15.2 m -141.35 51.89 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 65.04 110.838 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.57 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 34.4 t90 -34.53 138.99 0.32 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 75.3 110.921 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.57 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 54.4 Cg_endo -69.65 -39.88 1.23 Allowed 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.712 -1.787 . . . . 74.33 112.36 -0.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 m -69.45 -169.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 65.45 111.113 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.6 t -130.64 149.22 52.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.52 110.855 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.09 -109.23 0.45 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 64.14 112.508 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -142.44 -170.46 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 75.24 110.891 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -102.02 -34.52 9.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.893 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -55.61 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 63.34 110.896 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -87.72 -68.32 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 65.3 110.913 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 43.72 2.19 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 22.43 112.482 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.6 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 55.4 111.161 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.882 0.372 . . . . 61.55 110.869 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 121.26 23.65 2.61 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.808 -0.711 . . . . 73.24 112.508 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.3 -172.83 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.941 0.4 . . . . 51.24 110.883 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -144.31 127.6 16.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 63.55 111.176 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.3 p -108.33 63.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 75.35 110.845 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.7 t -54.82 -26.3 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 64.54 111.136 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.49 -19.75 65.63 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 71.2 112.518 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.2 30.46 7.8 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 64.02 112.556 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 9' ' ' THR . 2.2 t -139.63 107.18 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 65.2 111.132 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.54 37.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 72.42 110.876 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -73.81 75.59 1.61 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 72.14 110.866 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.561 HG22 ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -116.39 154.45 48.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.575 0.702 . . . . 53.03 111.14 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.561 ' HD2' HG22 ' A' ' 12' ' ' THR . 54.2 Cg_endo -69.75 90.4 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.676 2.25 . . . . 75.12 112.352 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.28 4.83 25.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 53.34 112.472 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 52.2 t -140.19 103.95 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 32.15 110.894 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.29 127.5 36.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 42.2 111.13 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.2 t -52.32 138.02 27.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.852 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 19' ' ' TRP . 15.1 m -144.01 53.5 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 71.31 110.869 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.553 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 53.2 t90 -34.1 138.61 0.3 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.589 0.709 . . . . 63.15 110.882 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.4 Cg_endo -69.78 -39.51 1.32 Allowed 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.673 -1.803 . . . . 61.53 112.314 -0.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.52 -168.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 61.41 111.132 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 21.1 t -150.86 139.2 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 43.34 110.874 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.75 -94.45 0.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 52.34 112.487 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -148.65 -170.3 3.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 74.22 110.863 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.39 -37.27 4.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 73.01 110.908 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -51.47 13.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 73.24 110.906 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -93.91 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 73.23 110.944 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.76 37.39 1.57 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 31.41 112.478 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 52.21 111.137 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.855 0.359 . . . . 71.34 110.904 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.64 21.04 73.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 61.4 112.504 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -117.92 -172.19 2.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.99 0.424 . . . . 74.51 110.844 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.09 130.09 17.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 43.1 111.15 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.5 p -110.64 59.88 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 63.22 110.86 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -51.28 -36.6 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 70.43 111.134 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.13 -29.11 74.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 73.12 112.547 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.42 37.01 3.16 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 65.42 112.482 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -149.96 109.8 4.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 63.01 111.159 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.0 28.12 0.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 73.32 110.912 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -72.1 81.33 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.874 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.07 158.84 31.56 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.593 0.711 . . . . 54.23 111.154 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 85.02 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.648 2.232 . . . . 40.34 112.352 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.15 3.9 12.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 65.35 112.458 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 154.76 43.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 74.23 110.888 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -127.57 157.07 41.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 62.34 111.139 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.7 t -78.71 145.07 34.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 72.42 110.876 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' TRP . 38.6 m -143.11 53.07 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 71.22 110.819 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.565 ' CG ' ' HA ' ' A' ' 20' ' ' PRO . 50.7 t90 -36.6 138.66 0.48 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.577 0.704 . . . . 75.44 110.892 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.565 ' HA ' ' CG ' ' A' ' 19' ' ' TRP . 53.9 Cg_endo -69.74 -37.39 1.99 Allowed 'Cis proline' 0 C--N 1.342 0.204 0 C-N-CA 122.667 -1.805 . . . . 65.45 112.345 -0.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 m -67.71 -168.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 75.43 111.099 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.2 t -149.45 140.91 23.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 52.45 110.911 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.0 -92.4 0.14 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 62.22 112.486 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -150.78 -171.05 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.326 . . . . 75.52 110.891 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -113.63 -38.04 4.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 72.15 110.889 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -58.05 3.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 73.22 110.866 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -87.12 -69.3 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 63.34 110.922 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.17 57.7 0.95 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 53.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 71.51 111.14 -179.962 . . . . . . . . 0 0 . 1 stop_ save_